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Abstract: Over the course of their lifetime, about 25% of the U.S. population will 
meet criteria for one or more of the anxiety-related disorders, all of which are 
characterized by pathological fear responding. Researchers have made significant strides 
in improving treatment efficacy through the development of cognitive-behavioral models 
for understanding the acquisition and treatment of pathological fear. Although cognitive-
behavioral treatments produce marked reductions in pathological fear on average, a 
subgroup of patients do not respond to treatment. In an effort to improve the prevention 
and treatment of pathological fear, this dissertation synthesizes data from a series of 
studies aimed to (a) improve our understanding of factors that contribute to the 
development of pathological fear in a real-world setting (Study 1), (b) examine factors 
that influence response to exposure therapy, a technique used across gold-standard 
treatments pathological fear (Study 2), and (c) investigate novel strategies that could be 
added to exposure therapy to further improve treatment response (Study 3). Specifically, 
Study 1 demonstrates the contribution of cognitive appraisal (i.e., threat perception) to 
the onset of pathological fear in response to stressors encountered in a real-world, high-
stress environment (warzone deployment). Study 2 is a meta-analysis exploring the 
influence of unnecessary protective actions, or safety behaviors (SBs), on outcomes of 
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exposure therapy. Data demonstrate that removing SBs during exposure therapy 
improves treatment outcomes, whereas adding SBs during exposure therapy produces 
inferior outcomes under certain conditions, such as when treating specific phobia 
symptoms. Finally, Study 3 is a randomized clinical trial investigating the use of two 
behavioral strategies, alone and in combination, to enhance exposure therapy outcomes: 
(1) a brief pre-exposure fear memory reactivation trial (PE-FMR) and (2) deepened 
extinction. Results suggest that neither PE-FMR nor deepened extinction improve 
outcomes at post-treatment or one-week follow-up. However, PE-FMR augmentation 
produced more rapid fear reduction during treatment, and equivalent outcomes even 
when the duration of exposure therapy (tailored to speed of fear reduction) was shorted 
by 21% on average. Together, these lines of research contribute to our understanding of 
cognitive and behavioral influences on the development and treatment of pathological 
fear.  
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GENERAL INTRODUCTION 
At some point in their lifetime, about one in four people in the U.S. will meet 
criteria for an anxiety-related disorder (Kessler et al., 2005). These disorders are 
associated with a host of consequences, including reduced quality of life (Mendlowicz & 
Stein, 2000), and work impairment (Greenberg et al., 1999), as well as increased risk for 
physical disorders and disability (Sareen, Cox, Clara, & Asmundson, 2005), substance 
use disorders (Grant et al., 2004), depression (Wittchen, Kessler, Pfister, Höfler, & Lieb, 
2000), and suicidal ideation and attempts (Sareen et al., 2005). The economic burden of 
anxiety disorders is also substantial, with direct and indirect costs estimated at more than 
42 billion dollars per year in the U.S. alone (Greenberg et al., 1999).  
Due to the heavy cost and consequences of anxiety disorders, decades of research 
have focused on developing models for understanding their onset and maintenance, with 
the aim of boosting treatment efficacy. Though anxiety disorders span a wide variety of 
clinical presentations, they share the common element of a persistent and pathological 
fear response. For this reason, the models and treatments for anxiety disorders have more 
similarities than differences. In support of this idea, researchers have succeeded in 
developing several trans-diagnostic treatments for anxiety disorders that target their 
common maintaining factors (Barlow et al., 2010; Schmidt et al., 2012). Similarly, recent 
recommendations put forth by the National Institutes of Health suggest that researchers 
focus on common domains across diagnostic categories, such as the domains of potential 
and active threat (anxiety/fear), rather than studying particular diagnostic categories 
(Morris & Cuthbert, 2012). In line with these recommendations, the synthesis of research 
in this dissertation will focus on a trans-diagnostic view of pathological fear.  
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The projects in this dissertation will build upon prior research in the development 
of cognitive behavioral and neurobiological models for understanding the onset and 
treatment of pathological fear. Specifically, study 1 is an investigation of the role of 
cognitive appraisal (i.e., perceived threat) in the onset of pathological fear in response to 
environmental stressors. Study 2 will use meta-analytic methods to investigate the impact 
of safety behaviors (i.e., unnecessary protective actions), on the reduction of pathological 
fear during psychotherapy. Finally, study 3 is an investigation of two behavioral 
strategies for enhancing exposure-based treatments of pathological fear: (1) fear memory 
reactivation, developed from the neurobiological model of fear reduction via 
reconsolidation update mechanisms; and (2) deepened extinction, based on the model of 
fear reduction via prediction error. Together, these lines of research contribute to the 
further development of cognitive behavioral models for the acquisition and treatment of 
pathological fear. Before describing these studies in more detail, this chapter will set the 
backdrop by briefly summarizing relevant models for the onset and treatment of 
pathological fear, discussing the current status of psychotherapy for pathological fear, 
and reviewing prior research on treatment augmentation.  
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Models of Fear Acquisition and Extinction 
BEHAVIORAL MODELS 
Fear Conditioning and Extinction 
Pavlov (1927) developed one of the earliest behavioral models of fear acquisition 
with his description of classical conditioning. Applying the model of classical 
conditioning to fear specifically, the model suggests that fear can be acquired by the 
repeated pairing of a neutral stimulus with an aversive stimulus, until the neutral stimulus 
develops a conditioned association with the aversive stimulus, such that it begins to 
independently produce an aversive response. Watson and Rayner (1920) demonstrated 
this process of fear acquisition in their “little Albert” experiment. Young Albert first 
expressed interest in a white rat, but after repeated pairings of the white rat (neutral 
stimulus) with a loud and unpleasant noise (unconditioned stimulus), Albert eventually 
displayed fear (conditioned response) when presented with the white rat (conditioned 
stimulus). This classical conditioning model represents one of the earliest explanations of 
fear acquisition. Operant conditioning (Skinner, 1938) helped to explain its maintenance.  
Operant conditioning suggests that behavioral responses that are paired with 
reinforcement or reward will increase over time, whereas responses that are not 
reinforced or are punished will decrease over time. Mowrer’s two factor learning theory 
(1960) applied operant conditioning to the maintenance of fear responding. Specifically, 
the theory describes how avoidance or escape from a feared stimulus is negatively 
reinforced by a reduction in fear. Furthermore, avoidance and escape from the feared 
stimulus then perpetuates its association with threat because escape and avoidance 
prevent the possibility of new experiences that could extinguish the fear response.  
From these behavioral models of fear acquisition and maintenance, it logically 
follows that repeated exposure to the feared stimulus in the absence of the feared 
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consequence extinguishes the fear response. In other words, after repeated presentations 
of the conditioned stimulus (CS) in the absence of the unconditioned stimulus (UCS), the 
CS eventually ceases to produce the conditioned response (CR). This behavioral 
procedure is referred to as fear extinction in the animal literature, and as exposure therapy 
in the psychotherapy literature.  
Counter-conditioning and Reciprocal Inhibition 
Mary Cover Jones (1924) was among the first to document the use of exposure 
therapy to treat pathological fear. Before therapy, her participant, young Peter, had a 
strong fear response to a white rabbit. After repeated, non-threatening encounters with the 
rabbit, Peter’s fear of the rabbit eventually extinguished, and he displayed marked 
progress in his ability to approach the rabbit. This describes a classic extinction procedure 
used to reduce fear responding. During the second stage of treatment, Jones elaborated on 
the procedure by pairing the presentation of the rabbit with food Peter likes (candy), with 
the idea that this would condition a new, positive association with the rabbit. This 
process, pairing the stimulus with a new unconditioned stimulus to produce a new 
conditioned response, is called counter-conditioning.  
Wolpe (1954; 1968) took the theory of counter-conditioning a step further with 
his idea of reciprocal inhibition. Reciprocal inhibition was inspired by the law of 
reciprocal innervation, demonstrating that smooth limb movement occurs because flexing 
one muscle produces automatic relaxation of the opposing muscle (Ciuffreda & Stark, 
1975). Wolpe (1968) analogously suggested treating pathological fear by pairing the 
presentation of the feared stimulus with relaxation, a physiological state inhibitory to the 
fear response. He developed a treatment procedure based on this technique called 
systematic desensitization. Patients first mastered self-induced relaxation through several 
sessions of training in progressive muscle relaxation. They then were instructed to 
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imagine confronting the feared stimulus (a process called imaginal exposure), very 
gradually increasing the difficulty of the imagined situations while maintaining a 
physiological state of relaxation. Whenever their anxiety increased, patients were 
instructed to pause imaginal exposure to regain a physiological state of relaxation. 
Although systematic desensitization was among the first empirically supported treatments 
for anxiety, it fell out of favor as soon as researchers demonstrated that patients have 
equal or superior responses to exposure therapy in the absence of relaxation training and 
graduated stimulus presentation procedures (Boulougouris, Marks & Marset, 1971; 
Emmelkamp, 1974; Keane, Fairbank, Caddell, & Zimering, 1989).  
Problems with Behavioral Models 
Although basic conditioning models of fear acquisition and extinction dominated 
the field for several decades, researchers began to uncover several phenomena that could 
not be accounted for by conditioning models. For example, studies demonstrated that 
many cases of phobia are not preceded by a traumatic/conditioning event (Öst, 1991; 
Poulton, Davies, Menzies, Langley, & Silva, 1998), and that certain phobias are more 
easily conditioned and extinguished in the laboratory than others (Mineka & Ohman, 
2002). Furthermore, evidence suggests that the acquisition and extinction of fear can be 
facilitated through social learning. For example, acquisition can be facilitated by 
watching another individual have a fearful response to the stimulus (Rachman, 1977), and 
extinction can be facilitated by watching another individual model successfully coping 
with the feared stimulus (Askew & Field, 2007; Dunne & Askew, 2013). Additionally the 
basic conditioning theories cannot explain why many individuals experience traumatic 
events without developing conditioned fear responses (Rachman, 1977). Cognitive-
behavioral models of fear acquisition and extinction were developed to account for the 
shortcomings of strictly behavioral, conditioning models.  
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COGNITIVE-BEHAVIORAL MODELS 
Cognitive-behavioral models extend beyond behavioral models. These theories 
primarily emphasize that it is not just exposure to particular situations, but the perception 
and cognitive processing of those situations, that determines behavioral and emotional 
responses (Bandura, Adams, & Beyer, 1977; Clark & Beck, 2011; Clark & Wells, 1995; 
Ehlers & Clark, 2000). A number of theories describing the acquisition and treatment of 
pathological fear fall under the umbrella of cognitive-behavioral models.  
Emotional processing theory (EPT) is a well-known cognitive-behavioral theory 
of fear reduction. EPT is based on the foundation of Lang’s bioinformational theory and 
Rachman’s (1980) proposal of the construct of emotional processing, but Foa and 
Kozak’s (1986) elaboration of the theory is perhaps the version that is the most frequently 
cited. Foa and Kozak (1986) defined emotional processing as “the modification of 
memory structures that underlie emotions” (p. 20). They broke fear memory structures 
into three components: (1) characteristics of the feared stimulus; (2) responses to the 
feared stimulus (verbal, physiological, and behavioral responses); and (3) interpretive 
meaning of the stimulus and responses. They described two key elements of treatments 
that modify pathological fear structures: (1) initial activation of the fear structure during 
treatment, and (2) confrontation with, and incorporation of, information incompatible 
with the fear structure. Finally, they proposed three signs that emotional processing is 
occurring (1) initial fear activation, (2) within-session habituation, and (3) between-
session habituation.  
A more recent update to emotional processing theory incorporated newer 
findings, such as data demonstrating a lack of correlation between within-session 
habituation and treatment outcomes (Foa, Huppert, & Cahill, 2006). Authors suggest that 
the most critical component of the theory is confrontation with threat-disconfirming 
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information, and conclude that within-session habituation, therefore, should only provide 
threat disconfirmation for individuals who have a belief that their anxiety will continue 
indefinitely unless they escape from the feared situation. The critical role of attention to, 
and interpretation of, threat in emotional processing theory highlights its key cognitive 
component.    
Expectancy theory also falls under this cognitive-behavioral umbrella (Reiss, 
Peterson, Gursky, & McNally, 1986). This theory suggests that fear response can be 
predicted by probability of harm (danger) added to the product of the probability of 
experiencing anxiety with anxiety sensitivity (i.e., dispositional tendency to respond 
fearfully to fear itself). Note that this model highlights the critical role of the cognitive 
predisposing factor of anxiety sensitivity in predicting fear response. On the basis of this 
model, Reiss and McNally suggest that fear should decrease when (1) the expectancy of 
harm decreases, and (2) when the expectancy of anxiety decreases for individuals with 
anxiety sensitivity. Later models elaborated further on this theory, adding elements such 
as social evaluation expectancy and rejection sensitivity (Reiss, 1991); for individuals 
with social evaluation sensitivity, fear should decrease when their expectancy of social 
evaluation decreases. Similar to EPT, this model also emphasizes the important role of 
the cognitive appraisal of experiences, such as anxiety and social evaluation, in governing 
the onset and attenuation of fear.   
Bandura’s famous self-efficacy theory would also fall under the umbrella of 
cognitive-behavioral models, in that he describes the role of perceiving an inability to 
cope with a given situation in governing fear acquisition, and the role of increased 
perception of mastery or ability to cope with a particular situation in facilitating fear 
reduction (Bandura, 1988). Bandura posits that changes in self-efficacy can occur by 
acquiring new information from four different sources: (1) performance 
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accomplishments, including direct experiences such as those that occur in exposure 
therapy, (2) vicarious experiences, such as witnessing another person interact with the 
feared stimulus, (3) verbal persuasion, such as being persuaded that one has the skills 
necessary to cope with the feared situation, and (4) emotional arousal, such as 
interpreting lower physiological arousal in the presence of the feared stimulus as an 
indicator of increased coping ability (Bandura, 1977). The concept of self-efficacy 
extends beyond beliefs about the ability to cope with a situation behaviorally, and 
includes beliefs about the ability to cope with thoughts and feelings while in a fear-
provoking situation (Valentiner, Telch, Petruzi, & Bolte, 1996). The central role of 
perceived coping ability is the putative mediator of fear onset and attenuation in this 
model.  
NEUROBIOLOGICAL MODELS  
Although he did not propose a neurobiological model, Pavlov (1927) was one of 
the first to propose that, rather than unlearning a fear during extinction training, a new 
memory is created that inhibits the fear response. Evidence for the persistence of the 
original fear memory after extinction has emerged over time, as researchers gathered data 
demonstrating that fear can return after extinction under a variety of conditions, such as 
after the passage of time (spontaneous recovery of fear), after a change in context (fear 
renewal), and after re-exposure to the unconditioned stimulus (reinstatement; Bouton, 
2002).  
The original fear memory is labile, and susceptible to disruption or updating 
during a 6-hour window of time while its biological structure is solidifying, or 
consolidating (Schafe & LeDoux, 2000). Similarly, researchers have found that when a 
fear memory is primed by a brief confrontation with the feared stimulus, the memory 
structure re-enters a 6-hour labile window and requires additional protein synthesis to 
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persist. During this time, the original fear memory trace is susceptible to disruption or 
updating (Monfils, Cowansage, Klann, & LeDoux, 2009; Nader, Schafe, & Le Doux, 
2000). If new information about the feared stimulus is encountered during this period of 
memory lability, the information overwrites or updates the original fear memory. This 
process is called the “reconsolidation update” mechanism. It will be reviewed in further 
detail in study 3, which will use a brief fear memory reactivation trial before exposure 
therapy in an effort to trigger reconsolidation update rather than inhibitory learning. 
Overall, it is important to note that new inhibitory learning and reconsolidation update are 
the primary putative mechanisms in contemporary neurobiological models of fear 
attenuation during extinction training.  
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Psychotherapy for Pathological Fear and Anxiety: Current Status 
Despite extensive research on models of the onset, maintenance, and treatment of 
anxiety, many people with anxiety disorders do not receive treatment. For example, in a 
study of primary care patients in the U.S., more than 40% of people with anxiety 
disorders reported no current treatment (Kroenke, Spitzer, Williams, Monahan, & Lo ̈we, 
2007). Due to sampling from a healthcare setting in a first-world country, this study 
likely overestimates treatment seeking in comparison with the world population. In line 
with this idea, an international study found that more than 55% of people worldwide with 
panic disorder, generalized, anxiety disorder, or OCD, do not receive treatment (Kohn, 
Saxena, Levav, & Saraceno, 2004). Other findings have been even more pessimistic, 
suggesting that less than 30% of individuals with anxiety disorders seek treatment (Leon, 
Portera, & Weissman, 1995). Though the exact statistic differs across studies, these data 
provide a clear picture of the substantial gap between the need for, and use of, mental 
health services among individuals with anxiety disorders.  
Across the variety of psychotherapeutic approaches for anxiety treatment, 
cognitive-behavioral therapy has emerged as the modality with the strongest empirical 
support, with meta-analyses demonstrating medium to large effect sizes across anxiety 
disorders (Butler, Chapman, Forman, & Beck, 2006; Hofmann & Smits, 2008; Norton & 
Price, 2007). However, a substantial number of patients do not respond to treatment. An 
examination of a sample of randomized controlled trials (RCTs) suggests that 
approximately 15 to 35% of patients who receive gold-standard treatments for anxiety 
disorders do not respond to treatment (see Table 1 for example studies).  
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Table 1: Response and remission rates after gold-standard psychotherapy in a sample 
of randomized controlled trials across anxiety disorders. 
 
This statistic is likely even an overestimation of the response rate to CBT in the 
community, since RCTs provide therapists with access to training and supervision 
resources well beyond those typically available in community settings. This problem has 
spurred decades of research in an effort to improve the available interventions for anxiety 
disorders.  
Citation Disorder Treatment % Responders 
Telch et al., 1993 Panic 
Disorder 
Group Panic 
Inoculation 
Training  
37% did not meet criteria for 
recovery at 6-month follow-up 
Ladouceur et al., 
2000 
Generalized 
Anxiety 
Disorder 
Cognitive 
Behavioral 
Treatment 
23% still met diagnostic 
criteria for GAD at 6 and 12-
month follow up 
Foa, Liebowitz et 
al., 2005 
  
Obsessive-
Compulsive 
Disorder 
Exposure and 
Response 
Prevention  
14% of treatment completers 
were classified as non-
responders 
Clark et al., 2006 Social 
Anxiety 
Disorder 
Cognitive 
Therapy 
16% still met diagnostic 
criteria at post-treatment 
Foa et al., 1999 Posttraumatic 
Stress 
Disorder 
Prolonged 
Exposure  
35% of treatment completers 
still met diagnostic criteria at 
1-year follow-up 
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Improving Intervention: Exposure Therapy Augmentation Research 
Across the various cognitive-behavioral treatment packages for anxiety disorders, 
exposure therapy is among the most potent and commonly used treatment techniques. 
Many researchers, therefore, have sought to identify methods to enhance exposure 
therapy, using both pharmacological and non-pharmacological techniques.  
PHARMACOLOGICAL AUGMENTATIONS 
Pharmacological augmentation of exposure therapy can be thought of as falling 
into two categories: anxiolytic pharmacotherapy, and cognitive-enhancing 
pharmacotherapy. The use of anxiolytic pharmacotherapy as an augmentation strategy for 
exposure-based treatments has a long history of disappointing outcomes (see Telch, 
Tearnan, & Taylor, 1983). A systematic review of the literature revealed little to no 
benefit of adding medication to gold-standard treatments for anxiety (Otto, McHugh, & 
Kantak, 2010). In fact, some findings suggest that combining CBT with anxiolytic 
medications can even lead to more relapse in the long-run than CBT alone (Otto et al., 
2010).  
In contrast, experimenters have produced promising findings for a number of 
cognitive enhancers, such as D-Cycloserine (DCS; Norberg, Krystal, & Tolin, 2008), 
yohimbine (Holmes & Quirk, 2010; Powers, Smits, Otto, Sanders, & Emmelkamp, 
2009), glucocorticoids (Soravia et al., 2006) and Methylene Blue (Telch, Bruchey, 
Rosenfield, Cobb, & Smits, 2014). However, evidence suggests that the benefits of DCS 
attenuate across sessions, leading researchers to propose that its main benefit is in 
improving the speed of fear reduction during treatment (Norberg et al., 2008). 
Furthermore, many patients are reluctant to use medications. For instance, a recent survey 
of anxiety patients identified a strong preference for cognitive-behavioral over 
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pharmacological treatment methods (Deacon & Abramowitz, 2005). Non-
pharmacological strategies also would be more readily available to a wider array of 
mental health settings and could even be translated into self-directed treatment, thus 
providing a more cost-efficient solution to treatment augmentation.   
NON-PHARMACOLOGICAL AUGMENTATIONS 
Many researchers have explored non-pharmacological strategies to boost the 
efficacy of exposure therapy. Some of these strategies simply manipulate the parameters 
by which exposure therapy is implemented, such as massing versus spacing exposure 
therapy sessions (Foa, Jameson, Turner, & Payne, 1980), presenting feared stimuli in a 
graduated or non-graduated manner (Everaerd, Rijken, & Emmelkamp, 1973), using 
imaginal or in vivo presentation of feared stimuli (Emmelkamp & Wessels, 1975), 
conducting treatment in individual or group settings (O'Connor et al., 2005), or providing 
exposure therapy with or without the therapist present (Gloster et al., 2011). There 
appears to be relatively strong evidence for the advantage of therapist-directed over self-
directed exposure, and in vivo exposure over imaginal exposure; although findings are 
generally more mixed for the manipulation of other parameters (see Telch, Cobb, & 
Lancaster, 2014 for a review).  
Another line of research has focused on the augmentation of exposure therapy 
through the addition of cognitive or behavioral strategies. For example, relaxation 
training in the form of “breathing retraining” has been added to multi-component 
cognitive-behavioral treatment manuals for anxiety (Barlow & Craske, 2006; Foa, 
Hembree, & Rothbaum, 2007). An earlier incarnation of exposure therapy called 
systematic desensitization also combined relaxation (in the form of progressive muscle 
relaxation) with exposure therapy (Wolpe, 1958). In both instances, researchers have 
demonstrated that adding relaxation training to exposure therapy does not improve 
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outcomes (Boulougouris, Marks, & Marset, 1971; de Ruiter, Ryken, Garssen, & 
Kraaimaat, 1989; Deacon et al., 2012; Schmidt et al., 2000).  
Other exposure augmentation strategies have been more successful. For instance, 
several studies have demonstrated that exposure therapy is more effective when therapists 
incorporate modeling effective strategies for coping with anxiety (Bandura, Blanchard, & 
Ritter, 1969; Blanchard, 1970; Denney, Sullivan, & Thiry, 1977). Although in need of 
replication, there are also promising preliminary findings for augmentation strategies 
such as providing physiological feedback during treatment as evidence of fear reduction 
(Telch, Valentiner, Ilai, Petruzzi, & Hehmsoth, 2000), and using antagonistic actions 
during exposure therapy (i.e., actions opposite to anxiety-related action tendencies; 
Wolitzky & Telch, 2009). Findings have been more mixed for other augmentation 
strategies. For example, some research suggests that the addition of cognitive therapy 
strategies enhances the efficacy of exposure therapy (Bryant et al., 2008; Kamphuis & 
Telch, 2000; Taylor, 1996), whereas other studies suggest that exposure therapy works 
equally well with or without cognitive therapy techniques (Feske & Chambless, 1995; 
Foa, Hembree, et al., 2005).  
Similarly, the findings in regard to safety behavior use during exposure therapy 
have also been mixed. Safety behaviors can be defined as, “unnecessary actions taken to 
prevent, escape from, or reduce the severity of a perceived threat” (Telch & Lancaster, 
2012, p. 315). Some randomized controlled trials have demonstrated that allowing the 
patients to use safety behaviors during exposure therapy detracts from its efficacy 
(Powers, Smits, & Telch, 2004; Sloan & Telch, 2002). However, other studies have 
found no differences between groups, leading some researchers to the conclusion that 
safety behavior use does not impact treatment efficacy (Deacon, Sy, Lickel, & Nelson, 
2010). Others even suggest that safety behavior use might be beneficial in some ways, 
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such as making exposure therapy more acceptable to patients (Milosevic & Radomsky, 
2013). However, a qualitative review of exposure therapy studies with and without fading 
of safety behaviors suggests that this form of safety behavior manipulation produces 
more consistent treatment benefits (Telch & Lancaster, 2012). Although the search for 
exposure therapy augmentation strategies has been ongoing for the last several decades, 
relatively few strategies (such as incorporating therapist assistance and modeling during 
exposure) have emerged as consistently beneficial.  
  16 
Overview of Dissertation Studies 
This dissertation includes three studies that collectively aim to expand upon prior 
research related to cognitive behavioral models for the acquisition and treatment of 
pathological fear. Each study uses a different methodology to address this over-arching 
goal. Study 1 uses observational methods to investigate the role of threat perception in 
the onset of anxiety and related disorders, in an effort to provide clarification about the 
mechanisms of the development of pathological anxiety, and to identify early markers of 
psychopathology to assist in targeting at-risk populations. Study 2 employs meta-analysis 
to examine the impact of safety behavior use and fading on the treatment of pathological 
fear in the context of exposure therapy. Finally, study 3 is a randomized controlled trial 
investigating two behavioral strategies for enhancing the efficacy and efficiency of 
exposure therapy: fear memory reactivation, predicated on the neurobiological 
mechanism of reconsolidation update; and deepened extinction, predicated the 
mechanism of prediction error.  
STUDY 1: IS WARZONE THREAT PERCEPTION ASSOCIATED WITH ONSET OF STRESS-
RELATED PATHOLOGY FOR SOLDIERS DURING DEPLOYMENT?  
Cognitive-behavioral models of stress (Lazarus & Folkman, 1984), emotional 
disorders (Beck, 1979; Clark & Beck, 2011), and general psychological functioning 
(Bandura, 1986; 1988) suggest that cognitive appraisal plays a central role in the human 
stress response. In line with this idea, prior studies have found that threat perception 
correlates with the onset of PTSD (Ozer, Best, Lipsey, & Weiss, 2003). However, a 
significant weakness of prior research in this area is the use of retrospective measures of 
threat perception, particularly because the onset of posttraumatic symptoms increases the 
retrospective recall of threat perceived during the traumatic event (Southwick & Morgan, 
1997). This study reports on the use a novel, web-based strategy to collect data in the 
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deployed setting to assess the association of threat perception with the early onset of 
PTSD symptoms (and concurrent symptoms of depression) in the deployed setting. The 
identification of early risk factors such as threat perception plays a key role in targeting 
at-risk groups for preventive interventions in active duty military personnel, a population 
with a significant gap between the need for, and use of, mental health services (Hoge et 
al., 2004; Tanielian & Jaycox, 2009). Furthermore, this research provides an additional 
step toward establishing the causal role of threat appraisal in the onset of PTSD.    
STUDY 2: DOES SAFETY BEHAVIOR USE IMPACT THE EFFICACY OF EXPOSURE THERAPY? 
Study 2 will build upon prior research investigating the impact of safety behavior 
use on the efficacy of exposure therapy. Researchers have produced mixed findings with 
regard to the impact of safety behaviors on exposure therapy, and the issue of whether 
safety behaviors detract from exposure therapy has become a controversial one in the 
field (e.g., Rachman, Radomsky, & Shafran, 2008; Parrish, Radomsky, & Dugas, 2008). 
However, a careful qualitative examination of the evidence to date highlights a number of 
differences in the way experimenters manipulate safety behaviors, which may in turn 
impact study findings. For instance, a qualitative review suggests that the impact of 
fading naturally occurring safety behaviors during exposure therapy consistently 
produces superior treatment outcomes; however, the influence of investigator-initiated 
safety behavior use during exposure therapy appears to be much less consistent, with 
some studies showing no influence and others showing an impendence in fear reduction 
(Telch & Lancaster, 2012). It is also possible that procedural variations may govern the 
influence of safety behavior use on treatment outcome, specifically, whether safety 
behaviors are faded as treatment progresses, or whether they are maintained throughout 
treatment. Cognitive theories (Salkovskis, 1991) would suggest that maintained safety 
behaviors would be more detrimental to fear attenuation because the experience of safety 
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would be misattributed to the safety behavior across all trials, effectively blocking any 
experience of threat disconfirmation.  
Although there have been a number of excellent qualitative reviews of safety 
behavior use during exposure therapy (Helbig-Lang et al., 2014; Rachman, Radomsky, & 
Shafran, 2008), there has been only one quantitative, meta-analytic review to date 
(Meulders, Daela, Volders, & Vlaeyen, 2016). The findings were unfortunately 
“inconclusive... and could not provide strong evidence supporting either the removal or 
addition of [safety behaviors] during exposure-based treatment” (p. 151).  Notably, there 
was a moderate to high degree of variance in the effect sizes across studies, suggesting 
that the strength of effect sizes may depend on certain variables, such as the type of 
assessment used, the sample of patients, and the procedures by which safety behaviors 
were manipulated (e.g., selection of investigator initiated versus naturally occurring 
safety behaviors). Therefore, in addition to examining the overall influence of adding and 
removing safety behaviors on exposure therapy, study 2 will also use meta-analysis to 
examine potential moderators of effect size, to explore the conditions under which safety 
behaviors influence treatment outcomes.  
STUDY 3: DO FEAR MEMORY REACTIVATION AND DEEPENED EXTINCTION ENHANCE 
EXPOSURE THERAPY?  
Study 3 will test novel treatment augmentation strategies informed by basic 
science on the mechanisms of fear extinction. Specifically, recent behavioral 
neuroscience studies on fear conditioning and extinction studies have revealed two 
behavioral techniques that seem to enhance fear attenuation: pre-exposure fear memory 
reactivation (PE-FMR; Monfils et al., 2009) and deepened extinction (Rescorla, 2006). 
Data suggest that PE-FMR enhances fear reduction by promoting the reconsolidation 
update mechanism (Monfils et al., 2009), whereas deepened extinction enhances fear 
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reduction through the error correction mechanism (Leung & Westbrook, 2008). Study 3 
will test the independent and combined effects of FPE-MR and deepened extinction on 
the efficacy of one-session exposure therapy for fear of snakes and spiders.  
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STUDY 1 - THE ROLE OF PERCEIVED THREAT IN THE 
EMERGENCE OF PTSD AND DEPRESSION SYMPTOMS DURING 
WARZONE DEPLOYMENT1 
Combat-exposed military personnel are four to five times more likely to develop 
posttraumatic stress disorder (PTSD) relative to those deployed but not exposed (Smith et 
al., 2008), yet less than 10% develop PTSD symptoms, and fewer meet diagnostic criteria 
for PTSD (LeardMann et al., 2009). The heterogeneity of warzone-stress reactions (e.g., 
Dickstein, Suvak, Litz, & Adler, 2010) underscores the importance of identifying factors 
beyond combat exposure alone that increase risk for experiencing psychological 
symptoms as a reaction to deployment stress. 
It has been well established that appraisal of threat plays a central role in general 
psychological functioning (Bandura, 1988), stress reactions (Lazarus & Folkman, 1984), 
and the onset and maintenance of emotional disorders (e.g., Beck et al., 1979). From a 
theoretical perspective, the impact of a stressor hinges on the individual’s appraisal of the 
demands of the stress relative to their capacity to cope; this cognitive appraisal dictates 
the response to the event (Lazarus & Folkman, 1984). The perception of threat occurs 
when the demands of the situation are perceived as exceeding one’s capacity to cope. In 
the short-run, perceived threat can result in activation of the hypothalamic pituitary 
adrenocortical (HPA) axis, leading to physiologically adaptive compensations such as 
increased adrenaline to boost one’s strength for fleeing or fighting. However, more 
persistent perception of threat (i.e., chronic stress) is associated with dysregulation of the 
HPA axis and the onset of illness and psychopathology (Miller, Chen, & Zhou, 2007). 
                                                
1 Study published in peer-reviewed journal. Citation: Lancaster, C. L., Cobb, A. R., Lee, 
H. J., & Telch, M. J. (2016). The role of perceived threat in the emergence of PTSD and 
depression symptoms during warzone deployment. Psychological Trauma: Theory, 
Research, Practice, and Policy, 8(4), 528-534. 
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For instance, prior studies have associated threat perception with depression (Beck et al, 
1979), panic and agoraphobia (Clark, 1986; Telch, Brouillard, Telch, Agras, & Taylor, 
1989), and PTSD (Ehlers & Clark, 2000).  
Perceived threat of warzone experiences has been defined as  “fear for one’s 
safety and well-being in the warzone” (L. A. King, King, Vogt, Knight, & Samper, 2006, 
pg. 98) and is conceptually distinct from the endorsement of warzone stressors. Whereas 
the measurement of warzone stress refers to frequency of stressors encountered in the 
warzone, such as endorsing “receiving hostile incoming fire” or “being wounded or 
injured in combat,” warzone threat perception relates to the individual’s evaluation of the 
probability and severity of danger, which can occur at any time during warzone 
deployment. For instance, the thought, “I was concerned that my unit would be attacked 
by the enemy,” can occur in the absence of one of the specific warzone stressors included 
on standardized checklists. Furthermore, one could potentially experience a warzone 
stressor in the absence of perceived danger, such as going on convoy in Iraq in the 
absence of concerns about receiving incoming fire or encountering an improvised 
explosive device. Perceived threat has been reliably linked to PTSD and depression in 
service members across wars, branches, and nationalities (e.g., James, Van Kampen, 
Miller, & Engdahl, 2013; D. W. King, King, Gudanowski, & Vreven, 1995; Phillips, 
LeardMann, Gumbs, & Smith 2010; van Wingen, Geuze, Vermetten, & Fernández, 
2011). This association has remained after controlling for combat exposure (James et al., 
2013; Vogt, Proctor, King, King, & Vasterling, 2008), and importantly, perceived threat 
has been shown to mediate deployment stressors’ impact on post-deployment PTSD 
(Franz et al., 2013; D. W. King et al., 1995; Renshaw, 2011).  
Two fundamental limitations exist in prior investigations of perceived warzone 
threat and its association with warzone stressors, and the development of 
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psychopathology. First, warzone threat perception has been assessed retrospectively, 
months or even years after returning from the warzone (e.g., D W. King et al., 1995; 
Renshaw, 2011). However, experiencing deployment-related psychopathology may 
inflate recall of both the frequency of stressors and of threat perception – a hypothesis 
supported by longitudinal evidence that PTSD amplifies retrospective reports of both 
threat (Heir et al., 2009) and combat exposure (Engelhard, van den Hout, & McNally, 
2008; Southwick et al., 1997). Secondly, studies have yet to test whether perceived threat 
potentiates the emergence of PTSD and depression symptoms during deployment in 
response to varying levels of warzone stress exposure. 
Here we present new data from the Texas Combat PTSD Risk Project (Lee, 
Goudarzi, Baldwin, Rosenfield, Telch, 2011; Telch, Rosenfield, Lee, & Pai, 2012), a 
proof-of-concept prospective risk study focused on identifying risk and resilience factors 
associated with the emergence of PTSD and depression. A unique feature of the project 
was the use of a web-based in-theater assessment system in which soldiers provided 
repeated assessments of warzone stress variables and symptom ratings of PTSD and 
depression while deployed in Iraq. This study reports new data on the association 
between perceived threat in the warzone, and the in-theater emergence of PTSD and 
depression symptoms. We hypothesized that threat perception would be associated with 
symptoms of PTSD and depression, beyond the effects of warzone stressors and key pre-
deployment covariates, including lifetime history of psychopathology. Based on previous 
work (e.g., D. W. King et al., 1995), we also predicted that threat perception would 
potentiate warzone stressors’ impact on symptoms of PTSD and depression. 
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Methods 
PARTICIPANTS 
To enroll in the study, soldiers had to meet the following criteria: (a) age 18 or 
older, (b) no prior military deployments, and (c) planned deployment to Iraq within 3 
months of consent. Among those briefed about the study, 82% (N = 184) provided 
consent, 6 did not deploy, 1 withdrew, and 16 did not complete assessments, leaving 161 
soldiers with viable data. Assessments were excluded if they did not include measures 
used in this analysis, leaving 308 observations from 150 soldiers, and 302 observations 
from 146 soldiers for the PTSD and depression models, respectively. According to the 
last in-theater survey completed, deployment lasted an average of 14.98 months (SD = 
2.25; range = 8.00 – 18.43). The sample was predominantly male (88%), White (73%), 
and young (M = 25.33 years, SD = 6.08, range: 19 - 49 years). Among the soldiers 
included in the data set, 54% screened positive for lifetime history of an Axis I disorder.  
The PI (M. J. T.) and project director briefed soldiers from nine units selected by 
Army command that were scheduled to deploy from Ft. Hood to Iraq between August 
2007 and August 2009. These nine units included four combat units, four combat service 
support units, and one combat support unit. Unit leaders agreed to uphold the principle of 
voluntary participation in the study and were not present during the briefing and consent 
process to mitigate the potential for perceived coercion. During the briefing, soldiers 
were informed that study participation was completely voluntary and that consent could 
be withdrawn at any time without penalty. Participants were informed that their data 
would be de-identified and were reassured by the PI (M. J. T.) and an appointed Army 
ombudsman (not connected to the project) that the Army would not have access to their 
data. 
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Soldiers consented to the parent project, the Texas Combat PTSD Risk Study, a 
longitudinal study evaluating risk factors for the onset of PTSD and depression in 
soldiers deployed to Iraq (see Lee et al., 2011 for additional details). Consented soldiers 
were transported to The University of Texas at Austin to complete a comprehensive pre-
deployment assessment battery, including genetic, cognitive, neuroimaging, hormonal, 
and psychosocial measures. During deployment, soldiers received monthly email 
reminders to complete the Combat Experience Log (CEL), a de-identified, web-based 
assessment of warzone stressors and warzone stress reactions. Since it was unlikely that 
soldiers would be able to complete web-based assessments each month due to the 
logistical constraints of the deployed setting, they were instructed to complete 
assessments as frequently as possible. Out of the total number of study participants (N = 
177), over 90% (N =161) completed at least one CEL during deployment. Assuming a 
deployment cycle of 14 months on average, the full data set for the Combat Experiences 
Log included 42% of the total possible observations (Lee et al., 2011). After elimination 
of data points with missing data for one or more of the variables used in the present 
analysis, the final data set for this study included 12% of the total possible observations 
with a range of 1 to 6 observations per soldier (M = 2.07 observations per soldier; SD = 
1.62 for the depression data set; M = 2.05 observations per soldier; SD = 1.61 for the 
PTSD data set). Data for the present study were drawn from the pre-deployment 
assessment and the CEL.  
PRE-DEPLOYMENT MEASURES 
Soldiers completed a comprehensive pre-deployment assessment from which 
demographics and clinical diagnostic data from the Structured Clinical Interview for 
DSM-IV Axis I Disorders (SCID-I-IV; First, Spitzer, Gibbon, & Williams, 1996) were 
used for the present analysis. Doctoral students with at least one year of experience in 
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diagnostic interviewing administered the SCID, and diagnoses were confirmed in a 
follow-up interview with the PI (M. J. T.) with perfect agreement between evaluators.  
IN-THEATER MEASURES 
Stressors were assessed with a checklist adapted from the Deployment Risk and 
Resilience Inventory (DRRI; D. W. King, King, & Vogt, 2003), including 18 items 
assessing incidence of common deployment stressors, and 2 items allowing report of 
stressors not on the checklist. Perceived threat during the prior month was assessed using 
the 15-item Deployment Concerns section of the DRRI (D. W. King et al., 2003). PTSD 
symptoms within the last month were reported using the validated 4-item version of the 
PTSD Checklist (Bliese et al., 2008; Weathers, Litz, Herman, Huska, & Keane, 1993), 
and depression within the past week was reported using the validated 10-item version of 
the Center for Epidemiological Studies Depression Scale (Andresen, Malmgren, Carter, 
& Patrick, 1994). 
STATISTICAL ANALYSES 
Data were analyzed with random intercept multilevel models using the nlme 
package in R (Pinheiro, Bates, DebRoy, & Sarkar, 2014; R Core Team, 2014), with 
repeated observations nested within soldiers. All candidate predictors were entered into 
the initial model, and then backwards elimination of non-significant effects (p > .05) was 
used to select the final models. Initial models included: (1) gender (male = 0; female = 1), 
(2) minority status (White = 0; Non-White = 1), (3) lifetime Axis I disorder based on the 
SCID-IV (absence = 0; presence = 1), (4) months since the start of deployment (linear 
and quadratic effects), (5) number of deployment stressors, (6) perceived threat, and (7) 
the stressors by perceived threat interaction. All variables were Z-transformed (including 
gender, minority status, and lifetime Axis I disorder) to allow comparison across 
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standardized effect estimates. To probe interactions, perceived threat was centered 1 SD 
above and below the mean to determine the conditional effects of stressors, given low or 
high perceived threat (Aiken & West, 1991). Maximum likelihood estimation was used to 
compare nested models, whereas restricted maximum likelihood estimation was used to 
generate reported results (Raudenbush & Bryk, 2002; Maas & Hox, 2005). Descriptive 
statistics for the data set are presented in Table 2. 
 
Table 2:  Descriptive statistics for modeled variables. 
 
 
Note. PCL-4 = PTSD Checklist – 4 Items. CES-D-10 = Center for Epidemiological 
Studies Depression Scale - 10 Items. aReflects presence of lifetime, including current, 
DSM-IV-TR Axis I disorders based on pre-deployment SCID-IV interview. bBased on 
308 observations from 150 soldiers. cBased on 302 observations from 146 soldiers. 
dCalculated across soldiers. eCalculated across soldiers and deployment months. 
fQuestionnaire from the Combat Experience Log. 
Variable N % M SD 
  Male 132 88  - - 
  Caucasian 110 73 - - 
  Lifetime Axis I Disordera 81 54 - - 
  Total Deployment Duration (Months)b 150 - 14.98 2.25 
  Monthly Deployment Stressorsb, d 150 - 2.79 2.90 
  Perceived Threatb, e, f 150 - 27.60 10.94 
  PCL-4b, e, f 150 - 5.26 2.13 
  CES-D-10c, e, f 146 - 7.16 4.86 
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Results 
PTSD MODEL 
Starting with the full model for PTSD symptoms, the first step in the backward 
elimination of non-significant effects was removal of the main effect of minority status 
from the model (β = -.04, se = .08, p = .584). The second step was removing the 
quadratic effect of months deployed at the time of survey completion (β = -.05, se = .04, 
p = .190), the third step was removing the main effect of gender (β = .09, se = .07, p = 
.196), and the fourth step was removal of the main effect of lifetime history of an Axis I 
diagnosis (β = .10, se = .07, p = .144). This produced the final model for PTSD 
symptoms, which included months deployed at the time of survey completion, the main 
effects of deployment stressors and threat perception, and their interaction (see Table 3).  
The finalized model revealed that soldiers reported lower levels of PTSD 
symptoms at later months in the deployment cycle (β = -0.26, se = .05, p < .001). 
Assessments included in the present analyses were completed on average closer to the 
end of the deployment cycle (M = 12.42 months, SD = 3.60 months). This downward 
trajectory of PTSD symptoms over time is consistent with prior analyses demonstrating 
that PTSD symptoms decline over the course of the last half of the deployment cycle 
(Lee et al., 2011).  In regard to the primary variables of interest, the final model revealed 
a significant interaction between deployment stressors and perceived threat, indicating 
that perceived threat amplified the effect of stressors on PTSD symptoms (β = .24, se = 
.04, p < .001). Probing revealed a significant impact of stressors on PTSD symptoms for 
those with high (β = .40, se = .06, p < .001), but not low perceived threat (β = -.08, se = 
.07, p = .295; see Figure 1). After the removing the interaction term to examine 
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independent main effects, perceived threat (β = .18, se = .06, p = .002) and stressors (β = 
.20, se = .05, p < .001) both independently contributed to PTSD symptoms. 
Figure 1:  Simple effects of low (-1 SD), average, and high (+1 SD) perceived threat 
on PTSD symptoms (PCL-4) across levels of stressor exposure.  
 
Note. PCL-4 = PTSD Checklist– 4 Items. Error bars reflect 95% confidence intervals. 
DEPRESSION MODEL 
Starting with the full model for depression symptoms, the first step in the 
backward elimination procedure was removal of the impact of minority status from the 
model (β = -.04, se = .07, p = .586). The second step was removal of the stressor by threat 
interaction (β = .07, se = .05, p = .168). After removing this interaction from the model, 
the main effect of stressors was non-significant (β = .04, se = .06, p = .537), whereas 
perceived threat was significantly associated with depression (β = .23, se = .06, p < .001).  
After backward elimination of all non-significant predictors, the final model for 
depression symptoms included gender, lifetime history of an Axis I disorder, the linear 
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and quadratic effect of deployment month, and perceived threat. In regard to gender, 
women reported higher levels of depression symptoms during deployment relative to men 
on average (β = .13, se = .07, p = .051). The final model also revealed that lifetime 
history of an Axis I disorder conferred risk for depression symptoms during deployment 
(β = .13, se = .06, p = .044). Furthermore, the combined linear (β = -.23, se = .06, p < 
.001) and quadratic effect (β = -.14, se = .05, p = .007) of deployment month 
demonstrated a downward sloping convex relationship, such that the predicted values for 
depression symptoms increased slightly and then declined across the remaining 
deployment months. Since assessments included in the present analyses were completed 
on average closer to the end of the deployment cycle, this downward trajectory of 
depression symptoms over time is consistent with prior analyses showing the decline in 
depression symptoms during the latter half of the deployment cycle (Lee et al., 2011). 
After accounting for gender, history of an Axis I disorder, and the month during 
deployment at which the survey was completed, increases in perceived threat were found 
to be associated with increases in depression symptoms during deployment (β = .23, se = 
.06, p < .001). Final models generated after the removal of all non-significant effects are 
reported in Table 3. 
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Table 3:  Final Models of PTSD (PCL-4) and depression (CES-D-10) symptoms 
during deployment. 
PTSD Symptomsa 
Variable β SE β p 
Intercept -0.07 0.07 0.369 
Months -0.26 0.05 < .001 
Deployment Stressors 0.16 0.05 0.002 
Perceived Threat 0.13 0.05 0.020 
Stressors x Perceived Threat 0.24 0.04 < .001 
Depression Symptomsb 
Variable β SE β p 
Intercept -0.02 0.06 0.780 
Gender 0.13 0.07 0.051 
Lifetime Axis I Disorder 0.13 0.06 0.044 
Months -0.23 0.06 < .001 
Months x Months -0.14 0.05 0.007 
Perceived Threat 0.23 0.06 < .001 
Note. PCL-4 = PTSD Checklist – 4 Items. CES-D-10 = Center for Epidemiological 
Studies Depression Scale - 10 Items. aBased on 308 observations from 150 soldiers. 
bBased on 302 observations from 146 soldiers. 
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Discussion 
SUMMARY OF FINDINGS 
Our overarching aim was to investigate the association between service members’ 
perceived threat of the warzone environment and the emergence of PTSD and depression 
symptoms. Consistent with our first prediction, perceived threat was associated with the 
emergence of depression and PTSD symptoms during deployment, independent of 
warzone stressors. These findings are consistent with prior evidence linking warzone 
threat perception with PTSD and depression (Franz et al., 2013, James et al., 2013; D. W. 
King et al., 1995; Renshaw, 2011; Vogt et al., 2008). However, prior studies assessed 
threat perception months, or even years after deployment (e.g., D. W. King et al., 1995; 
Renshaw, 2011; Vogt et al., 2008). The in-theater assessments used in this investigation 
thus strengthen existing evidence by providing support that these effects are not a mere 
reflection of psychological symptoms inflating retrospective reports of threat perception 
and stressors in the warzone. 
Interestingly, findings also suggest that in-theater reports of warzone stressors and 
perceived warzone threat impact PTSD and depression symptoms differently. Whereas 
both warzone stressors and perceived threat independently predicted the emergence of 
PTSD symptoms, warzone stressors were not associated with depression symptoms after 
controlling for the effects of perceived threat. Furthermore, our second prediction, that 
perceived threat would potentiate the effects of warzone stressors, was supported for 
PTSD symptoms but not for depression. These data provide additional support for prior 
studies demonstrating the critical role of threat perception in mediating the impact of 
warzone stressors on PTSD symptoms (Franz et al., 2013; D. W. King et al., 1995; 
Renshaw, 2011).  
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IMPLICATIONS 
Overall, these data reveal the important association between perceived threat and 
the onset of PTSD and depression symptoms during warzone deployment. In terms of 
theoretical implications, findings demonstrate that it is the perception of stressors, and not 
just their occurrence, that contributes to the development of psychopathology during 
deployment. Interestingly, findings reveal that threat perception potentiated the onset of 
PTSD with increased number of warzone stressors, whereas threat perception, but not 
warzone stressors, predicted depression.  
The discrepant effects for perceived threat and warzone stress on depression as 
compared with PTSD could be related to specific sub-types of stressors associated with 
these disorders. For example, meta-analytic findings have demonstrated that PTSD is 
robustly associated with endorsing the perception of threat to one’s life (Ozer, Best, 
Lipsey, & Weiss, 2003), and it is likely that more frequent warzone stressors increase the 
probability of experiencing one or more life-threatening events. Findings for depression, 
however, emphasize that the number of warzone stressors has no predictive utility, after 
controlling for threat perception. Though prior research has demonstrated that life 
stressors precipitate the onset of depression (Hammen, 2005), all deployed personnel 
share the general stress associated with military deployment, which includes the 
interpersonal stressor of displacement from the home environment and support network. 
Since extensive research has documented the role of interpersonal loss experiences, such 
as separations, as predictive of the onset of depression (Paykel, 2003), it is possible that 
the quantity of deployment stressors, over and above the general stress associated with 
military deployment, is not predictive of depression in the warzone. It may be useful to 
conduct further research to determine whether specific categories of stressors, such as 
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interpersonal stressors versus life-threatening stressors, increase the likelihood of 
depression versus PTSD.  
In addition to the theoretical implications, these findings have practical 
implications. For example, deployed military psychologists could use assessment of 
perceived threat to identify those service members most at risk for the onset of depression 
and PTSD symptoms during deployment. This at-risk group could be followed with more 
frequent screenings and provided with preventive interventions as needed. At-risk service 
members additionally may benefit from brief psycho-education on the profiles of PTSD 
and depression symptoms, so that they will have the information needed to recognize 
when they may benefit from seeking out treatment. 
LIMITATIONS 
Several study limitations deserve mention. First, although over 90% of our soldier 
cohort completed one or more in-theater assessments, soldiers often missed monthly 
assessments (additional information about the missing data and the reasons for it can be 
found in Lee et al., 2011). The data set used for this study included a maximum of 6 
observations per soldier, though soldiers received monthly email reminders to complete 
assessments, and they were deployed on average for over one year. Future researchers 
may be able to capture data more consistently during deployment as technology continues 
to advance, and service members have greater capabilities for accessing web-based 
surveys throughout the deployment cycle. Furthermore, though data were captured during 
warzone deployment, the analyses are still cross-sectional, in that threat, stressors, and 
symptoms were measured simultaneously during deployment, which limits conclusions 
about the causal influence of warzone stress and threat perception on psychological 
symptoms. Capturing data more frequently than once per month may allow researchers to 
produce more powerful prospective models, such as cross-lagged models, to assess 
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whether warzone stressors and threat perception precede the onset of PTSD and 
depression symptoms during the subsequent days or weeks. Second, the limited number 
of observations for several soldiers precluded parsing of the month-to-month changes 
(time variant effects) from the average (time invariant effects) of perceived threat and 
deployment stressors. Additionally, this convenience sample of first-time deployed 
soldiers from nine units stationed at Fort Hood represents a small proportion of the 
military service personnel deployed to Iraq and may not be representative of military 
personnel from other Army units or service branches.  
Furthermore, due to the necessity for a brief in-theater assessment battery, we 
used a short, validated assessment of warzone threat perception, rather than assessing the 
perception of threat associated with each specific warzone stressor. Future researchers 
may benefit from a more fine-grained assessment, including investigating the variability 
in threat perception among military personnel in the same unit who experience who 
experience the same combat stressor. However, even such a fine-grained analysis may 
have inherent problems regarding differences in each individual’s unique experience 
during the same stressful event; for example, in a unit under enemy fire, some personnel 
may receive incoming fire at closer proximity than others in their unit.   
Finally, the mean levels of PTSD and depression symptoms in our sample 
indicate that the average soldier assessed during deployment was asymptomatic. While 
one might argue that the use of such a sample would limit our ability to draw conclusions 
regarding the development of psychopathology, it is important to bear in mind that post-
deployment data suggest that the military personnel who develop PTSD or depression in 
reaction to warzone stress are in the minority (Smith et al., 2008; Wells et al., 2010). 
Furthermore, the rates of PTSD and depression observed in our sample during 
deployment are similar or higher than those observed in prior research at post-
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deployment (e.g., Smith et al., 2008; Tanielian & Jaycox, 2008; Wells et al., 2010). 
Applying cutoff criteria from prior psychometric research to our sample, we averaged 
soldiers’ scores across surveys completed during deployment, and found that 13% 
exhibited clinically significant levels of PTSD symptoms (total ≥ 7; Bliese et al., 2008), 
and 23% exhibited clinically significant levels of depression symptoms (total ≥ 10; 
Andresen et al., 1994). Not only does this document that we have sufficient levels of 
psychopathology in our sample to test our hypotheses, it also provides evidence that a 
significant minority of service members experience symptoms of PTSD and depression 
while still in the deployed setting. The early emergence of PTSD and depression 
symptoms highlights the need for the identification of acute markers of risk (such as high 
threat perception) and the development of preventive intervention strategies.  
CONCLUSIONS  
Our findings are novel in suggesting that in-theater assessment of threat 
perception is associated with the emergence of PTSD and depression, and that perceived 
threat amplifies the effects of warzone stressors on PTSD symptoms. The in-theater 
assessment of these warzone variables provides increased confidence that prior findings 
are not merely a reflection of psychological symptoms inflating service members’ 
retrospective reporting of warzone stressors and threat perception. Future studies are 
warranted to determine whether in-theater assessment of warzone and soldier variables 
more effectively capture the reciprocal interplay between warzone stressors, threat 
perception, and the emergent trajectories of adaptive and maladaptive stress-reactions. 
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STUDY 2 - THE EFFECTS OF ADDING OR REMOVING SAFETY 
BEHAVIORS DURING EXPOSURE THERAPY: A META-
ANALYSIS 
In the face of threat, humans are hard-wired to engage in protective actions, or 
safety behaviors. Salkovskis (1991) defined a safety behavior as “overt or covert 
avoidance of feared outcomes that is carried out within a specific situation.” This broad 
definition encompasses both adaptive and maladaptive safety behaviors. Examples of 
adaptive safety behaviors include wearing a seatbelt in the car, running out of the way in 
the face of an oncoming truck, and putting on protective gloves before removing a hot 
pan from the oven.  
Engaging in safety behaviors becomes maladaptive, however, when they are used 
to protect against a perceived threat that exceeds the actual threat. These maladaptive 
safety behaviors, also called false safety behaviors, can be defined as “unnecessary 
actions taken to prevent, escape from, or reduce the severity of a perceived threat” (Telch 
& Lancaster, 2012; p. 315). For the purpose of brevity, the term “safety behavior” will be 
used to refer to maladaptive, or false, safety behaviors henceforward.  
Safety behaviors are most commonly associated with anxiety disorders, but also 
emerge in other psychological disorders associated with exaggerated threat perception 
(e.g., fear of the consequences of not getting enough sleep in insomnia; Ree & Harvey, 
2004). Correlational studies have demonstrated that higher anxiety is associated with 
more frequent safety behavior use (Cuming et al., 2009; Kamphuis & Telch, 1998; Rowa 
et al., 2015). More importantly, experimental studies have demonstrated that introducing 
safety behaviors increases anxiety in the related domain (Deacon & Maack, 2008; 
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Olatunji, Etzel, Tomarken, Ciesielski, & Deacon, 2011). Table 4 lists psychological 
disorders and associated examples of exaggerated threat and safety behaviors.  
Table 4:  Examples of false safety behaviors associated with exaggerated threat 
perception in DSM-V, Axis I disorders.  
Disorder Exaggerated Threat Examples Safety Behavior Examples 
Panic Disorder Concern about dying from cardiac arrest 
because of a panic attack  
-Eliminating all caffeine intake 
-Carrying an anxiolytic “rescue” 
medication at all times 
Agoraphobia  Concern about embarrassing oneself if a 
panic attack occurs in a public place  
-Avoiding leaving the house as much 
as possible 
-Brining a companion whenever 
leaving the house who could help in 
case of a panic attack  
Social Anxiety 
Disorder 
Concern that other people at a party will 
be likely to notice signs of anxiety and 
will be judgmental of it  
-Going to the bathroom regularly to 
check for excessive sweating or 
blushing  
-Mentally reviewing the conversation 
afterwards to make sure there were no 
signs of nervousness  
Generalized 
Anxiety Disorder 
Concern about being fired from a stable 
job  
-Checking with boss regularly to 
receive reassurance about adequate 
job performance  
-Continuous research on other job 
opportunities to prepare back-up 
options  
Specific Phobia 
(Animal) 
Concern about being attacked by an 
unprovoked dog while on a walk in the 
neighborhood  
-Avoiding certain streets where dog 
owners live 
-Carrying a large stick to use as 
protection if attacked 
Obsessive 
Compulsive 
Disorder 
Concern about contracting a fatal illness 
when eating at a restaurant 
-Using a paper towel to open doors  
-Cleaning with hand sanitizer after 
touching tables, chairs, and menus  
Post-traumatic 
Stress Disorder 
Concern about being assaulted when 
going shopping  
-Carrying pepper spray at all times 
-Avoiding going out alone  
Illness Anxiety 
Disorder 
Concern about high probability of 
getting skin cancer 
-Checking changes in moles by taking 
pictures every week  
-Extensively researching signs of skin 
cancer on the internet  
Insomnia  Concern about loosing a job due to poor 
performance at work after sleep 
deprivation  
-Eliminating all caffeine intake  
-Repeatedly checking the time before 
falling asleep to make certain that it is 
not too late to get enough sleep 
Bulimia Nervosa Concern about appearing overweight -Avoidance of tight fitting clothing 
-Regularly checking mirrors and 
scales to monitor weight gain 
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THE INFLUENCE OF SAFETY BEHAVIORS ON EXPOSURE THERAPY: THEORETICAL 
DEVELOPMENTS 
Negative Reinforcement and Conditioned Safety Signals 
Mowrer’s (1960) two factor learning theory was one of the first models to address 
safety behaviors in its discussion of avoidance and escape. The theory described how 
avoidance and escape are maintained by the rewarding experience of anxiety reduction. It 
furthermore suggests that avoidance and escape behaviors interfere with exposure to the 
conditioned stimulus, thereby preventing fear extinction.  
Mowrer later added to this theory a “safety signal hypothesis” which was 
elaborated by Gray (1971), to describe the role of safety signals in maintaining anxiety. 
This modification to the theory suggests that certain stimuli become conditioned safety 
signals because they are associated with the non-occurrence of a predicted negative 
outcome. For example, the presence of a companion can become a signal of safety for 
someone with agoraphobia because the companion is associated with instances in which 
the patient was able to leave the home without the feared consequences. Therefore, the 
presence of the companion also serves to maintain the fear of leaving home.  
Response Induction or Judicious Use 
In line with these ideas, Rachman (1983; 1984) described how avoidance 
behavior is reduced in the presence of a safety signal (e.g., a companion or a talisman 
associated with safety, such as an anxiolytic medication), and proposed the possibility of 
using safety signals therapeutically. Specifically, he suggested facilitating approach 
behaviors by placing safety signals within the feared environment, so that the 
agoraphobic individual would need to enter the feared situation to approach the safety 
signal. Rachman (1983) predicted that, although the safety signals would be temporarily 
reinforced, their presence would increase approach behavior towards feared situations, 
  39 
which would result in decreases in physiological anxiety responses and subjective fear, 
which would, in turn, eventually produce the effect of decreasing dependency on the 
safety signal. Put simply, Rachman predicted that using safety behaviors therapeutically 
might facilitate, rather than interfere, with the process of exposure therapy.   
Very much in line with his original ideas, Rachman and colleagues more recently 
provided an argument for the judicious use of safety behaviors in anxiety treatment 
(Rachman, Radomsky, & Shafran, 2008). The authors described studies in which safety 
behavior use did not interfere with threat disconfirmation or fear reduction in the context 
of exposure therapy, and in some cases, may have facilitated treatment outcomes (e.g., 
Bandura, Jeffery, & Wright, 1974; Rachman, Craske, Tallman, & Solyn, 1986). Based on 
his review of the literature, Rachman and colleagues (2008) suggest that safety behaviors 
should be used “in a limited manner and only for a limited period, especially in the early 
stages of treatment” and also “if an obstacle is encountered later in the course of 
treatment” (p. 171). These descriptions are reminiscent of the use of safety behaviors in 
Bandura’s guided mastery treatment (Bandura, Jeffery, & Gajdos, 1975), in which 
response induction aids are used to induce approach behaviors and increase self-efficacy, 
and are then faded over time. Rachman and colleagues (2008) contrast the judicious use 
of safety behaviors to the approach used by cognitive therapists, whom he suggests, 
“often encourage patients to drop their safety behavior completely and as soon as 
possible” (p.164).  
Threat Disconfirmation and Misattribution of Safety 
Whereas Rachman’s view highlights a potential therapeutic use of safety 
behaviors as response induction tools, cognitive theory, on the other hand, provides a 
heavier emphasis on the potential pitfalls of safety behavior use. In terms of treatment 
recommendations, Salkovskis and colleagues suggest that, “it is important to eliminate 
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any safety-seeking behaviors which may be maintaining catastrophic cognitions” 
(Salkovskis, Clark, & Gelder, 1996). Safety behaviors are seen as blocking threat 
disconfirmation because the experience of safety is misattributed to the use of the safety 
behaviors (Salkovskis, 1991; Telch, 1991). For instance, someone with a fear of heights 
might misattribute safety to his habit of tightly gripping the rails whenever he is in a high 
place, preventing him from receiving evidence that he is unlikely to fall even when not 
gripping the rails. Safety behaviors therefore are reinforced due to the perception that the 
predicted catastrophes are averted (Salkovskis, Clark, Hackmann, Wells, & Gelder, 
1999).   
In line with threat disconfirmation theory, a systematic review of the safety 
behavior literature conduced by Goetz, Davine, Siwiev, and Lee (2016) concluded that 
preventive safety behaviors were more detrimental to exposure therapy than restorative 
safety behaviors. Preventive safety behaviors prevent full exposure to the threatening 
situation (e.g., wearing a glove while touching a perceived contaminated object), whereas 
restorative safety behaviors restore safety after unprotected exposure to the threatening 
situation (e.g., using a sanitary wipe after direct contact with an object perceived to the 
contaminated). In line with findings from Goetz et al. (2016), cognitive theory would 
predict that restorative safety behaviors would be less detrimental than preventive safety 
behaviors because restorative safety behaviors allow for full confrontation with the 
threatening situation, even if only for brief period of time prior to performance of the 
safety behavior. A limiting factor of the prior research in this area is that nearly all 
research on restorative safety behaviors has been conducted within populations typically 
associated with rituals used to reduce threat, most often OCD or health anxiety.  
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Reducing Attentional Resources  
Telch and colleagues (Sloan & Telch, 2002; Telch & Lancaster, 2012) have 
suggested that SBs may interfere with exposure therapy by interfering with the 
processing of threat disconfirmation via a redirection of attentional resources to the 
presence of safety cues and the execution of safety behaviors. In support of this 
formulation, Telch and colleagues (Kamphuis & Telch, 2000; Telch et al., 2004) found 
that adding a heavy cognitive load task during exposure therapy for claustrophobia 
reduces treatment efficacy. Moreover, in three independent exposure therapy studies, 
Telch and colleagues (Kamphuis & Telch, 2000; Sloan & Telch, 2002; Telch et al, 2000) 
showed that experimental manipulations designed to explicitly increase attention to 
threat-disconfirming information enhance exposure treatment outcomes. These findings 
are consistent with emotional processing theory (Foa & Kozak, 1986), which underscores 
the importance of attending to the feared stimulus and threat-disconfirming information 
throughout treatment as a necessary precursor to emotional processing.   
Threat Transmission Hypothesis 
Telch and colleagues (Sloan & Telch, 2002; Telch & Lancaster, 2012) have also 
suggested the possibility of a non-cognitive model, in which the mere engagement in 
protective actions is hypothesized to transmit threat signaling via lower-level, limbic-type 
activation. In line with this idea, Niedenthal (2007) introduced the theory of embodied 
emotion suggesting that physical enactments consistent with a given emotion action 
tendency may lead to increased activation of the target emotion. Data supporting the 
threat transmission model comes from several more recent experiments demonstrating 
that having non-anxious populations engage in unnecessary protective actions is 
anxiogenic (Deacon & Maack, 2008; Olatunji, Etzel, Tomarken, Ciesielski, & Deacon, 
2011). 
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Inhibitory Learning  
Inhibitory learning theory similarly suggests the potential drawbacks of using 
safety behaviors. Inhibitory learning theory emerged from data in basic science models 
demonstrating that fear can re-emerge after extinction, and that this return of fear is more 
likely after a change in context, such as a change in environment (fear renewal) or even 
simply the passage of time (spontaneous recovery of fear; Bouton, 2000). It was therefore 
concluded that fear extinction procedures result in the formation of a new, context-
dependent safety memory that competes with the original fear memory for expression. It 
follows, then, that exposure therapy should be more effective when the generalizability of 
the inhibitory memory is maximized. Blakely and Abramowitz (2016) integrated the 
long-standing debate on the therapeutic use of safety behaviors with the emergence of 
inhibitory learning theory to provide specific recommendations. They suggest that 
clinicians should perform a careful functional analysis of safety behaviors, and eliminate 
any safety behaviors that might reduce the generalizability of the inhibitory memory, 
reduce the discrepancy between anticipated and actual outcomes during exposure 
therapy, or reduce acquisition of distress tolerance skills during exposure therapy. The 
latter two recommendations are essentially strategies that fit under the umbrella of the 
first recommendation, to maximize the generalizability of the inhibitory memory. 
According to the definition of safety behaviors proposed by Telch and Lancaster (2012), 
any safety behavior would then have detrimental effects; when safety behaviors are 
defined as actions taken to “prevent, escape from, or reduce the severity of a perceived 
threat,” every safety behavior would reduce the discrepancy between the anticipated and 
actual outcome.  
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PRIOR RESEARCH SYNTHESES  
The theoretical discussion regarding the impact of safety behaviors has been 
ongoing for many years, and several qualitative reviews of the data on this topic have 
been published within in the last decade (Blakey & Abramowitz, 2016; Goetz, Davine, 
Siwiev, & Lee, 2016; Helbig-Lang & Petermann, 2010; Parrish, Radomsky, & Dugas, 
2008; Rachman et al., 2008). Based on experimental data, some psychologists have 
tentatively suggested the potential benefits of judicious safety behavior use (Parrish, 
Radomsky, & Dugas, 2008; Rachman et al., 2008), whereas others have generally 
cautioned against their use (Blakey & Abramowitz, 2016; Helbig-Lang & Petermann, 
2010; Sloan & Telch, 2002; Powers et al., 2004). Given the long-standing debate and 
numerous qualitative syntheses of the data, it is surprising that only one quantitative 
synthesis of the research in this area has been conducted to date (Meulders, Van Daele, 
Volders, & Vlaeyen, 2016).  
Meulders and colleagues (2016) completed two separate meta-analyses 
investigating (a) the impact of adding safety behaviors, and (b) the impact of removing 
safety behaviors, as compared with a baseline/control condition (for example, a group 
with no instructions regarding safety behaviors). Authors identified a marginally 
significant effect in favor of removing of safety behaviors relative to a baseline control 
group, and no statistically significant effect of the addition of safety behaviors relative to 
a baseline control group. Overall they described their findings as “inconclusive,” and 
stated that they “could not provide strong evidence support either the removal of addition 
of [safety behaviors] during exposure-based treatment” (p. 151). They also observed 
moderate to high heterogeneity in effect sizes, highlighting the inconsistency of results 
across studies included in their analysis. This heterogeneity in effect sizes may be in part 
related to the inclusion of studies that varied widely in their methodological rigor. When 
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one averages across studies of varying methodological rigor, the average true effect size 
of the manipulation may be diluted due to the reduced power of some studies to 
accurately measure the true effect of the manipulation.  
For example, authors did not account for whether studies equated treatment 
conditions for safety behavior use/availability at the time of assessment. In some studies, 
for example, researchers compare fear ratings at the end of an intervention, while one 
group is using safety behaviors and the other is not (e.g., Langer & Rodebaugh, 2013). 
Other studies, in contrast, conduct a separate assessment after the treatment manipulation, 
during which neither group has access to safety behaviors (e.g., Goetz & Lee, 2015). One 
might expect that using safety behaviors reduces fear in the short-run (while the safety 
behaviors are available), but increases fear in the long-run (when presumably safety 
behaviors may be less available; Mowrer, 1960; Salkovskis et al., 1996). Therefore, when 
safety behavior use/availability is not equated during the outcome assessment, one might 
expect lower fear in the group with access to safety behaviors. However, when both 
groups are tested under equivalent conditions (e.g., when neither has access to safety 
behaviors), one might then expect to detect higher fear in the group that had access to 
safety behaviors during treatment. Therefore, differences in effect sizes when testing 
conditions are and are not equivalent, in regard to safety behavior availability and use, 
could be a significant source of variability in study effect sizes.   
Another potential drawback of Meulder’s and colleagues (2016) approach was the 
inclusion of studies that used within-subjects designs (e.g., Wells et al., 1995). Although 
there are benefits of using more generous study inclusion criteria (e.g., increased 
statistical power), the use of within-subjects designs poses a critical methodological 
problem when studying the impact of safety behavior use on treatment outcome. Various 
theoretical perspectives on safety behaviors (e.g., threat disconfirmation, response 
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induction, and inhibitory learning) describe their long-term, learning-based influences. 
Therefore, using a within-subjects design to test the influence of a safety behavior 
manipulation poses the potential problem of carryover effects. These are effects that can 
carry over from the first phase of the study into the second, and thus obscure observation 
of the impact of an experimental manipulation in a within-subjects design (Wellek & 
Blettner, 2012). Therefore, excluding studies using a within subjects design may increase 
the ability to detect the true effect of safety behavior manipulations.  
A third limitation of their findings relates to the relatively narrow search terms 
used by authors in their literature review. Meulders and colleagues (2016) narrowed their 
literature review by searching for studies that explicitly mentioned safety behaviors. The 
generalizability of findings could be increased by examining a broader array of studies in 
line with the approach taken prior authors of systematic reviews in this area (e.g., Goetz 
et al., 2016), who included studies that did not explicitly use the term “safety behavior” 
(e.g., distraction-related studies).  
Finally, Meulders and colleagues (2016) noted the limitations of their 
methodology in selecting only one outcome measure to code per study, specifically, self-
reported fear at the last available time point. Rather than selecting one primary effect to 
code for each study, it is possible to code all study outcomes and average across them to 
generate findings more generalizable across outcome measures (Cooper, 1998). This 
could strengthen the generalizability of conclusions, and produce the added benefit of 
allowing one to test moderators related to assessment type. It is also noteworthy that even 
with incorporating only one type of outcome measure, Meulders and colleagues (2016) 
still observed medium to high heterogeneity in effect sizes across studies. Therefore, in 
addition to testing potential moderators related to assessment characteristics, it may be 
useful to examine moderators related to study characteristics as well.  
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POTENTIAL EFFECT SIZE MODERATORS  
Assessment Characteristics 
It remains to be determined whether the characteristics of certain assessments 
make them more or less sensitive to detecting the influence of safety behavior 
manipulations on exposure therapy. For instance, assessment time point could influence 
effect sizes. If safety behavior use does indeed reduce the generalizability of learning as 
inhibitory learning theory would suggest (Blakely & Abramowitz, 2016), then follow-up 
tests conducted weeks to months after treatment would be predicted to show larger effect 
sizes relative to assessments conducted immediately after treatment. Furthermore, some 
aspects of anxiety (behavior performance, physiological response, or subjective ratings) 
could be relatively more or less sensitive to detecting the influence of safety behaviors on 
exposure therapy. Given the rooting of safety behavior manipulations in cognitively 
focused theories (e.g., threat disconfirmation), one might expect subjective ratings to 
demonstrate higher sensitivity to detecting the influence of safety behaviors relative to 
other assessment modalities.  
Clinical Status and Treatment Target  
Related to study design features, the impact of safety behaviors may also depend 
on the clinical status of the sample. Due to the potency of exposure therapy as a general 
treatment technique and potential for floor effects in non-clinical samples, one might 
expect to see a stronger influence of safety behaviors on exposure therapy outcomes as 
the clinical sample increases in severity (e.g., within diagnosed versus sub-threshold 
patients). Additionally, the impact of safety behaviors may depend on the psychological 
condition under investigation. Safety behaviors are often implemented to divert a specific 
threat. Therefore, one might expect to see a stronger influence of safety behaviors on 
circumscribed threat perceptions, such as specific phobias.  
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Safety Behavior Characteristics 
Features of the safety behavior manipulation within a given study could also 
contribute to the relative strength or weakness of their influence on exposure therapy 
outcomes. For example, most studies investigating the influence of adding safety 
behaviors to exposure therapy conduct this manipulation by providing participants with a 
specific list of safety behaviors from which to choose (i.e., investigator-initiated safety 
behaviors). This type of safety behavior manipulation is limited in its ecological validity, 
since safety behaviors provided by investigators might not map onto the safety behaviors 
participants would use in a real-world scenario. Furthermore, investigator initiated safety 
behaviors may have a weaker influence on outcomes relative to safety behaviors that 
participants have used prior to study participation. The latter behaviors would likely have 
a stronger history as a conditioned safety signals, in turn making them more potent for 
blocking extinction learning (Rescorla, 1969).  
Furthermore, the use of investigator-initiated safety behaviors poses limits to 
construct validity. It is possible that a given behavior that one individual views as 
increasing safety, another individual views as decreasing safety. The behavior of looking 
away from a spider, for example, could increase a sense of safety by allowing for 
distraction or experiential avoidance. However, this same behavior could also decrease a 
sense of safety by preventing hyper-vigilant watching of the spider’s movement. Thus, 
the use of investigator-initiated safety behaviors, as opposed to safety behaviors selected 
by the participant, poses a number of methodological issues that could impact the 
integrity of the safety behavior manipulation.  
Studies investigating the addition of safety behaviors to exposure therapy also 
differ on whether investigators require the use of these safety behaviors during treatment, 
or alternatively, simply allow, but do not require, performance of safety behaviors (for 
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examples of each type of manipulation, see Powers, Smits, & Telch, 2004; and Sy, 
Dixon, Lickel, Nelson, & Deacon, 2011). Individual studies have found no differences 
between these two treatment conditions (e.g., Powers et al., 2004; Sy et al., 2011). 
However, this feature of safety behavior manipulation has yet to be investigated as one 
that might explain variability in findings within the safety behavior literature more 
broadly.  
STUDY AIMS  
We therefore conducted a meta-analysis of the safety behavior literature, 
improving on limitations in prior research syntheses (Meulders et al., 2016), with the 
primary aim of investigating the impact of adding safety behaviors (SB+) and removing 
safety behaviors (SB-) on outcomes of exposure therapy. Our secondary aim was to 
examine potential moderators of effect sizes. This included evaluating the moderating 
influence of characteristics related to assessments, such as the modality of assessment, 
and duration of follow-up; and characteristics related to studies, such as the severity of 
the clinical population, the diagnostic target of treatment, and the characteristics of the 
safety behaviors manipulated.    
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Methods 
LITERATURE SEARCH PROCEDURES  
We searched for published, peer-reviewed articles from 1909 to February 2015 in 
PsychINFO, Medline, PsychARTICLES, and the Psychology and Behavioral Sciences 
Collection. The search terms consisted of two domains of keywords: the first set of terms 
related to safety behaviors and the second set related to psychotherapy. The first term list 
included: safety behavior, safety behaviors, safety behaviour, safety behaviours, safety 
seeking, safety signal, safety signals, safety aid, safety aids, response prevention, ritual 
prevention, distraction, response aid, response aids, response induction aid, response 
induction aids, guided mastery, and participant modeling. The second term list included: 
treatment, therapy, psychotherapy, counseling, counselling, intervention, and exposure. 
All possible combinations of these two sets were searched for in the abstracts, titles, and 
subject terms. We then completed a backward literature review, reviewing the references 
from relevant review articles as well as the references in empirical studies selected for 
inclusion in the meta-analysis. After removing duplicates, this search process yielded a 
total of 2,228 unique records. Articles were then screened and selected according to 
specific inclusion/exclusion criteria (see below). 
STUDY INCLUSION/EXCLUSION CRITERIA 
Studies were reviewed by one of three researchers (first, second, and third 
authors). Upon review of 100 randomly selected articles from the overall literature 
search, the authors demonstrated 100% agreement on decisions regarding study inclusion. 
All study reviewers were trained and supervised by the first author, who reviewed each 
study selected for inclusion a second time to ensure all studies met the inclusion criteria. 
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See Figure 2 for an overview of the study selection process. Each article was evaluated 
based on the following inclusion/exclusion criteria:  
(1) Studies were required to provide an experimental (randomized) manipulation 
of safety behaviors in the context of subjects receiving exposure therapy.2 Two major 
subtypes of SB manipulations were included: (a) studies which randomized subjects to an 
experimental condition that made safety behaviors/safety aids available for use (SB+) 
versus an exposure only control; and (b) studies which randomized subjects to an 
experimental condition that required subjects to eliminate their SBs during exposure  
(SB-) versus exposure control (i.e., allowing subjects to complete exposure therapy 
without SB elimination)  
(2) Both the experimental and control groups had to receive equivalent forms of 
exposure therapy, defined as confronting a situation (in vivo), thought (imaginal), or 
bodily sensation (interoceptive) for the primary purpose of reducing symptoms of 
psychopathology. This criterion led to the exclusion of studies that compared distraction 
to focusing or mindfulness-based conditions.3 In the context of our primary research 
questions, these studies would confound the impact of the safety behavior (distraction), 
with the potential facilitating effects of increasing attention and focus toward the 
symptom-provoking stimulus (Foa & Kozak, 1986). Instead, we only selected distraction 
studies that compared the impact of distraction to an exposure-only control group. 
(3) Studies using crossover designs were excluded due to the potential for carry-
over effects to obscure the effects of SB+ or SB- manipulations. 
                                                
2 We excluded complete avoidance of feared stimuli from the category of safety behaviors, because by this 
definition, all forms of exposure therapy would qualify as safety behavior reduction. 
3 The exclusion of conditions that added a mindfulness or focusing component to treatment was based on a 
careful review of the study procedures, rather than relying solely on labels for study conditions provided by 
authors.  
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(4) Studies were excluded if the article provided insufficient data to allow for the 
determination of between-group effect sizes. 
Figure 2:  Overview of study selection.   
 
 
CODING PROCEDURES  
A double data entry procedure was used. Two authors (first and second) 
independently coded each effect size, along with the characteristics associated with the 
type of outcome assessment, the nature of the clinical sample and diagnostic target of 
exposure therapy, as well as the characteristics related to the safety behavior 
manipulations within each study. Any disagreements in independent coding were 
resolved through discussion and unanimous agreement of both coders.  
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Assessment Characteristics 
Each outcome assessment was coded as having either equivalent or non-
equivalent safety behavior instructions during the assessment. For example, fear ratings 
provided at the end of treatment, while one group is using safety behaviors and the other 
is not, would be considered a non-equivalent comparison; whereas a behavioral 
avoidance test or questionnaire administered after treatment, during which there were no 
between-group differences in safety behavior use or availability, would be considered an 
equivalent testing condition.  
Each outcome was additionally coded for follow up duration, specifically, the 
number of days since treatment completion. Outcomes that were assessed at the end of 
treatment or on the same day that treatment was completed were coded as “end of 
treatment” or “post treatment” measures, respectively (0 days); and all other outcomes 
were coded as “follow-up” assessments. Finally, we coded the modality of outcome 
indices. All reported outcome indices were first subdivided into two broad assessment 
categories – (1) symptom questionnaires, or (2) behavioral approach tests (BATs) – 
defined as assessments obtained while the participant directly encounters a fear-
provoking target. BAT indices were further subdivided into measurements of observed 
approach behavior, subjective ratings of experience (e.g., Likert ratings of anticipated or 
peak fear/distress), and physiological reactivity (e.g., heart-rate or electrodermal 
responding) during the encounter. 
Coding of Sample and Treatment Target Characteristics 
The clinical status of the sample was categorized as (a) meeting diagnostic criteria 
for the psychopathological condition targeted for treatment; (b) “symptomatic,” defined 
as a sample displaying elevated symptom levels for the psychopathological condition 
targeted for treatment; or (c) “general sample,” defined as a sample recruited from the 
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general population without screening for symptom level or diagnostic status. Studies 
were furthermore categorized according to the diagnostic condition targeted by exposure 
therapy. For example, exposure therapy aimed at reducing cleaning rituals in response to 
germ exposure was coded as treatment for OCD symptoms, whereas exposure therapy 
fear of spiders or enclosed spaces was coded as treatment for specific phobia symptoms.  
Coding of Safety Behavior Characteristics 
Coders additionally categorized studies by the nature of the safety behavior 
manipulation. First, studies were subdivided into those that tested exposure therapy with 
and without the addition of safety behaviors (SB+ studies); and those that tested exposure 
therapy with and without the removal of safety behaviors (SB- studies; Meulders et al., 
2016). Due to differences in the study designs, the interpretation of effect sizes for each 
of these two study subgroups differs. Therefore, averaging across them would produce 
effect size estimates that would be difficult to interpret.  
The remaining safety behavior characteristics were used for the purpose of 
moderator tests. Studies were categorized regarding whether or not they focused solely 
on the manipulation of distraction. Although a prior meta-analysis included distraction in 
the conceptualization of safety behaviors, authors did not use distraction as a search term 
in the literature review (Meulders et al., 2016). Since the present study included this as a 
search term, many additional articles related to distraction were included. We therefore 
decided to examine whether the impact of simply manipulating distraction differed from 
the impact of manipulating other subtypes of safety behaviors (more representative of the 
safety behaviors included in a prior research syntheses; Meulders et al., 2016). 
We furthermore categorized studies regarding whether or not safety behavior use 
was required. For example, in the study designs of Powers and colleagues (2004) and Sy 
and colleagues (2011), authors exposed participants to a claustrophobia chamber; in one 
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condition, experimenters made safety behaviors available without requiring their use, and 
in another condition, experimenters required the use of one or more safety behaviors 
during exposure therapy. The former condition was coded as safety behaviors “not 
required,” whereas the latter condition was coded as safety behaviors  “required.”   
Finally, studies were categorized into those involving safety behaviors that were 
suggested or selected by the investigator (“investigator initiated” safety behaviors) versus 
safety behaviors that were selected by the participant (“naturally occurring” safety 
behaviors). When participants were provided with suggestions for safety behaviors from 
the investigator, but were also allowed to add safety behaviors of their preference, the 
study was categorized as manipulating “naturally occurring” safety behaviors. This 
ensures that the categorization delineates groups with more versus less tailoring of safety 
behaviors toward actions that the individual participant views as increasing a sense of 
safety. 
Studies testing the removal of safety behaviors from exposure therapy (SB- 
studies) exhibited the same safety behavior characteristics across all studies, so were not 
tested for moderation related to safety behavior characteristics. For example, no studies in 
the SB- group manipulated only distraction because participants were encouraged to fade 
a broader range of safety behaviors in these study designs. Furthermore, all studies 
manipulated naturally occurring, rather than investigator initiated safety behaviors, since 
the unique safety behaviors each participant presented with were removed during 
treatment. The categorization of “required” versus “not required” use of safety behaviors 
also was not relevant to this study design because no safety behaviors were introduced. 
Therefore moderator testing of safety behavior characteristics was conducted within the 
SB+ studies only.   
  55 
Effect Size Coding 
We coded effect sizes that represented outcome measures (not process or mid-
treatment assessments) for each study because our primary aim was to evaluate the 
impact of safety behaviors on treatment outcomes rather than treatment process. All 
included effect sizes therefore reflect assessments collected at the end of treatment or at a 
later follow-up date. Furthermore, effect sizes included in the analysis were all directly 
related to the psychological condition being targeted during the exposure-based therapy. 
Examples of effect sizes that were unrelated to the condition being targeted during 
exposure therapy include a subjective rating of “enjoyment of the experiment” and a 
depression questionnaire within studies targeting anxiety reduction. (Only 17 out of over 
200 data points were excluded due to being unrelated related to the primary condition 
being targeted by treatment.)   
To avoid over-weighting or double-counting of a single outcome assessment, 
whenever one outcome measure was presented in two separate forms by study authors, 
we selected the version of the outcome measure that was more sensitive to change, and 
the version that was more inclusive. For example, if study authors examined 
questionnaire outcomes both continuously (total score) and categorically (reached a 
cutoff or not), we selected the continuous measurement. When a questionnaire total was 
provided alongside all subscales in the measure, we selected the subscales for analysis, 
due to the potential for better sensitivity to change related to the presumably higher 
internal consistency within each subscale. However, when outcomes for one item within 
a questionnaire were presented alongside the questionnaire total score, we entered the 
more inclusive version of the measure (i.e., the questionnaire total score) to avoid loss of 
information.  
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Each effect size was coded in the direction reported in the original manuscript, 
and then categorized as to whether higher or lower scores represented greater 
psychological symptoms. Prior to analyses, the direction of effect sizes was then reversed 
when needed such that higher scores on assessments would uniformly represent higher 
symptom levels. Outcome effect sizes were then adjusted for pre-treatment levels by 
subtracting mean pre-treatment scores (when available) from mean post-treatment scores, 
within each of the two treatment groups in the comparison.  
To evaluate the impact of the safety behavior manipulation, we calculated the 
difference in the adjusted outcome scores between the two treatment groups. For ease of 
interpretation, the group with more safety behaviors was consistently placed first in the 
subtraction calculation (more safety behaviors minus less safety behaviors). For the SB+ 
studies, the group with safety behaviors added was listed first. For the SB- studies, the 
group without safety behavior fading was listed first. This series of calculations ensured 
that positive effect sizes in both SB+ and SB- studies could be interpreted as lower safety 
behavior use producing superior treatment outcomes.  
To maximize precision of the effect size calculations, we used means, standard 
deviations, and sample size for continuous variables (or probability of a given outcome, 
for dichotomous variables), whenever these data were available. When these data were 
not available, we derived effect sizes from statistical calculations (e.g., F-values or t-
values) using formulas recommended by Lipsey and Wilson (2001). When none of these 
data were available, effect sizes were estimated based on reported p-values.  
DATA ANALYSIS    
Effect sizes were calculated as Hedges’ g (Hedges & Olkin, 1984) since this 
formula is less biased than Cohen’s d for small sample sizes, which were prevalent 
among the studies in the present analysis (Table 5). Both g and d reflect the difference 
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between means in units of pooled standard deviation. However, the pooled standard 
deviation for Hedges’ g uses Bessel’s correction ((n-degrees freedom) rather than (n)) for 
calculating the pooled standard deviation, and it weights each standard deviation in the 
pooled calculation with its respective sample size. Although as sample sizes increase, 
Hedges’ g converges with Cohen’s d, among smaller sample sizes this correction protects 
against an upwardly biased estimate of effect size (Grissom & Kim, 2005). To adjust the 
post-treatment effect size for pre-treatment levels (when these data were available), we 
followed recommendations provided by Morris (2008). Pre-post change in each group 
was calculated by subtracting pre-treatment scores from post-treatment scores. Then, the 
mean pre-post change in the first treatment group (with more safety behavior use) was 
subtracted from the mean pre-post change in the second treatment group (with less safety 
behavior use), which was divided by the pooled and weighted pretest standard deviation. 
We then calculated 95% confidence intervals for weighted average effect sizes, and 
rejected the null hypothesis when the confidence interval did not contain zero.  
Correcting for Dependence Among Effect Sizes  
Following the assumption of the independence of each effect size can be 
problematic when the same sample of participants produces multiple effect sizes for a 
given study. A common occurrence of this violation was when multiple outcome 
measures were used for a given sample. We therefore used a shifting units of analysis 
approach to statistically account for dependent effect sizes (Cooper, 1998). Consistent 
with this methodology, we entered all available treatment outcome effects associated with 
each sample, and coded each in accordance with their associated study and assessment 
characteristics. An overall effect size was calculated by averaging across all available 
effect sizes for a given sample. When examining the influence of moderators related to 
  58 
subcategories of effect sizes, a given sample could contribute one effect size to each level 
of the moderator variable.  
Occasionally study design created another type of effect size dependence, such 
that the same treatment group was used in two unique between-group comparisons. In 
these cases, the sample size of the group used in both comparisons was halved to correct 
statistically for the problem of dependence among effect sizes. For example, some studies 
compared a standard exposure therapy control group with two experimental groups (one 
that required the use of safety behaviors, and one that made safety behaviors available but 
did not require their use; Powers et al., 2004; Sy et al., 2011). In this case, we coded the 
two unique between-group comparisons for each of the two experimental groups as 
compared with the exposure-only control group, and we halved the sample size of the 
control group in each comparison. We selected this option (halving the sample size of the 
control group rather than averaging across the two experimental groups) because this 
enabled us to test moderating effects associated with the various pairwise comparisons 
(e.g., differing impact of adding safety behaviors during exposure therapy when their use 
is required as compared to when it is not required).   
Fixed Versus Random Models 
After calculating Hedges’ g, we used both fixed and random effect models to 
examine the average overall effect of safety behaviors (adding or removing them) on 
exposure therapy outcomes. Due to low sample sizes and statistical power limitations, as 
well as the exploratory nature of the moderator analyses, we only used fixed effect 
models in the subsequent moderator analyses (see Qualitative Coding section a 
description of tested moderators). Fixed effects models assume that the source of error in 
the estimated effect size is due to sampling error associated with selecting a subset of 
studies from a single population of studies; whereas random effects models assume both 
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(a) sampling error associated with selecting a subset of studies from a single population 
of studies, and (b) sampling error associated with selecting a subpopulation of studies 
from super-population of studies (Field & Gillett, 2010). Although one could argue that 
random effects models produce findings that are more generalizable to studies outside the 
sample included in our paper, we selected fixed effects models for moderator analyses to 
maximize statistical sensitivity to detect moderator effects that may help to guide future 
research in this area.  
Moderator Tests  
Systematic differences in the characteristics of studies can contribute to the 
variance in their effect sizes, over and above sampling error alone. We used a goodness 
of fit test to determine whether the level of heterogeneity observed within effect sizes 
(Qw) was greater than what would be expected from sampling error alone. When the 
effect sizes were heterogeneous (as indicated by a statistically significant Qw), we 
performed further moderator tests to determine whether factors such as study 
characteristics explained variance in the effect sizes (Cooper, Hedges, & Valentine, 
2009). The predictive utility of each moderator was examined by testing whether the 
variance between groups of effect sizes (Qb) was greater than what would be expected 
from sampling error alone.  
Sequence of Analyses  
For the SB+ and SB- groups, we first conducted preliminary tests, which included 
(a) determining whether equivalence of testing conditions moderated the effect, and 
excluding non-equivalent tests in further analyses if indicated, and (b) examining the 
heterogeneity of the remaining effects. We then calculated fixed and random effects for 
the overall impact of adding and removing safety behaviors, relative to an exposure 
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therapy control group. Last, we reported fixed effects for moderator tests of assessment, 
study, and safety behavior characteristics, when this testing was indicated by significant 
heterogeneity in the effect sizes.  
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Results 
The literature review yielded a total of 32 articles, with 47 unique between-group 
comparisons. See Table 5 for a summary of the characteristics of each study. Among the 
studies that experimentally manipulated the addition of safety behaviors to exposure 
therapy (see Table 6), there were 42 between-group comparisons, which yielded a total of 
183 effect sizes. Among the studies that experimentally manipulated the removal of 
safety behaviors during exposure therapy (see Table 7), there were 5 unique between-
group comparisons, which yielded a total of 26 effect sizes. 
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Table 5:  Description of general study characteristics for included studies. 
Author (s) & Publication Year Type of Fear N Clinical Status Study Focus Findings & Conclusions 
Abramowitz & Moore, 2007 Hypochondriasis 
 
27 Diagnosed Effects of SB’s (e.g., checking) on 
anxiety when exposed to personally-
relevant health related stimuli.  
SB’s reduced anxiety and urge to perform 
SB’s. For patients in the no SB condition, 
a more gradual reduction in anxiety and 
urge to perform SB’s was observed. 
 
→ SB’s serve the function of immediately 
reducing anxiety. However, reductions in 
anxiety can also occur after 1 hour of 
refraining from SB use. 
 
Antony et al., 2001 Specific Phobia 60 Diagnosed Effects of distraction and coping style 
on exposure-based treatment 
Neither distraction, coping style, nor their 
interaction had a significant effect on 
outcomes. 
 
→Distraction does not produce an 
inhibitory effect on fear reduction in the 
short-term.  
 
Deacon et al., 2010 Specific Phobia 33 Symptomatic Judicious use of SB in augmenting 
exposure therapy tolerability  
Equivalent improvements for both groups. 
No reliable benefits or drawbacks 
associated with judicious use of SB’s. 
 
 → SB use during exposure therapy may 
not compromise therapy. 
 
Eifert & Heffner, 2003 Panic Disorder 40 Symptomatic Effects of control context 
(diaphragmatic breathing) on 
avoidance of aversive interoceptive 
cues 
Subjects in the control context condition 
(diaphragmatic breathing) did not differ 
significantly from the no instruction group 
on measures of cognitive, physiological, 
and experienced fear symptoms or on 
frequency of catastrophic thoughts. 
 
→ Diaphragmatic breathing does not 
provide an anxiolytic benefit in response 
to aversive interoceptive stimulation. 
 
 
 
 
  63 
Table 5, cont.  
 
Author (s) & Publication Year Type of Fear N Clinical Status Study Focus Findings & Conclusions 
Goetz & Lee, 2015 OCD 67 General sample Effects of preventive and restorative 
SB’s on exposure therapy 
The restorative SB group experienced 
greater reductions in fear and behavioral 
avoidance relative to the preventive SB 
group. The restorative SB group and no 
SB group experienced equivalent 
reductions in fear. The restorative SB 
group experienced greater reductions in 
behavioral avoidance relative to the no SB 
group. 
 
→Restorative SB’s facilitate exposure 
therapy and preventive SB’s impair 
therapeutic gains 
 
Hadjistavropoulos et al., 2000 Chronic Pain 30 Symptomatic 
 
Effects of health anxiety and coping 
strategies on response to physical 
therapy 
Coping strategy use had a minimal impact 
on response to physical therapy (when 
ignoring moderating effects of health 
anxiety levels). 
 
→Distraction is a better strategy for non-
health anxious patients. Distraction 
produced greater affective pain, and worry 
about injury for health anxious patients 
than for non-health anxious patients. 
 
Haw & Dickerson, 1998 Specific Phobia 72 Symptomatic Effects of distraction on 
desensitization and reprocessing of 
aversive information 
All groups experienced equivalent 
reductions in self-report and heart rate 
indices of anxiety. At follow-up, 
distraction groups displayed increased 
anxiety relative to the control group. 
 
→Distraction does not improve 
desensitization and reprocessing of 
aversive information 
 
Hood et al., 2010 Specific Phobia 43 Symptomatic Effects of SB’s on behavioral, 
cognitive, and subjective measures of 
fear during exposure therapy 
Both groups evidenced comparable 
reductions in self-reported anxiety and 
negative beliefs about spiders at post-
treatment and follow-up. 
 
→ Results challenge the notion that SB’s 
are always detrimental to the efficacy of 
exposure therapy 
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Table 5, cont. 
 
Author (s) & Publication Year Type of Fear N Clinical Status Study Focus Findings & Conclusions 
Kamphius & Telch, 2000 Specific Phobia 28 Symptomatic Test predictions from emotional 
processing theory of fear reduction 
Cognitive load task had a detrimental 
effect on fear reduction. 
 
→Fear reduction is hampered by 
distractions that are cognitively 
demanding 
 
Kim, 2005 Social Anxiety 45 Symptomatic Effects of decreased SB’s on social 
anxiety and negative thoughts 
Exposure with decreased SB’s under 
cognitive rationale produced the greatest 
reductions in anxiety and negative beliefs. 
Both exposure with decreased 
SB’s/cognitive rationale and exposure 
with decreased SB’s/extinction rationale 
outperformed exposure with no decrease 
in SB’s.  
 
→SB’s negatively impact exposure 
therapy 
 
Kircanski et al., 2012 Specific Phobia 44 Symptomatic Effects of distraction during exposure 
on fear responding 
The distraction and exposure alone groups 
did not differ on skin conductance 
response change 
 
→Distraction did not have a detrimental 
effect on exposure compared to exposure 
alone.  
 
Levitt et al., 2004 Panic Disorder 28 Diagnosed Effects of emotion regulation 
strategies during biological challenge 
No differences were found between the 
suppression group and the control group 
on any measures. 
 
→Suppressing emotions as a coping 
strategy does not necessarily increase 
anxiety relative to no instructions. 
However, it is possible that in this clinical 
sample patients in the control group 
naturally engaged in emotional 
suppression. 
 
Milosevic & Radomsky, 2008 Specific Phobia 62 Symptomatic Examine effects of SB’s on exposure 
treatment 
The safety behavior use group and the no 
safety behavior group experienced 
comparable treatment gains. 
 
→Safety behaviors may not interfere with 
exposure therapy. 
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Author (s) & Publication Year Type of Fear N Clinical Status Study Focus Findings & Conclusions 
Milosevic & Radomsky, 2013 Specific Phobia 126 Symptomatic Effects of SB’s on belief change 
during behavioral experiment 
Negative beliefs decreased more in the 
safety behavior group relative to the no 
safety behavior group. 
 
→Safety behavior may enhance cognitive-
behavioral therapy. 
 
Morgan & Raffle, 1999 Social Anxiety 30 Diagnosed Effects of dropping SB’s during group 
exposure therapy 
The group with instructions to drop SB’s 
evidenced greater treatment gains on 
measures specific to social anxiety relative 
to the control. 
 
→Instructions to drop SB’s may improve 
the efficacy of exposure tasks during CBT  
 
Oliver & Page, 2003 Specific Phobia 32 Symptomatic Replicate previous findings where 
distraction enhanced within-session 
fear reduction during exposure 
Exposure plus distraction produced the 
most fear reduction within-session, 
between-session, at posttreatment, and at 
follow-up. 
 
 →Distraction improves exposure 
treatment 
 
Oliver & Page, 2008 Specific Phobia 30 Symptomatic Effects of distraction on fear reduction 
during exposure 
Subjects in the distraction groups reported 
the greatest fear reduction.  
 
→Distraction improves fear reduction 
within and between exposure sessions.  
 
Penfold & Page, 1999 Specific Phobia 26 Symptomatic Effects of distraction on fear reduction 
during exposure 
Exposure plus distraction produced the 
greatest anxiety reduction within session.  
 
→Distraction may improve fear reduction 
during exposure.  
 
Powers et al., 2004 Specific Phobia 44 Symptomatic Investigate effects of perceived 
availability of SB’s on fear reduction 
during exposure therapy 
Exposure only achieved the highest end 
state functioning relative to exposure with 
SB’s available and exposure with SB 
utilization. SB availability vs SB 
utilization experienced comparable end 
state levels of functioning. 
 
→ The perception of available safety aids 
exerts a deleterious effect on fear 
reduction. 
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Author (s) & Publication Year Type of Fear N Clinical Status Study Focus Findings & Conclusions 
Rachman et al., 2011 OCD 80 General sample Effects of the judicious use of SB’s 
during exposure therapy 
Significant reductions in fear, disgust, and 
danger were experienced by both the ERP 
and exposure plus SB group. 
 
→SB’s do not impair treatment gains. 
 
Rodriguez & Craske, 1995 Specific Phobia 58 Symptomatic Effects of distraction on fear reduction 
during exposure 
Distraction produced a detrimental effect 
on fear reduction in the high intensity 
exposure group only. Distraction had no 
impact on fear reduction in the low 
intensity exposure group.  
 
→Distraction is more likely to negatively 
impact exposure when the intensity of the 
exposure is high. 
 
Salkovskis et al., 2006 Panic Disorder 16 Diagnosed Effects of dropping SB’s on exposure 
therapy outcomes 
Subjects who dropped SB’s improved 
significantly on self-report measures of 
anxiety, panic, and avoidance and 
completed more steps on a behavioral 
walk task 
 
→Instructions to drop SB’s may improve 
exposure therapy. 
 
Sloan & Telch, 2002 Specific Phobia 29 Symptomatic Examined effects of SB’s on fear 
reduction during exposure therapy 
Exposure with SB’s achieved a lower state 
of clinically significant change at 
posttreatment and follow-up relative to 
exposure alone 
 
→SB’s exert a detrimental effect on 
exposure therapy. 
 
Sy et al., 2011 Specific Phobia 58 Symptomatic Attempted to replicate deleterious 
effects of SB’s from Powers et al., 
2004 
Subjects in all groups improved 
substantially and no between group 
differences were found in respect to fear 
reduction. 
 
→SB’s may not have a deleterious effect 
on exposure therapy. 
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Author (s) & Publication Year Type of Fear N Clinical Status Study Focus Findings & Conclusions 
Taylor & Alden, 2010 (Study 1) Social Anxiety 50 Symptomatic Effects of SB’s on exposure therapy 
and social judgements 
Subjects in the exposure plus SB reduction 
group were less negative and made more 
accurate in their judgments of their 
performance.  
  
→Reducing SB’s may help to alleviate 
social anxiety. 
 
Taylor & Alden, 2010 
(Study 2) 
Social Anxiety 80 Diagnosed Effects of SB’s on exposure therapy 
and social judgements 
Subjects in the exposure plus SB reduction 
group were less negative and made more 
accurate in their judgments of their 
performance.  
 
→Reducing SB’s may help to alleviate 
social anxiety. 
 
Taylor & Alden, 2011 (same 
sample as Taylor & Alden, 2010, 
Study 2) 
 
Social Anxiety 80 Diagnosed Effects of SB’s on exposure therapy 
and social judgements 
Subjects in the exposure plus SB reduction 
group exhibited increased perceived and 
actual positive interpersonal outcomes. 
 
→Reducing SB’s may help to alleviate 
social anxiety by enhancing social 
approach behavior. 
 
Telch et al., 2004 Specific Phobia 45 Symptomatic Effects of high and low cognitive load 
distraction during exposure therapy 
Subjects in the exposure only group 
evidenced the highest end sate functioning 
relative to exposure with low or high 
cognitive load distraction. Exposure with 
high cognitive load distraction achieved 
the lowest end state functioning  
 
→High cognitive load distractions can 
impair emotional processing during 
exposure therapy. 
 
van den Hout et al., 2001 OCD 79 General sample Effects of neutralizing an obsessive 
thought on anxiety 
Immediate neutralization was 
accompanied by a steep reduction in 
anxiety. However, the no neutralizing 
group also experienced reductions in 
anxiety after 20 minutes.  
 
→Neutralization functions to reduce 
anxiety in response to obsessive thoughts. 
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Author (s) & Publication Year Type of Fear N Clinical Status Study Focus Findings & Conclusions 
van den Hout et al., 2002 OCD 120 General sample Effects of neutralizing an obsessive 
thought on anxiety 
Within 2 minutes anxiety decreased to 
near baseline levels for all groups. 
 
→Anxiety in response to an obsession 
reduces over time regardless of whether 
neutralization occurred 
 
van den Hout et al., 2011 OCD 29 Symptomatic Conduct an extended replication of 
Rachman et al., (2011) 
Findings were replicated. Both exposure 
alone and exposure with SB’s produced 
marked declines in feelings of 
contamination, fear, danger, and disgust. 
 
→The use of SB’s during exposure 
therapy should not be ruled out. 
 
van den Hout et al., 2012 OCD 32 Symptomatic Examined the effects of SB’s on 
commitment to engage in exposure 
trails during therapy 
SB’s facilitated feelings of control over 
emotions relative to no SB’s during 
exposure. 
 
→SB’s may have beneficial effects of 
exposure therapy 
 
*Note. Salkovskis et al., 2006 used the same sample as Salkovskis et al., 1999. To avoid data dependency due to the shared 
 sample, data were used from the final endpoint in Salkovskis et al., 2006.
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Table 6:  Description of relevant design features for safety behaviors added studies. 
 
 
 
Author(s) & Publication 
Year 
Exposure Description Safety Behavior Description Distra-
ction 
Study 
Required vs.  
Not Required 
Naturally 
Occurring vs. 
Investigator 
Initiated 
Safety 
Behaviors 
Maintained vs. 
Faded Across 
Treatment 
Assessments 
Under 
Equivalent 
Conditions 
Outcome Assessment 
Type 
Assessment Time 
Points 
Abramowitz & 
Moore, 2007 
Exposure to one 
idiosyncratic illness 
preoccupation trigger 
Idiosyncratic behavior identified 
during interview with 
participant 
No Required Naturally 
occurring 
Maintained No BAT-Subjective Baseline, End 
Treatment 
Antony et al., 2001 120 minutes of 
hierarchical exposure to 
spider combined with 
modeling 
Listened to educational 
audiocassette on world 
geography for the first hour of 
exposure 
Yes Required Investigator 
initiated 
Faded Yes BAT-Physio, 
BAT-Approach, 
BAT-Subjective, 
Questionnaire 
Baseline, 
Posttreatment 
Deacon et al., 2010 Graduated exposure in 
claustrophobia chamber. 
6, 5-minute trials. 
Three coping aids available: a) 
opening door on side of the 
chamber that faced a small fan 
blowing in fresh air, b) 
communicating with the 
experimenter via 2-way radio, c) 
having experimenter unlatch top 
of the chamber for the duration 
of the trial 
No Not 
Required 
Investigator 
initiated 
Faded Yes BAT-Subjective, 
Questionnaire 
Baseline, 
Posttreatment, 
Follow-up (7 
days) 
Eifert & Heffner, 
2003 
Two, 10-minute 10% 
CO2 challenges 
Diaphragmatic breathing taught 
before CO2 administration to 
gain control over symptoms 
during CO2 administration. 
No Required Investigator 
Initiated 
Maintained both BAT-Subjective, 
BAT-Approach  
Baseline, End 
Treatment, 
Posttreatment, 
Follow-up (28 
days) 
Goetz & Lee, 2015 Touching an object 
perceived to be 
contaminated 15 times 
Restorative SB group: Hand 
sanitizer use after touching 
contaminated object 
 
Preventive SB group: Using 
tissue to avoid contact with 
contaminated object 
 
No Required Investigator 
Initiated 
Maintained Yes BAT-Subjective, 
BAT-Approach 
Baseline, 
Posttreatment 
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Author(s) & Publication 
Year 
Exposure Description Safety Behavior Description Distra-
ction 
Study 
Required vs.  
Not Required 
Naturally 
Occurring vs. 
Investigator 
Initiated 
Safety 
Behaviors 
Maintained vs. 
Faded Across 
Treatment 
Assessments 
Under 
Equivalent 
Conditions 
Outcome Assessment 
Type 
Assessment Time 
Points 
Hadjistavropoulos et 
al., 2000 
45 min active 
physiotherapy session 
(physical therapy for 
chronic pain patients) 
 
Participants told to distract and 
avoid monitoring physical 
sensations (i.e., think of 
anything other than physical 
sensations during the sessions 
by using distraction) 
Yes Required Investigator 
Initiated 
Maintained Yes Questionnaire Baseline, 
Posttreatment 
Haw & Dickerson, 
1998 
6, 30-second exposures to 
a picture of a black 
widow spider on a 
computer screen 
Distractions (either (a) 
following a dot, (b) reading a 
word, (c) following and reading 
a word) 
Yes Required Investigator 
Initiated 
Maintained No BAT-Physio, 
BAT-Subjective 
Baseline, End 
treatment 
Hood et al., 2010 35 minutes of graduated 
exposure to tarantula 
Idiosyncratic -selected from 
author-generated list or 
suggested by participant 
No Required Either Maintained Yes BAT-Approach, 
Questionnaire 
Baseline, 
Posttreatment, 
Follow-up (7 
days) 
 
 
 
 
Kamphius & Telch, 
2000 
Six, 5-minute trials of 
exposure to tightly 
enclosed hallway 
 
Cognitive Load task- depressed 
button when three consecutive 
odd or even numbers were heard 
in their headphones, and added 
last two numbers whenever they 
heard a clicking noise 
 
Yes Required Investigator 
initiated 
Maintained Yes BAT-Physio, 
BAT-Subjective 
Bassline, 
Posttreatment, 
Follow-up (14 
days) 
Kircanski et al., 2012 10 exposure trials of 38 
seconds each sitting near 
a tarantula in a tank - 
same procedure repeated 
twice across two days 
Create and speak a sentence 
including an object or piece of 
furniture found in their home 
and a room or location in which 
the furnishing is found 
 
Yes Required Investigator 
initiated 
Maintained Yes BAT-Physio, 
BAT-Approach, 
BAT-Subjective 
Baseline, 
Posttreatment, 
Follow-up (7 
days) 
Levitt et al., 2004 15-minute inhalation of 
5.5% CO2 enriched air  
 
Listened to audiotape 
instructions prior to exposure 
instructing participants to 
suppress anxious thoughts and 
feelings and other discomfort 
 
No Required Investigator 
initiated 
Maintained No BAT-Physio, 
BAT-Subjective, 
Questionnaire 
Baseline, End 
treatment, 
Posttreatment  
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Table 6, cont. 
Author(s) & Publication 
Year 
Exposure Description Safety Behavior Description Distra-
ction 
Study 
Required vs.  
Not Required 
Naturally 
Occurring vs. 
Investigator 
Initiated 
Safety 
Behaviors 
Maintained vs. 
Faded Across 
Treatment 
Assessments 
Under 
Equivalent 
Conditions 
Outcome Assessment 
Type 
Assessment Time 
Points 
Milosevic & 
Radomsky, 2008 
45 minutes graduated in 
vivo exposure to snake 
 
Use of one or more response 
induction aids (parts of a bee 
keeper suit) when approaching 
snake 
 
No Not required Investigator 
initiated  
Maintained Both BAT-Subjective, 
BAT-Approach, 
Questionnaire 
Baseline, End 
treatment, 
Posttreatment 
Milosevic & 
Radomsky, 2013 
20-minute self-paced 
behavioral experiment 
confronting a spider 
 
Use of one or more response 
induction aids (parts of a bee 
keeper suit) when approaching 
spider 
 
No Required Investigator 
initiated 
Maintained Both BAT-Subjective, 
BAT-Approach, 
Questionnaire 
Baseline, End 
treatment, 
Posttreatment 
Oliver & Page, 2003 Three weekly 10-minute 
exposures to stimuli 
related to blood injection 
fears (two images with 
bloody wounds and a 
syringe filled with stage 
blood) 
 
Engage in conversation with the 
experimenter that is unrelated to 
the exposure  
 
Yes Required Investigator 
initiated 
Maintained Yes BAT-Subjective, 
Questionnaire 
Baseline, 
Posttreatment, 
Follow-up (30 
days) 
Oliver & Page, 2008 Three weekly 10-minute 
exposures to stimuli 
related to blood injection 
fears (two images with 
bloody wounds and a 
syringe filled with stage 
blood) 
 
External focus group: 
conversation with the 
experimenter that is unrelated to 
the exposure 
 
Internal focus group: 
conversation with the 
experimenter that is unrelated to 
feared stimuli and focused on 
"aspects of the internal 
environment" (e.g. 'tell me how 
your feet feel in your shoes right 
now')  
 
Yes Required Investigator 
initiated 
Maintained Yes Questionnaire Baseline, 
Posttreatment, 
Follow-up (30 
days) 
  72 
Table 6, cont. 
 
 
 
Author(s) & Publication 
Year 
Exposure Description Safety Behavior Description Distra-
ction 
Study 
Required vs.  
Not Required 
Naturally 
Occurring vs. 
Investigator 
Initiated 
Safety 
Behaviors 
Maintained vs. 
Faded Across 
Treatment 
Assessments 
Under 
Equivalent 
Conditions 
Outcome Assessment 
Type 
Assessment Time 
Points 
Penfold & Page, 1999 Exposure to blood injury 
injection stimuli (images 
and syringe) 
 
Exposure irrelevant 
conversation with experimenter 
 
Yes Required Investigator 
initiated 
Maintained No BAT-Subjective Baseline, End 
treatment 
Powers et al., 2004 30 minutes of in vivo 
exposure in 
claustrophobia chamber 
(6, 5-minute trials) 
 
SB available group: Told three 
safety aids would be available, 
but only use them if you must: 
(a) opening a small window in 
the chamber to allow access to 
fresh air blown in by a small fan 
(b) unlocking the door after 2 
minutes of exposure, c) 
communicating with 
experimenter via 2-way radio 
 
SB utilization group:  
Expected to use at least one of 
the above mentioned SB’s 
during exposure  
No SB available 
group: Not 
required 
 
SB 
utilization 
group: 
Required 
Investigator 
initiated 
Maintained Yes BAT-Subjective, 
Questionnaire 
Baseline, 
Posttreatment, 
Follow-up (14 
days) 
Rachman et al., 2011 Touching a selected 
contaminant 20 times 
during visit 1 and 16 
times during visit 2. 
Contaminant used was 
one of 6 that elicited 
highest feelings of 
contamination at baseline.  
 
Wiping with a hygienic wipe 
until feelings of contamination 
are reduced to 20% or lower. 
Immediately after exposure for 
the first 10 trials in visit 1, and 
after a 30 second delay after the 
second 10 trials in visit 1 and 
during visit 2. 
 
No Required Investigator 
initiated 
Maintained No BAT-Subjective Baseline, End 
treatment 
Rodriguez & Craske, 
1995 
Approached feared animal 
until fear is 70-80 on a 
100-point scale (high 
intensity group) or 40-50 
(low intensity group) and 
remain for 15-minutes  
 
Instructions to look at slides 
while confronting animal  
 
Yes Required Investigator 
initiated 
Maintained Yes BAT-Physio, 
BAT-Subjective, 
BAT-Approach 
Baseline, End 
treatment, 
Posttreatment 
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Table 6, cont. 
 
 
 
Author(s) & Publication 
Year 
Exposure Description Safety Behavior Description Distra-
ction 
Study 
Required vs.  
Not Required 
Naturally 
Occurring vs. 
Investigator 
Initiated 
Safety 
Behaviors 
Maintained vs. 
Faded Across 
Treatment 
Assessments 
Under 
Equivalent 
Conditions 
Outcome Assessment 
Type 
Assessment Time 
Points 
Sloan & Telch, 2002 Six, 5-minute exposure 
trials in a claustrophobia 
chamber 
 
SBs were optional but could be 
used if felt the need; a) opening 
window in chamber, b) standing 
near chamber door, c) checking 
door latch, d) talking with 
experimenter on intercom  
 
No Not 
Required 
Investigator 
initiated 
Maintained Yes BAT-Physio, 
BAT-Subjective,  
Questionnaire 
Baseline, 
Posttreatment, 
Follow-up (14 
days) 
Sy et al., 2011 Up to 30 minutes of in 
vivo exposure in 
claustrophobia chamber 
(6, 5-minute trials) 
 
SB available group: Told three 
safety aids would be available, 
but only use them if you must: 
(a) opening a small window in 
the chamber to allow access to 
fresh air blown in by a small fan 
(b) unlocking the door after 2 
minutes of exposure, c) 
communicating with 
experimenter via 2-way radio 
 
SB utilization group:  
Expected to use at least one of 
the above mentioned SB’s 
during exposure  
 
 
No SB available 
group: Not 
required 
 
SB 
utilization 
group: 
Required 
Investigator 
initiated 
Maintained Yes BAT-Subjective, 
Questionnaire 
Baseline, 
Posttreatment 
Telch et al., 2004 6, 5-minute trials in a 
claustrophobia chamber 
 
Low cognitive load:  
listened to 15 neutral words that 
were presented repeatedly (e.g., 
"banana") 
 
High cognitive load:  
participants listened to different 
tones and indicated if they were 
the same or different 
 
 
Yes Required Investigator 
initiated 
Maintained Yes BAT-Physio, 
BAT-Subjective 
Baseline, 
Posttreatment 
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Table 6, cont. 
 
Author(s) & Publication 
Year 
Exposure Description Safety Behavior Description Distra-
ction 
Study 
Required vs.  
Not Required 
Naturally 
Occurring vs. 
Investigator 
Initiated 
Safety 
Behaviors 
Maintained vs. 
Faded Across 
Treatment 
Assessments 
Under 
Equivalent 
Conditions 
Outcome Assessment 
Type 
Assessment Time 
Points 
van den Hout et al., 
2001 
Writing "I hope [name of 
friend or relative] is in a 
car accident" followed by 
closing eyes and thinking 
about the situation for a 
few seconds (tailored 
slightly if participants 
refused, or if they did not 
reach at least SUDS of 50 
on the test) 
 
Participants were told that they 
may do whatever they wish to 
try to reduce or cancel the 
effects of writing the sentence 
(e.g., tearing the sheet with the 
written-out sentence).  
 
No Required Either Maintained No BAT-Subjective Baseline, End 
treatment 
van den Hout et al., 
2002 
Exposure to 
uncomfortable Thought-
action-fusion sentence. "I 
hope…. is in a car 
accident." Then imagine 
the situation. Made sure it 
produced a SUDs rating 
of 50 or above, if not, 
visualization were made 
more intense.  
 
Participants were told that they 
may do whatever they wish to 
try to reduce or cancel the 
effects of writing the sentence 
(e.g., tearing the sheet with the 
written-out sentence).  
 
No Required Either Maintained Both BAT-Subjective Baseline, End 
treatment, 
Posttreatment 
van den Hout et al., 
2011 
Touching one item 
(picked from 6 baseline 
items) rated as most 
contaminated. 20 times 
per session with a 30 
second break between 
trials. 2 sessions about, 2 
weeks apart 
 
Using as many disinfectant 
wipes as desired for up to 30 
seconds between each trial. 
 
No Required Investigator 
initiated 
Maintained Yes BAT-Subjective Baseline, 
Posttreatment 
van den Hout et al., 
2012 
20 trials of touching a 
contaminant (1 out of 6 
rated as highest 
contamination rating at 
baseline) 
 
Use of liquid disinfectant 
between trials 
 
No Required Investigator 
initiated 
Maintained Both BAT-Subjective Baseline, End 
treatment, 
Posttreatment 
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Table 7:  Description of relevant design features for safety behaviors removed studies. 
Author (s) &  
Publication Year  
Exposure Description SB Description Distraction 
Study 
SB Methodological  
Taxonomy 
Assessments 
Under 
Equivalent 
Conditions 
Outcome Assessment 
Type 
Assessment Time 
Points 
Kim, 2005 5-minute speech 
presentation on 
"friendship in college 
students" that was 
videotaped. Subjects were 
told they would be rated 
by 10 undergrads on ideas 
and attitude presented 
 
Provided 
instructions to 
not use 
idiosyncratically 
identified safety 
behaviors  
 
No Naturally occurring No BAT-Subjective Baseline, End 
treatment 
Morgan & Raffle, 
1999 
10 days (80 hr) of 
treatment and 1 week of 
unsupervised exposure - 
social phobia group 
treatment 
 
Instructions to 
drop safety 
behaviors used 
by patient in 
social situation 
No Naturally occurring Yes BAT-Subjective, 
Questionnaire 
Baseline, 
Posttreatment 
Salkovskis et al., 
2006* 
Rationale followed by two 
1.5 hour sessions of 
exposure. Exposure 
procedure was 
idiosyncratic to the 
individual’s agoraphobic 
complaints 
 
Idiosyncratic to 
the individual 
 
No Naturally occurring Yes BAT-Subjective, 
BAT-Approach, 
Questionnaire 
Baseline, 
Posttreatment 
Taylor & Alden, 2010 
(Study 1) 
5-minute discussion with a 
confederate. Open-ended 
"getting to know you" 
conversation.  
 
Idiosyncratic 
(identified using 
an interview) 
 
No Naturally occurring No BAT-Subjective, 
BAT-Approach 
Baseline, End 
treatment 
Taylor & Alden, 2010 
(Study 2); Taylor & 
Alden, 2011 
5-minute discussion with a 
confederate. Open-ended 
"getting to know you" 
conversation.  
Idiosyncratic 
(identified using 
an interview) 
 
No Naturally occurring No BAT-Subjective, 
BAT-Approach 
Baseline, End 
treatment 
 
Note. *Salkovskis et al., 2006 used the same sample as Salkovskis et al., 1999. To avoid data dependency due to the shared 
sample, data were used from the final endpoint in Salkovskis et al., 2006.   
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ADDING SAFETY BEHAVIORS TO EXPOSURE THERAPY (SB+): PRELIMINARY ANALYSES  
Equivalent Versus Non-Equivalent Testing Conditions 
We began analyses by investigating the impact of assessing outcome when 
treatment groups were and were not equated for the availability or use of safety 
behaviors. Among the studies focused on the addition of safety behaviors (SB+), results 
suggest that the equivalence of testing conditions had a statistically significant influence 
on effect size (Q(1) = 4.10, p = .04). The addition of safety behaviors produced a trend 
for lower symptom levels when testing conditions were non-equivalent (g = -0.15; p = 
.08); and the addition of safety behaviors produced no statistically significant impact on 
symptom level when the testing conditions were equivalent (g = 0.05; p = .30; see Table 
8). Due to the moderating effect of the equivalence of testing conditions, and the 
methodological problems associated with using non-equivalent testing conditions to 
compare treatment groups, we performed the remaining analyses solely using the effect 
sizes that represented equivalent testing conditions.  
Heterogeneity  
After effect sizes for non-equivalent testing conditions were removed, 30 unique 
between-group comparisons remained in the sample of studies. To justify testing 
additional moderator testing, we evaluated the heterogeneity of remaining effect sizes. 
Heterogeneity was greater than what would be expected by sampling error alone (Q(29) = 
50.01, p = .01). This justified further testing of moderators to explore potential 
contributors to the heterogeneity in effect sizes.  
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ADDING SAFETY BEHAVIORS TO EXPOSURE THERAPY (SB+): PRIMARY OUTCOME 
Of the 30 studies that assessed the impact of adding safety behaviors to exposure 
therapy, 14 effect sizes were in a positive direction, and 16 were in a negative direction 
(see Figure 3). The effect sizes for each study ranged from -1.10 to 0.71. The weighted 
average effect size (g) in the fixed effects model was estimated as 0.05 with a 95% 
confidence interval from -0.05 to 0.15, suggesting that overall, the addition of safety 
behaviors during exposure therapy did not impact treatment outcome. The random effects 
model produced similar results (g = .01; 95% CI = -0.12 to 0.15; p = .84). 
Figure 3:  Forest plot for effect sizes of studies comparing exposure therapy with 
safety behaviors added to an exposure therapy control group.  
 
Note. SB = safety behaviors.  
  78 
ADDING SAFETY BEHAVIORS TO EXPOSURE THERAPY (SB+): MODERATOR TESTS 
Assessment-Related Moderators  
 We tested whether the modality of assessment impacted effect size across four 
different types of assessments: (1) avoidance behavior, (2) subjective ratings, and (3) 
physiological responding during a behavioral avoidance tests (BATs), and (4) responses 
on symptom questionnaires. Moderator testing suggested that the type of measurement 
did not impact effect size overall (Q(3) = 2.07, p = .56). The overall effect sizes within 
each modality of assessment were not different from zero (p’s ≥ .11).  
 We then examined whether the time-point at which the assessment was conducted 
explained variance in effect sizes. Sample size limitations prevented us from evaluating 
assessment time-point in a continuous fashion using meta-regression (with only k = 11 
follow-up effects available for analysis). Effect sizes were therefore categorized into 
those conducted on the same day as treatment ended (end of treatment), and those 
conducted one or more days after treatment was ended (follow-up). Moderator analyses 
suggested that measurement time-point did not impact the strength of the effect size 
(Q(1) = 1.17, p = .28), and the Hedge’s g estimate for the effect size at each of the two 
time points was not different than zero (p’s ≥ .15).   
Moderating Study Characteristics 
 Studies were grouped into categories based on the clinical severity of the recruited 
population (studies that had no inclusion criteria for clinical severity/used a general 
sample, those that recruited a symptomatic population, and those that recruited a 
population meeting diagnostic criteria for the condition targeted during exposure-based 
treatment). These categories did not moderate effect size (Q(2) = 1.65, p = .44), and 
Hedge’s g point estimates were no different from zero for each of the three categories 
(p’s ≥ .16).  
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 Studies were next grouped by the diagnostic condition corresponding to the 
symptoms targeted by the treatment. The most common treatment target was specific 
phobia symptoms. Studies were therefore categorized into whether they involved 
exposure therapy targeting specific phobia symptoms versus exposure therapy targeting 
symptoms associated with other diagnostic conditions. Moderator analysis suggested a 
significant impact of this distinction (Q(1) = 5.94, p = .01), such that exposure therapy 
targeting specific phobia symptoms was less effective when safety behaviors were added 
(g = .12; 95% CI = .01 to .23; p = .03), and exposure therapy targeting other 
psychological conditions was not impacted by adding safety behaviors (g = -.16, 95% CI 
= -.35 to .04, p = .11).  
Moderating Safety Behavior Characteristics  
 The next three moderation tests involved studying variables related to the safety 
behaviors themselves. The effect sizes for studies manipulating distraction were not 
statistically different from those manipulating other types of safety behaviors (Q(1) = 
1.13, p = .29). Furthermore, the effect size estimates within each of these two groups did 
not differ from zero (p’s ≥ .14).  
 Studies were furthermore categorized into those in which the instruction set in the 
safety behaviors added group required the performance of safety behaviors versus those 
in which safety behaviors were available but not required to be used. The moderator test 
yielded a marginal effect (Q(1) = 3.05, p = .08), such that adding and then requiring the 
use of safety behaviors did not have a statistically significant impact on symptom 
outcomes (p = .99), but making safety behaviors available without requiring their use led 
to higher symptom levels at the end of treatment (g = .20; 95% CI = .01 to .38; p = .04).  
 Finally, studies were categorized into those that involved the addition of safety 
behaviors that were selected by the investigator (“investigator initiated”) as compared 
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with the addition of safety behaviors that were suggested by the participant (“naturally 
occurring”). The type of safety behavior added did not have a statistically significant 
impact on treatment outcome (Q(1) = .46, p = .50), and neither the effect size estimate for 
investigator initiated safety behaviors nor for naturally occurring safety behaviors was 
different from zero (p’s ≥ .23). 
 
Table 8:  Moderator tests for studies testing the addition of safety behaviors to 
exposure therapy.    
Assessment Characteristics 
Outcome/Moderator k g 95% confidence interval 
Low Estimate       High Estimate 
Qb 
Testing Equivalence  
 
    4.10* 
Equivalent 30 
 
0.05 
 
-0.05 0.15  
Non-equivalent 
 
12 -0.15† -0.32 0.02  
Type of 
measurement 
 
    2.07 
BAT- Approach 
 
11 -0.05 -0.38 0.28  
BAT- Subjective 
 
24 0.13 -0.03 0.29  
BAT- Physiological 
 
9 0.11 -0.18 0.39  
Questionnaire 
 
17 -0.01 -0.16 0.14  
Time Point 
 
    1.17 
End of treatment 
 
30 0.02 -0.09 0.13  
Follow up 
 
11 0.15 -0.05 0.34  
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Table 8, cont.  
 
Sample and Treatment Target Characteristics 
Outcome/Moderator k g 95% confidence interval 
Low Estimate      High Estimate 
Qb 
Clinical Status 
 
    1.65 
 
General sample 
 
4 -0.15 -0.49 0.19  
Symptomatic 
 
23 0.08 -0.03 0.18  
Diagnosed 
 
3 -0.01 -0.37 0.35  
Treatment Target 
 
    5.94* 
Specific Phobia 
 
20    
0.12* 
0.01 0.23  
Other Diagnoses 
 
10  -0.16 -0.35 0.04  
Safety Behavior Characteristics 
Outcome/Moderator k d 95% confidence interval 
Low Estimate   High Estimate 
Qb 
Distraction Only     1.13 
 
Distraction- 
    Only SBs 
13 -0.01 -0.17 0.14  
Not Distraction- 
    Only SBs 
17 0.09 -0.03 0.22  
SB Instructions 
 
    3.05† 
SB Required 
 
25 0.0006 -0.11 0.11  
SB Not Required 
 
5 0.20* 0.01 0.38  
SB Selection     0.46 
 
Investigator 
Initiated  
27 0.06 -0.04 0.17  
Naturally 
Occurring 
3 -0.04 -0.34 0.25  
Note. *p ≤ .05 †p ≤ .10. SB = Safety behaviors.  
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REMOVING SAFETY BEHAVIORS FROM EXPOSURE THERAPY: PRELIMINARY ANALYSES 
Equivalent Versus Non-equivalent Testing Conditions  
 We first examined whether the effect sizes for removing safety behaviors from 
exposure therapy were dependent on whether or not the testing conditions were 
equivalent for safety behavior use instructions. Analyses suggested that within the SB- 
studies, this did not moderate effect sizes (Q(1) = .77, p = .38). The effect size estimates 
of both equivalent and non-equivalent measures suggested the benefit of removing safety 
behaviors (for equivalent assessments (k = 2); g = .59, 95% CI = .18 – 1.01, p < .01; for 
non-equivalent assessments (k = 3); g = .37, 95% CI = .10 – .65, p = .01). Due to the 
limited sample size, and also the fact that the equivalence of testing conditions did not 
moderate outcomes, we did not exclude effect sizes reflecting non-equivalent testing 
conditions in the remaining analyses.  
Heterogeneity 
 Effect sizes across the five SB- studies were not significantly heterogeneous (Q(4) 
= 2.90, p = .57). This lack of heterogeneity could be in part due to low sample size, 
however, I2, which is less dependent on sample size (Higgin, Thompson, Deeks, & 
Altman, 2003), similarly yielded a very low estimated of heterogeneity of effect sizes (I2 
< .01). Due to the lack of heterogeneity among effect sizes, further moderator testing was 
not indicated. Any variance in the average effect sized among these studies is likely 
accounted for by sampling error.   
REMOVING SAFETY BEHAVIORS FROM EXPOSURE THERAPY: PRIMARY OUTCOME  
Primary Outcome 
 All of the five studies that assessed the impact of adding safety behaviors to 
exposure therapy yielded an average effect in the positive direction. (see Figure 4). For 
individual studies, the estimated effect sizes (g) ranged from 0.28 to 0.74 (small to large 
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effects). In the fixed effects model, the weighted average effect size (g) was 0.44 with a 
95% confidence interval from 0.21 to 0.67.4 The direction of findings suggests that there 
were higher symptoms levels after exposure therapy that did not remove safety behaviors 
during therapy. In other words, data suggest that removing safety behaviors during 
exposure therapy yields better outcomes.  
Figure 4:  Forest plot for effect sizes of studies comparing exposure therapy with 
safety behaviors removed to an exposure therapy control group.  
 
Publication Bias  
 Publication bias was investigated in the final sample of effect sizes used in the 
primary analyses, examining the influence of adding (SB+) and removing (SB-) safety 
behaviors, as compared with an exposure therapy control group. A visual examination of 
the funnel plot for SB+ studies suggests that there was a bias toward publishing studies 
showing superior outcomes for adding safety behaviors among studies with higher 
standard error. This is consistent with a file drawer effect, suggesting that the overall 
effects for the SB+ studies might be somewhat biased in favor of adding safety behaviors 
(see Figure 5). No publication bias was evident in the SB- studies, however, a clear visual 
                                                
4 A random effects model was also calculated, and produced effects identical to the fixed effects model, 
likely due to the low sample size of studies included (k = 5).  
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examination of publication bias within the sample is challenging due to the low number 
of studies (see Figure 6).  
Figure 5:  Funnel plot for studies testing exposure therapy with and without the 
addition of safety behaviors. 
                    Hedge’s g 
 
Figure 6:  Funnel plot for studies testing exposure therapy with and without the 
removal of safety behaviors.  
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Discussion 
 We conducted a meta-analysis to evaluate the overall impact of adding (SB+) and 
removing (SB-) safety behaviors from exposure therapy. Findings suggest that adding 
safety behaviors to exposure therapy produced no overall effect on treatment outcome. 
However, a closer look at the data reveals significant heterogeneity among effect sizes, 
which was explained by a few moderators. First, the equivalence of testing conditions in 
their safety behavior use/availability was found to moderate effect sizes. Comparisons 
with non-equivalent testing conditions (in which one group had access to safety behaviors 
and the other did not), artificially inflated the benefits of adding safety behaviors to 
exposure therapy. After removing assessments with non-equivalent testing conditions, we 
found that adding safety behaviors made exposure therapy less effective under certain 
conditions, specifically when exposure therapy targeted specific phobia symptoms 
(relative to other conditions), and when safety behaviors were available, but their use was 
not required (relative to when safety behaviors were added and their use was required).  
 It is possible that effect sizes were more potent among SB+ studies targeting 
specific phobia, relative to other psychological conditions, due to the circumscribed 
nature of specific phobias. The vast majority of SB+ studies involved requiring 
participants to use one or more safety behaviors (SBs) suggested by the investigators 
(investigator initiated SBs; k = 27) rather than allowing participants to select their own 
safety behaviors (naturally occurring SBs; k = 3). Since specific phobias involve more 
circumscribed fears, it is likely that investigators were better able to guess the appropriate 
safety behaviors to circumvent the participant’s fear and increase a sense of safety. Based 
on this logic, one would expect that adding naturally occurring safety behaviors would be 
more detrimental to treatment outcome than adding investigator initiated safety 
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behaviors. Although in our moderator analyses we found no differences in effect size 
based on this variable, our test was severely limited in statistical power due to the low 
number of studies that have examined the addition of naturally occurring safety 
behaviors.  
 A second potential explanation for detrimental effect of adding SBs found among 
specific phobia studies may relate to the short treatment duration of specific phobia 
relative to other psychological conditions. The duration of exposure therapy within the 
SB+ studies was commonly quite low (typically less than an hour; see Table 6). Whereas 
specific phobia can be successfully treated within a single, two-hour session (Őst, 1989), 
treatment for other conditions such as panic disorder, social anxiety, and OCD, typically 
involves multiple treatment sessions (e.g., Craske & Barlow, 2007; Foa, Yadin, & 
Lichner, 2012; Heimberg & Becker, 2002). Since the experimental designs of these 
studies approximated the duration of standard specific phobia treatment more closely, 
perhaps the impact of adding safety behaviors to treatment was stronger, whereas to 
observe the impact of adding safety behaviors on exposure therapy for conditions such as 
social anxiety disorder, one may need a longer treatment protocol.  
 We were surprised to find that adding safety behaviors to exposure therapy was 
more detrimental to treatment outcomes when their use was not required, relative to when 
their use was required. Given prior research showing no differences between these two 
groups (Powers et al., 2004; Sy et al., 2011), we did not expect the impact to differ in our 
meta-analysis. However, the moderator test reached trend-level, and the point estimate 
(g) suggested a statistically significant drawback of adding safety behaviors without 
requiring their use. Although a tentative explanation, it is possible that internal versus 
external attribution of safety behavior use plays a role in this effect. Perhaps participants 
attribute the use of the safety behavior to their own inability to cope (internal attribution) 
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when its use is not required. This could have a more negative impact on treatment 
outcomes, relative to using safety behaviors because the experimenter requires it 
(external attribution). Internal attribution of safety behavior use may lead to more marked 
reductions in self-efficacy to cope as compared with external attribution of safety 
behaviors use (Bandura & Adams, 1977). However, this is a tentative hypothesis that 
would require further empirical examination. It is also important to interpret this effect 
with caution, given the trend-level of the moderator test.   
 Among studies that evaluated the removal of safety behaviors (SB-), we found a 
clear benefit for removing safety behaviors during exposure therapy, as compared with an 
exposure-only control condition. There was no difference among effect sizes that 
reflected equivalent and non-equivalent testing conditions (in terms of safety behavior 
instructions) within the SB- studies. Non-equivalent testing conditions within these 
studies would involve a comparison in which one group was still operating under 
instructions to remove safety behaviors, whereas the control group would have no 
instructions related to safety behaviors. Under both equivalent and non-equivalent testing 
conditions, results suggested the benefit of removing safety behaviors. Therefore, the 
overall effect size did not appear to be influenced by artificially dampening the impact of 
the SB removed group, which was tested under more challenging exposure therapy 
conditions when instructions for safety behavior use were non-equivalent. Furthermore, 
the overall effect sizes demonstrated very little heterogeneity outside what one would 
expect due to sampling error, which strengthens confidence in the conclusion that 
removing safety behaviors produces overall superior treatment outcomes.   
 Results from the present study aligned with a previous meta-analysis (Meulders et 
al., 2016) in that we found that adding safety behaviors did not impact exposure therapy 
outcomes on average across all studies. However, due to the heterogeneity observed 
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among effect sizes (another finding in common with Meulders et al., 2016), we tested 
various effect size moderators and were able to identify conditions under which adding 
safety behaviors worsened treatment outcomes. Regarding our analysis of SB- studies, 
findings differed somewhat from those of Meulders and colleagues (2016), who found a 
“borderline significant overall effect size in favor of omitting [safety-seeking behaviors]” 
(p. 151). The present analysis identified a clear benefit for the removal of safety 
behaviors.  
 There are several potential explanations for the discrepancy between the results in 
the present meta-analysis, and the results of Meulders and colleagues (2016). First, we 
added several study exclusion criteria to increase the methodological rigor of the studies 
used in our meta-analysis. For example, we removed studies that used within-subjects, 
crossover designs due to the potential for carryover effects. We furthermore added 
another study exclusion criteria not used in previous research; not only did both treatment 
groups have to receive exposure therapy, but exposure therapy procedures also had to be 
equivalent with the exception of the safety behavior manipulation (or related instructional 
sets). These additional exclusion criteria, while clearly coming with the drawback of 
lowering our sample size, might have increased our ability to detect the true impact of 
removing safety behaviors from exposure therapy.  
 It is also possible our findings differed from Meulders and colleagues (2016) 
because we used different procedures for coding and calculation study effect sizes. We 
coded multiple outcome assessments within studies, as opposed to selecting one time 
point and assessment (i.e., self-reported fear at the last available time point; Meulders et 
al., 2016). Furthermore, when pre-treatment data were available, we adjusted post-
treatment outcomes for pre-treatment differences. Therefore in addition to screening out 
studies with more methodological problems, we also made an effort to calculate effect 
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sizes using procedures that would be more sensitive to detecting the true effect of the 
experimental manipulation.  
IMPLICATIONS FOR THEORETICAL DEVELOPMENT  
 In terms of the theoretical development, a close comparison of the actual 
treatment recommendations from authors on both sides of the safety behavior debate 
reveals that they agree more than they disagree. Authors on one side of the debate suggest 
that clinicians “eliminate…safety behavior as soon as possible” (Blakey & Abramowitz, 
2016, p. 13) or “eliminate any safety-seeking behaviors which may be maintaining 
catastrophic cognitions” (Salkovskis et al., 1996); whereas authors on the other side of 
the debate suggest that, safety behaviors “should be used in a limited manner and only for 
a limited period, especially in the early stages of treatment” (Rachman et al., 2008, p. 
171). Both perspectives acknowledge the importance of reducing safety behaviors over 
the course of exposure therapy, which has been further confirmed by our quantitative 
synthesis of data demonstrating the benefits of removing safety behaviors during 
exposure therapy. 
  However, only one theoretical perspective (judicious use/response induction) 
would predict that introducing safety behaviors could produce superior treatment 
outcomes, and only under the condition that safety behaviors are faded out over the 
course of treatment (e.g., Rachman et al., 2008). Unfortunately, even after a 
comprehensive review of the literature, we still cannot address the question of whether or 
not judiciously adding safety behaviors to exposure therapy improves outcomes. Only 
two out of the twenty-six identified SB+ studies evaluated the impact of adding, and then 
fading, safety behaviors (see Table 6). Much additional research is needed in this area 
before we can draw any firm conclusions on the relative benefits or drawbacks of 
judicious safety behavior use.  
  90 
 Several SB+ studies examined the use of safety behaviors that are introduced and 
maintained throughout treatment. However, there are no theoretical perspectives, to our 
knowledge, that would predict superior treatment outcomes when safety behaviors are 
added, and then maintained, for the full course of treatment. Our overall null findings on 
the impact of adding safety behaviors to exposure therapy could then be viewed as 
somewhat surprising (note that the vast majority of studies included in this analysis 
maintained safety behaviors throughout treatment). However, examination of study effect 
sizes reveals a high degree of variance, greater than what one would expect from 
sampling error alone.  
 This high variance in study effect sizes highlights the importance of moving away 
from the question of whether or not safety behaviors impact treatment outcome, and 
instead working towards identifying under which conditions adding safety behaviors 
impacts exposure therapy outcomes. In this investigation, we identified a few of these 
moderators (e.g., worse outcomes were found when safety behaviors were added during 
exposure therapy for specific phobia symptoms), but there are certainly many more 
moderators that could be investigated moving forward. For example, only three SB+ 
studies evaluated the impact of adding naturally occurring as opposed to investigator 
initiated safety behaviors. Further examination of the impact of adding naturally 
occurring safety behaviors to exposure therapy is an example of one area of research that 
will require additional data collection, particularly since this type of manipulation is more 
applicable to clinical settings. Additionally, determining whether the influence of safety 
behaviors is moderated by whether or not safety behaviors are faded over the course of 
treatment would help move forward the debate regarding the hypothesized benefits of 
judicious safety behavior use.   
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LIMITATIONS OF EXISTING RESEARCH AND FUTURE RESEARCH DIRECTIONS  
 Results from the present study highlight a number of limitations in the existing 
research on safety behaviors, which provide key directions for future research. For 
example, our findings highlight the importance of taking more care in the design of future 
studies testing the addition of safety behaviors to exposure therapy (SB+ studies). 
Specifically, our findings demonstrated that among SB+ studies, effect sizes were 
moderated by whether or not testing conditions were equivalent. Several studies 
evaluated differences between groups while one group had access to safety behaviors and 
the other did not. Our data suggest that this has the effect of falsely inflating the benefits 
of adding safety behaviors to exposure therapy. This methodological issue could easily be 
guarded against in future studies by providing a post-treatment assessment during which 
neither group has access to safety behaviors.  
 There are several additional limitations in the prior research on safety behavior 
use during exposure therapy, which suggest important areas for future research. Although 
clinical investigators are typically most interested in the end goal of translating findings 
to benefit treatment-seeking populations, very few studies recruited samples that met 
diagnostic criteria for the psychological condition under investigation (less than 25% of 
the studies reviewed; see Table 5). Recruitment of samples exhibiting more severe 
symptoms might be particularly important for further investigation of the judicious use of 
safety behaviors. Specifically, in his review, Rachman et al. (2008) suggested that “safety 
behavior ...[may be] significantly more effective than conventional therapy in treatment 
patients with high-intensity/severe fears” (p. 170). Given the emphasis on the idea that 
judicious safety behavior use might make therapy “more acceptable to patients” 
(Rachman et al., 2008; p.170), it will be especially important to conduct future 
investigations in populations with more severe fears to fully test this hypothesis. 
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Furthermore, given the potency of exposure therapy, it is relatively easy to reach a floor 
effect when treating populations with low symptom levels, which would mask the ability 
to detect potential influences of safety behavior use on treatment outcome. Using 
treatment-seeking populations in future studies would therefore provide data that would 
better generalize to applied clinical work.  
 As observed by authors of prior research reviews in this area (Helbig-Lang & 
Petermann, 2010), the conclusions we can draw from these studies rely entirely on the 
integrity of the experimental safety behavior manipulation within each study. However, 
manipulation checks within some safety behavior studies (e.g., Morgan & Raffle, 1999) 
have revealed low integrity of the manipulation, that is, ensuring that participants follow 
instructions to either use or suppress safety behaviors. When manipulation checks do not 
confirm the integrity of the safety behavior manipulation, the conclusions we can draw 
from study findings are severely limited. To ensure higher integrity of the manipulation 
of safety behaviors, it may be helpful to provide participants with repeated reminders of 
the instructions on safety behavior use or fading throughout exposure therapy. 
Participants encountering feared stimuli during exposure therapy may have difficulty 
attending to and following the experimental instructions they received prior to starting 
treatment.  
 In future studies evaluating the influence of adding safety behaviors, it may also 
be useful to allow participants to select their own safety behaviors. This is more in line 
with clinical practice, in which therapists would typically tailor treatment to the 
individual. Furthermore, this would help to eliminate the guesswork involved in 
investigators suggesting safety behaviors that may or may not increase a given 
participant’s sense of safety during exposure therapy. As suggested by prior reviews 
(Helbig-Lang & Petermann, 2010; Telch & Lancaster, 2012), a functional evaluation of 
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the behavior is recommended as a prerequisite to concluding that a given behavior serves 
a protective function for that individual. For example, although distraction is often 
viewed as a safety behavior (an unnecessary protective action to reduce exposure to 
internal psychological distress or to reduce awareness of the feared stimulus) distraction 
can also serve the opposite function. For example, visual distraction from the feared 
stimulus (e.g., a spider) might increase the potency of exposure among patients who use 
hyper-vigilant attendance to a feared stimulus as a safety behavior (e.g., closely watching 
a spider’s movement). Therefore, in future investigations, it may be useful to focus 
primarily on the manipulation of naturally occurring safety behaviors, or safety behaviors 
identified by the individual participant as (unnecessary) protective actions. Doing so 
would further increase the integrity of the experimental manipulation.  
 Another limitation the present study relates to the fact that findings may not 
necessarily generalize to the impact of using of safety behaviors in daily life, outside the 
context of formal exposure therapy procedures. Experimental studies evaluating the 
impact of adding safety behaviors during daily life routines provide important 
information of the role of safety behaviors in provoking anxiety. There have been few 
such studies conducted to date (Deacon & Maack, 2008; Olatunji et al., 2011); although 
findings thus far suggest that introducing safety behaviors in daily life increases 
psychopathology. Findings from the reviewed studies additionally cannot comment on 
the impact of fading safety behaviors, outside the context of formal exposure therapy 
procedures. However, findings to date on a treatment protocol focused purely on safety 
behavior fading highlights the promise of this intervention strategy (Schmidt et al., 2012). 
 Furthermore, it would be beneficial for more studies to evaluate the impact of 
safety behavior use (or removal) on treatment outcomes for conditions other than anxiety-
related disorders. Although prior studies have identified an association between safety 
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behavior use and symptoms of conditions other than anxiety, such as eating disorders 
(Shafran, Fairburn, Robinson, & Lask, 2004), insomnia (Ree & Harvey, 2004), and 
chronic pain (Tang et al., 2007), there are relatively few experimental investigations of 
the impact of safety behavior use in disorders outside anxiety-related conditions (for an 
example, see Hadjistravropoulos, Hadjistravropoulos, & Quine, 2000). Although 
correlational studies are an excellent start, further experimental investigations are 
required for stronger causal inferences.  
 Finally, the present study was somewhat limited in terms of the number of final 
studies included in the analyses, particularly for the SB- studies. The relatively low 
sample size was in large part due to our rigorous exclusion criteria, which emphasized 
screening out studies with methodological weaknesses. This involved excluding studies 
that altered aspects of exposure therapy procedures in addition to the safety behavior 
manipulation, and studies that used crossover designs to investigate this learning-based 
paradigm. A relative strength in this screening approach, however, is that the data we 
evaluated produce outcomes that are easier to interpret and eliminate extraneous sources 
of error. This might have increased our sensitivity to detect the true effect of the safety 
behavior manipulation.   
CONCLUSIONS  
 Findings from this meta-analysis highlight the clear benefits of removing safety 
behaviors during exposure therapy, relative to a standard exposure therapy procedure. 
Across studies examining the addition of safety behaviors to standard exposure therapy, 
we did not find an overall impact of adding safety behaviors on treatment outcomes. 
However, there was a high degree of variability in the study effect sizes. This highlights 
the importance of investigating the conditions under which adding safety behaviors 
during exposure therapy influences treatment outcomes. Exploratory moderator analyses 
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suggest that adding safety behaviors produces worse outcomes when exposure therapy 
targeted specific phobia symptoms (relative to other conditions), and when the use of 
safety behaviors was not required (relative to when their use was required). Further 
research is needed to address important questions in the area of safety behavior use 
during exposure therapy, specifically testing whether the judicious use of safety 
behaviors, introduced early in treatment and faded over the course of treatment, produce 
superior outcomes relative to exposure therapy alone.  
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STUDY 3 - AUGMENTING EXPOSURE THERAPY WITH PRE-
EXTINCTION FEAR MEMORY REACTIVATION AND DEEPENED 
EXTINCTION 
 Approximately 28.8% of the American population will meet criteria for an 
anxiety disorder at some point in their lifetime (Kessler et al., 2005). Exposure therapy, 
either alone or in the context of cognitive-behavioral therapy, is one of the most effective 
treatment techniques available for anxiety disorders (Butler, Chapman, Forman, & Beck, 
2006; Hofmann & Smits, 2008; Powers, Halpern, Ferenschak, Gillihan, & Foa, 2010; 
Wolitzky-Taylor, Horowitz, Powers, & Telch, 2008). However, some patients do not 
fully respond to treatment, and other patients relapse after successful treatment (e.g., Fava 
et al., 2001; Franklin, Abramowitz, Kozak, Levitt, & Foa, 2000; Foa et al., 2005), so 
there is clearly much room for the improvement of exposure therapy outcomes.  
 Decades of research have focused on the investigation of both pharmacological 
and non-pharmacological strategies to boost the efficacy of exposure therapy. Promising 
non-pharmacological techniques include strategies such as providing physiological 
feedback demonstrating fear reduction (Telch, Valentiner, Ilai, Petruzzi, & Hehmsoth, 
2000), increasing focus on threat-disconfirming evidence (Kamphuis & Telch, 2000; 
Sloan & Telch, 2002), fading safety behaviors (Helbig-Lang & Petermann, 2010), and 
increasing the variety of feared stimuli used during exposure therapy (Rowe & Craske, 
1998). Pharmacological augmentations, such as D-Cycloserine (DCS; B. M. Graham, 
Langton, & Richardson, 2010) and Methylene Blue (Telch et al., 2014), have also shown 
some evidence of boosting the efficacy of exposure therapy. These pharmacological 
interventions were originally developed in non-human animal research, allowing for fine-
tuned testing of their neural mechanisms due to the ability to investigate molecular 
markers of neural change in a variety of brain regions after euthanizing animals. 
  97 
Although DCS and Methylene Blue were translated from the animal literature on fear 
extinction (Bouton, Vurbic, & Woods, 2008; Gonzalez-Lima & Bruchey, 2004), there 
has been surprisingly little research translating non-pharmacological exposure 
augmentation strategies recently developed in the context of animal research. This study 
will test the use of two of these behavioral strategies: pre-extinction fear memory 
reactivation and deepened extinction.  
PRE-EXTINCTION FEAR MEMORY REACTIVATION (PE-FMR) 
 The traditional procedure for exposure therapy involves repeated or prolonged 
extinction trials. Extinction training (as it is called in animal models) or exposure therapy 
(as it is called in treatment models) involves the repeated or prolonged presentation of a 
fear-provoking stimulus in the absence of the feared consequence, persisting until the fear 
response subsides. However, researchers have found that, even when fear subsides after 
exposure therapy, the fear response can re-emerge under a number of conditions. For 
example, fear is more likely to re-emerge when the feared stimulus is encountered in an 
environment dissimilar to the one used during extinction training (Bouton, 1993; 2000; 
2002). Researchers posit that extinction therefore creates a context specific memory that 
inhibits fear when activated, but leaves the original fear memory trace intact. In other 
words, exposure therapy produces a second inhibitory memory that competes with the 
original fear memory for expression. When the inhibitory memory is not activated (e.g., 
in environments dissimilar to extinction training), the maladaptive fear response returns 
(Bouton, 1993; 2000; 2002).  
 Alternatively, some researchers have suggested that, rather than creating a 
secondary competing/inhibitory memory, it might be possible to eliminate return of fear 
by directly “updating” the initial fear memory (Clem & Huganir, 2010; Monfils, 
Cowansage, Klann, & LeDoux, 2009; Nader, Schafe, & Le Doux, 2000; Schiller et al., 
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2010; Xue et al., 2012). Consolidation theory asserts that new memories do not 
immediately consolidate (or solidify), and instead are susceptible to updating for a critical 
window of time prior to consolidation (Dudai, 1996). Analogously, recent research 
suggests that a consolidated fear memory can re-enter a labile state (i.e., “re-
consolidation”) when the memory is activated via a brief encounter with the feared 
stimulus. Specifically, data from rodent models demonstrate that fear memories that have 
been re-activated by a single, brief encounter with the feared stimulus are then 
susceptible to disruption and/or updating during the 6-hour window after reactivation 
(Monfils et al., 2009; Nader et al., 2000). According to the proposed reconsolidation 
update mechanism (Monfils et al., 2009), exposure therapy conducted within the 
reconsolidation window would produce more persistent fear attenuation. In other words, 
the new information about the safety of the feared stimulus acquired during exposure 
therapy is assimilated into the fear memory when it reconsolidates, directly “updating” 
the original fear memory trace.  
 In a series of basic conditioning experiments in rodents, Monfils and colleagues 
(2009) were the first to demonstrate that the addition of a reactivation trial before 
extinction protects against return of fear. The benefits of pre-extinction memory 
reactivation (PE-MR) have been replicated in animal models of fear extinction (Baker, 
McNally, & Richardson, 2013; Clem & Huganir, 2010; Flavell, Barber, & Lee, 2011; 
Shumake & Monfils, 2015), drug addiction (Ma, Zhang, & Yu, 2011; Millan, Milligan-
Saville, & McNally, 2013; Xue et al., 2012), and appetitive responding (Flavell et al., 
2011; Kredlow, Unger, & Otto, 2016). However, other experiments in animal models 
have failed to replicate the benefits of PE-MR (Chan, Leung, Westbrook, & McNally, 
2010; Costanzi, Cannas, Saraulli, Rossi-Arnaud, & Cestari, 2011; Ishii et al., 2012; Ma et 
al., 2011; Millan et al., 2013). Researchers have suggested that procedural variations may 
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explain discrepant findings, such as the type of calculation used to measure return of fear 
(Chan et al., 2010), and the duration of the time lapse between conditioning and 
extinction (Costanzi et al., 2011; Kredlow et al., 2016) or reactivation and extinction 
(Kredlow et al., 2016; Ma et al., 2011). 
 In translating these animal models to humans, several studies have found that the 
addition of PE-MR to exposure therapy enhances the durability of memory updating 
(Chan & LaPaglia, 2013; Schiller et al., 2010; Xue et al., 2012). Moreover, these findings 
have generalized to a wide range of paradigms, including extinction of fear conditioned 
in the laboratory (Oyarzún et al., 2012; Schiller et al., 2010), extinction of response to 
drug cues in heroin addicts (Xue et al., 2012), and even updating of declarative memory 
(Chan & LaPaglia, 2013), with results lasting through 6-month (Xue et al., 2012) and 1-
year follow-ups (Schiller et al., 2010). Imaging studies have demonstrated that pre-
extinction fear memory reactivation (PE-FMR) decreases dependency on the prefrontal 
cortex (PFC) during fear extinction recall, supporting the engagement of a neural 
mechanism that is independent from PFC-dependent inhibitory learning (Schiller, Kanen, 
LeDoux, Monfils, & Phelps, 2013). Although some experiments in human populations 
have failed to replicate the benefits of PE-FMR (Golkar, Bellander, Olsson, & Öhman, 
2012; Kindt & Soeter, 2013; Drexler et al., 2014), meta-analysis suggests that overall, 
PE-FMR produces small to moderate effects for enhancing persistent attenuation of fear 
in human models (Kredlow et al., 2016). Importantly, however, previous research has 
primarily focused on the extinction of fear conditioned in the laboratory, as opposed to 
naturally acquired fears, such as the fears of patients with pathological anxiety.  
 A recent pilot study (N = 32) provided preliminary evidence of the effectiveness 
of PE-FMR in a population with naturally acquired (i.e., not laboratory-conditioned) fear 
of snakes or spiders (Telch, York, Lancaster, & Monfils, 2017). Results revealed that 
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relative to standard exposure procedures, the addition of a PE-FMR trial produced lower 
fear responding during a behavioral approach test in a new situation (a generalization 
test) at one-month follow-up (Telch, York & Monfils, 2010; Telch et al., 2017), . 
Participants in the PE-FMR group also experienced faster fear decline based on lower 
expected and peak fear ratings in the initial exposure therapy trials (Telch et al., 2017). In 
contrast, a second pilot study (N = 32) in a spider phobic sample found exposure therapy 
with and without PE-FMR to be equally efficacious (Shiban, Brütting, Pauli, & 
Mühlberger, 2015). Contrasting findings may be due to differences between the two 
treatment protocols. For example, Telch et al. (2017) tested the benefits of a one-session, 
in vivo exposure therapy protocol with and without an in vivo PE-FMR. In contrast, 
Shiban et al. (2015) used a two-session treatment protocol, randomizing participants to 
receive one session of virtual reality with and without a virtual reality PE-FMR, followed 
by one session of in vivo exposure (with the second, in vivo session being the same 
across both treatment groups and neither receiving PR-FMR prior to this session).  
 Telch and colleagues’ (2017) findings were particularly unique in that they were 
the first to find that PE-FMR increases the speed of fear reduction during treatment. The 
increased efficiency of fear reduction might mimic the effects of some pharmacological 
enhancers, since they seem to trigger overlapping neural mechanisms of learning. For 
example, when D-Cycloserine, an NMDA (N-methyl-D-aspartate) receptor agonist, is 
used in conjunction with exposure therapy, it facilitates neuroplasticity and produces 
more rapid fear reduction across therapy sessions (Graham et al., 2010). The NMDA-
agonizing effects of DCS also enhance consolidation of “successful” learning 
experiences, in that the facilitating effects of DCS are dependent upon successful within-
session fear reduction (e.g., Smits et al., 2013). Prior research similarly suggests that 
NMDA receptor agonists also play a critical role in the reconsolidation of memory 
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(Milton, Lee, Butler, Gardner, & Everitt, 2008; Tronson & Taylor, 2007). A brief 
reactivation trial may therefore produce effects similar to D-Cycloserine, facilitating the 
speed of fear reduction and boosting consolidation of successful learning experiences.  
 Although findings from individual studies have been mixed, the data overall 
suggests that PE-FMR is a promising strategy for improving exposure therapy outcomes 
(Kredlow et al., 2016). However, outside of two pilot studies (each N = 32; Telch et al., 
2017; Shiban et al., 2015), prior research focused on the extinction of laboratory-
conditioned, rather than naturally acquired, fear. Additional research is needed to test the 
use of PE-FMR to improve exposure therapy outcomes in larger samples of participants 
with naturally acquired fear. Furthermore, preliminary findings suggest that PE-FMR 
may also increase the speed of fear reduction during treatment (Telch et al., 2017). 
However, it is unclear whether treatment could then be terminated earlier, while still 
retaining the benefits of PE-FMR.  
DEEPENED EXTINCTION  
 Rescorla (2006) found promising effects for a second behavioral strategy called 
deepened extinction, a two-step procedure for enhancing fear reduction. In the deepened 
extinction procedure, two or more feared stimuli are first presented in isolation, until the 
fear response to each stimulus is extinguished individually (elemental extinction). 
Afterwards, the stimuli are presented simultaneously (compound extinction). The 
compound presentation causes a resurgence of the fear response, which is then re-
extinguished (Reberg, 1972; Rescorla, 2006). According to Rescorla and Wagner’s 
(1972) elemental model of associative learning, extinguishing two feared stimuli 
simultaneously produces a summation of the fear associations of the stimuli, resulting in 
a greater prediction error signal than if either stimulus were extinguished in isolation. 
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This increased error signal is hypothesized to be the operative mechanism governing the 
enhancement of fear attenuation brought about by the deepened extinction procedure. 
 In contrast to the idea that greater prediction error would lead to greater extinction 
learning, prior studies in animals and humans have found that presentation of aversive 
stimuli in compound can block fear extinction associated with the individual stimuli 
(Pineño, Zilski, & Schachtman, 2007; Vervliet, Vansteenwegen, Hermans, & Eelen, 
2007). However, in these studies, the feared stimuli were not presented independently 
prior to compound extinction, which Rescorla (2006) suggests may be a critical element 
of the deepened extinction procedure. Specifically, he suggests that when two excitatory 
stimuli are presented in compound, they compete for associative learning. He describes 
that an overshadowing effect can occur when the stimuli differ in their salience, in that 
the more “salient” (or more feared) stimulus will take on more of the associative learning, 
preventing associative learning for the relatively less salient stimulus. He suggests the 
deepened extinction procedure will protect against overshadowing by ensuring that each 
stimulus is equally “salient” by the process of extinguishing their fear responses 
elementally prior to compound extinction.  
 Other researchers (Culver, Vervliet, & Craske, 2015) suggest that presentation of 
the stimuli individually before in compound promotes elemental processing and 
summation of the stimulus’ excitatory properties. This ensures that the stimuli are not 
processed together during compound extinction as one whole and distinct stimulus 
configuration (see Pearce, 1987 for a competing model predicting configural processing). 
If the two stimuli presented together are processed as one whole configuration rather than 
as two elements together, this would prevent the desired fear-summation and deepened 
extinction effects. Thus, researchers suggest that prior learning in an elemental fashion 
might promote elemental processing of stimuli during compound extinction (Culver et 
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al., 2015; Vervliet et al., 2007). Overall, theoretical rationale and prior research are 
consistent with the idea that extinguishing both stimuli elementally before compound 
presentation is critical for promoting deepened fear extinction. In practical terms, 
conducting elemental prior to compound extinction is also consistent with the graduated 
fear extinction procedures most commonly used in evidenced-based treatments for 
anxiety disorders (e.g., Barlow & Craske, 2006; Foa, Hembree, & Rothbaum, 2007).  
 Several studies have demonstrated the efficacy of the deepened extinction 
procedure. In an experiment involving extinction of conditioned fear in rodents, Rescorla 
(2006) was the first to demonstrate that following elemental with compound extinction 
led to less return of fear than elemental extinction alone. This pattern of findings has been 
extended to the extinction of appetitive conditioning in rodents (Janak & Corbit, 2010; 
Rescorla, 2006), cocaine addiction in rodents (Kearns, Tunstall, & Weiss, 2012), and 
Pavlovian sign tracking in pigeons (Rescorla, 2006). Relatively recently, it was replicated 
in a fear conditioning and extinction paradigm in humans (Culver et al., 2015). 
Surprisingly, these promising findings have yet to be empirically tested as a method of 
boosting the efficacy of treatment for anxiety disorders.  
PURPOSE 
 The primary aim of this study is to investigate the singular and combined effects 
of PE-FMR and deepened extinction for enhancing outcomes of exposure therapy in a 
large sample (N = 130) of participants with pathological fear of snakes or spiders. The 
primary prediction is that PE-FMR and deepened extinction will each independently 
enhance fear reduction relative to control groups without these augmentations, and that 
their combined use will produce the most potent fear reduction. Secondly, we predict that 
PE-FMR will produce more rapid fear reduction during exposure therapy, replicating the 
effects observed in a smaller pilot study (Telch et al., 2017). To build on this prior 
  104 
research, we will test whether the benefits of PE-FMR are retained, even when treatment 
is ended earlier among participants who reach a threshold of low fear responding earlier 
in treatment.  
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Methods 
PARTICIPANTS  
 Participants (ages 18-65) displaying a marked fear of spiders or snakes were 
recruited from the community and from college psychology courses. Marked fear was 
operationalized on the pre-screening assessment as (a) scoring 70 or higher on an online 
version of the Fear of Snakes/Spiders Questionnaire (Szymanski & O'Donohue, 1995), 
and (b) answering “no” on a yes/no question, “Would you be able to touch a spider/snake 
with your bare hands?” After meeting pre-screening criteria, participants then completed 
an in-person screening visit during which they were assessed for exclusion criteria, which 
included: (a) insufficient fear level, defined as ability to place hand flat on the bottom of 
a tank containing the feared animal, or ability to touch the feared animal with a bare 
fingertip in the context of behavioral approach tests; (b) concurrent treatment for fear of 
snakes or spiders, or (c) change in medication status during the previous month. (See 
Table 9 for demographic characteristics of participants.) 
  106 
Table 9:  Demographics of participants screened and treatment completers.  
 Participants Screened  
N = 280 
Treatment Completers 
N = 130 
Age    
 M = 19 SD = 1.59 M = 19 SD = 2.04 
 Range 18-34 Range 18-34 
Target Fear Stimulus     
   Spider  N = 144 51.43% N = 87 66.92% 
   Snake N = 136 48.57%  N = 43 33.08% 
Gender      
   Male N = 62 22.14% N = 26 20.00%  
   Female N = 218 77.86% N = 104 80.00%  
Ethnicity     
   Non-Hispanic N = 202 72.14% N = 88 67.69%  
   Hispanic  N = 78 27.86% N = 42 32.31% 
Race     
   Caucasian/White N = 185 66.07% N = 87 66.92% 
   American Indian/Alaska 
Native 
N = 6 2.14% N = 5 3.85% 
   Asian N = 68 24.29% N = 29 22.31% 
   African American/black N = 21 7.50% N = 9 6.92% 
STUDY DESIGN  
 The first study visit served as the prescreening assessment of study exclusion 
criteria, and also served as a formal pretreatment assessment. During this visit, 
participants completed a battery of self-report rating scales and two different behavioral 
approach tests (see measures). Eligible participants were then stratified based on their 
target fear (snake or spider) and baseline severity of peak, self-reported fear during the 
generalization BAT5, and randomized to one of four exposure conditions: (a) exposure 
therapy as usual, (b) exposure therapy with PE-FMR, (c) exposure therapy with deepened 
extinction (DE), and (d) exposure therapy with both PE-FMR and DE (see Figure 7). All 
                                                
5 The first 18 participants who qualified for study participation were stratified as above or below a cutoff of 
a peak fear rating of 75 or higher out of 100 on the generalization BAT. Most participants in this group fell 
into the higher fear category. Therefore, after this point, participants were stratified as above or below a 
cutoff of a peak fear rating of 83 (the median peak fear rating for the first 18 participants who qualified for 
study participation).  
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exposure treatment was completed in one session approximately one week after baseline 
assessment (M = 6 days, 10.28 hours; SD = 3 days, 0.58 hours). Two behavioral approach 
tests (in the treatment context and in a generalization context) were completed at 
baseline, immediately after treatment (post-treatment), and at follow-up approximately 
one week after treatment (M = 8 days, 7.47 hours; SD = 2 days, 3.82 hours). 
Questionnaire measures of phobia severity were completed at baseline and one-week 
follow-up. The Institutional Review Board at the University of Texas at Austin approved 
all study procedures.  
Figure 7:   Participant flow diagram.  
 
Note. PE-FMR = Pre-extinction (25 minutes prior) fear memory reactivation. DE = 
Deepened extinction.  
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STUDY PROCEDURES 
 Figure 8 provides a visual timeline for the therapeutic procedures implemented in 
each treatment arm. 
Figure 8:  Therapeutic procedures for each treatment arm.  
Note. A = Exposure to spider/snake 1. B = Exposure to spider/snake 2. AB = Exposure to 
spiders/snakes 1 and 2 simultaneously. *Average duration between baseline visit and 
treatment visit. PE-FMR = Pre-extinction fear memory reactivation.  
TREATMENT PROCEDURES 
Procedures Common to All Exposure Conditions 
 Exposure therapy included three phases (see Figure 8). All participants completed 
the same procedure for phases 1 and 2. Phase one consisted of exposure to one spider or 
snake (stimulus A) alone, and phase two consisted of exposure to a second spider or 
snake (stimulus B) alone. Participants were randomly assigned one of two potential 
snakes or spiders as stimulus A, and were assigned the remaining spider or snake as 
stimulus B. Spiders included a Chilean rose tarantula (Grammostola rosea) and an 
Arizona blonde tarantula (Aphonopelma chalcodes). Snakes included a common corn 
snake (Elaphe guttata) and a Mexican milk snake (Lampropeltis triangulum annulata).  
Treatment 
Assignment  
Time Lapse 
Between 
Reactivation and 
Exposure  
Exposure Phase 1 
Duration =  
To Individualized 
Criterion 
Exposure: Phase 2 
Duration =  
To Individualized 
Criterion 
Exposure: Phase 3 
Duration =  
12 Minutes 
 
Exposure Only  6 days* A B A 
Exposure  
+ PE-FMR 25 minutes A B A 
Exposure  
+ DE 6 days* A B AB 
Exposure  
+ PE-FMR + DE 25 minutes A B AB 
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During each treatment phase, participants worked through eight progressively 
challenging approach steps: (1) standing five feet away from an open tank with the feared 
animal inside, (2) standing three feet away from the tank, (3) standing directly in front of 
the tank (heels one foot away from the tank), (4) placing one hand even with the top of 
the tank, (5) lowering one hand to one-third of the tank’s depth (total of 12 inches in 
depth), (6) lowering one hand to two-thirds of the tank’s depth, (7) touching the bottom 
of the tank with the fingertips of one hand, and (8) placing the palm of one hand flat on 
the bottom of the tank. Participants were permitted to move from one step to the next as 
soon as they felt able to do so throughout treatment. Additionally, they were specifically 
instructed by experimenters to move to the next step when their self-reported fear reached 
25 or below on a 100-point scale.  
 Phases 1 and 2 of exposure therapy terminated when an individualized criterion 
was met, when either (a) the participant demonstrated sufficient habituation by reporting 
a fear level of 25 or below (mild fear) on the final approach step, or (b) the participant 
reached a time maximum of 40 minutes. (The time limit was selected to ensure that the 
full treatment could be implemented within one visit.) These first two phases were 
terminated based on individualized criteria rather than a set duration. We selected 
individualized criteria because researchers have posited that it is critical to extinguish the 
fear response to both stimuli individually before beginning compound extinction 
(Rescorla, 2006). Furthermore, assuming that PE-FMR produces more rapid fear 
reduction, we would then be able to determine whether the benefits of PE-FMR would be 
retained even when treatment was ended earlier.  
Pre-Extinction Fear Memory Reactivation (PE-FMR) 
 The fear memory reactivation procedure consisted of two, 10-second phases. 
During phase 1, participants called to mind the sensory details of a real or imagined 
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encounter with the feared animal while looking at the actual animal contained in an open, 
clear tank on the table. During phase 2, the participant attempted to touch the bottom of 
the tank containing the animal. For the reactivation procedure, we used the first animal 
confronted during treatment (stimulus A; see Figure 8). This two-part procedure was 
selected to ensure the full activation of the fear memory, including activating a fear 
response and engaging the most potent episodic memory available.  
 Participants assigned to the two PE-FMR augmentation conditions (groups 2 and 
4) completed the reactivation procedure at the beginning of their second/treatment visit to 
the lab. After reactivation, they completed a 25-minute distraction break before exposure 
therapy, during which they watched a re-run of a television show, an episode of Seinfeld 
titled “The Chinese Restaurant.” The use of distraction helped to ensure that participants’ 
thoughts were shifted from the feared animal, providing the requisite period of 
disengagement from the feared stimulus after retrieval (Monfils et al., 2009). We selected 
a 25-minute duration of disengagement because the reconsolidation update mechanism is 
active between 10 minutes and 1 hour after retrieval, but is no longer active at 6 hours 
after retrieval (Monfils et al., 2009).   
PE-FMR Control 
 Participants without the PE-FMR augmentation (Groups 1 and 3) completed the 
reactivation procedure at the end of their baseline assessment (one to fourteen days 
before the treatment visit; minimum = 19 hours, maximum = 14 days, 1 hour; M = 6 
days, 10.28 hours, SD = 3 days, 0.58 hours). The time lapse of at least one day between 
retrieval and treatment ensured that exposure therapy occurred well outside the 6-hour 
window of time in which the reconsolidation-update mechanism is presumably activated 
(Monfils et al., 2009). To provide further experimental control, these participants also 
watched the Seinfeld episode just before treatment.   
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Deepened Extinction 
 Groups 3 and 4 received deepened extinction during phase 3 of exposure therapy 
(see Figure 8). The procedure for deepened extinction was identical to the procedure used 
during phases 1 and 2 of treatment with one stimulus, except two tanks were used, one 
containing stimulus A used during phase 1 of treatment, and the other containing stimulus 
B used during phase 2 of treatment. The tanks were placed side by side on the table. 
Participants proceeded through the same approach steps used during phases 1 and 2. The 
only difference in procedure was that for steps 4 through 8, the participants lowered each 
of their hands into one of the two tanks. Phase 3 was terminated after 12 minutes.  
Deepened Extinction Control 
 Groups 1 and 2 did not receive deepened extinction. To ensure equivalent 
duration of exposure treatment, participants in Groups 3 and 4 completed 12 extra 
minutes of exposure to the feared animal used during phase 1 of treatment (Stimulus A). 
ASSESSMENTS  
 Assessments included two behavioral approach tests and five self-report 
questionnaires used in previous studies for the assessment of spider or snake fear. 
Behavioral approach tests were completed at the baseline/screening visit, at the end of 
exposure treatment (visit 2), and at 1-week follow-up. Questionnaires were completed at 
baseline and one-week follow-up.  
Treatment Process Measures 
 At the end of each minute during treatment, subjective fear level was assessed on 
a 100-point scale, with the anchors of 0, no fear at all, to 100, the highest fear level 
imaginable. Behavioral approach also was recorded on an 8-point Guttman scale 
representing the treatment step the participant was on when they reported their fear level.  
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Behavioral Approach Test, Treatment Context (BAT-T) 
 BAT-T provided a test of phobic responding in the exposure treatment context. 
During BAT-T, participants approached stimulus A (the first animal confronted during 
treatment) by working through the same eight progressively difficult approach steps used 
during treatment: (1) standing five feet away from an open tank with the feared animal 
inside, (2) standing three feet away from the tank, (3) standing directly in front of the 
tank, (4) placing one hand even with the top of the tank, (5) lowering one hand to one-
third of the tank’s depth, (6) lowering one hand to two-thirds of the tank’s depth, (7) 
touching the bottom of the tank with the fingertips of one hand, and (8) placing the palm 
of one hand flat on the bottom of the tank. Participants were instructed to progress 
through as many of the eight steps as possible within 15 seconds. Phobic response during 
BAT-T was assessed in two domains: (1) subjective report, as measured by participant 
ratings of anticipated and peak fear and disgust on a scale ranging from 0, none at all, to 
100, the highest level imaginable, and (2) behavioral approach scored using a 8-point 
Guttman scale corresponding to the number of steps completed (1 – 8). 
Behavioral Approach Test, Generalization Context (BAT-G) 
 This test provided an assessment of phobic responding in a non-treatment context, 
thus providing an index for assessing treatment generalization. During BAT-G, 
participants were asked to perform up to four behavioral approach steps for five seconds 
each using different animals than those used during treatment – a Mexican golden red 
rump tarantula (Brachypelma albiceps) for spider phobic participants and a coral corn 
snake (Pantherophis guttatus) for snake phobic participants. The tasks included: (1) 
touching the animal (held by an experimenter) with a Q-tip and a gloved hand, (2) 
touching the animal (held by an experimenter) with one finger of a gloved hand, (3) 
touching the animal (held by an experimenter) with one finger of a bare hand, and (4) 
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holding the animal with bare hands. The task was discontinued if a participant 
discontinued one of the four steps before the full five-second duration was completed. 
BAT-G was scored using a 5-point Guttman Scale corresponding to the number of BAT-
G items successfully completed (0 to 4), and subjective phobic response was assessed in 
the same manner as in BAT-T.  
Questionnaires 
 Participants received questionnaires tailored toward their target fear (either snakes 
or spiders). Since the questionnaires selected were originally developed to assess either 
snake phobia or spider phobia (but not both), we created an adapted version of each 
questionnaire so that the same questionnaire could be used to assess both groups. 
Minimal adaptations were made to the questionnaires to keep them as similar as possible 
for the snake and spider phobic participants. For example, if a questionnaire was 
originally designed to assess snake phobia, the word snake was replaced with spider 
throughout the questionnaire. (Adapted scales are available upon request.)   
Fear of Spiders/Snakes Questionnaire (FSQ) 
 The FSQ is a self-report questionnaire originally developed to assess fear of 
spiders. We created a second version of this questionnaire to assess fear of snakes as 
well. For this questionnaire, participants endorse their level of agreement with each of 18 
spider or snake-phobic thoughts on a Likert scale from 0, strongly disagree, to 6, strongly 
agree. The FSQ has good internal consistency, test-retest reliability, and convergent 
validity (Szymanski & O'Donohue, 1995). It can successfully discriminate between 
phobics and nonphobics and detect change over time as a function of treatment response 
(Szymanski & O'Donohue, 1995). Factor analysis suggests that it assesses for two 
distinct dimensions of specific phobia, including a dimension related to avoidance/help 
seeking and a dimension related to fear of harm (Szymanski & O'Donohue, 1995).  The 
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FSQ had good internal consistency in present study sample (N = 130 treatment 
completers; α = .82).  
Spider/Snake Beliefs Questionnaire (SBQ) 
 The SBQ is a self-report questionnaire originally developed to assess fear of 
spiders (Arntz, Lavy, & Van den Berg, 1993). We created a second version of the 
questionnaire to assess fear of snakes. The scale includes 78 statements regarding phobic 
responses to encounters with a spider or snake. Participants rate each statement on a scale 
from, 0, I do not believe it at all, to 100, I absolutely believe it. Psychometric evaluation 
revealed good internal consistency and adequate test-retest reliability (Arntz et al., 1993). 
The SBQ discriminates between phobic and nonphobic individuals and has good 
convergent validity with other phobia assessments (Arntz et al., 1993). The SBQ had 
excellent internal consistency in the present study sample (α = .97). 
Agoraphobic Cognitions Questionnaire for Snake/Spider Phobia (ACQ-S) 
 The ACQ-S is a 17-item assessment adapted by Radomsky and colleagues (1996) 
from the Agoraphobic Cognitions Questionnaire (ACQ; Chambless, Caputo, Bright, & 
Gallagher, 1984) to assess for cognitions related to snake phobia. We created a second 
version of the scale to assess for spider phobia. This scale includes 12 items from the 
ACQ that measure physical concerns and cognitions about loss of self-control and in a 
feared situation, and five additional items that specifically address cognitions about the 
feared animal. This scale has excellent internal consistency (Milosevic & Radomsky, 
2008), and the scale upon which it is based (the ACQ) has adequate psychometric 
properties (Chambless et al., 1984). The ACQ-S had excellent internal consistency in the 
present study sample (α = .87). 
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Self-Efficacy Questionnaire for Spider and Snake Phobia. (SEQ) 
 The SEQ is two-part, self-report questionnaire in which participants rate their 
confidence (on a scale from 0 percent to 100 percent confident) that they could (a) 
perform the eight approach steps used during treatment (SEQ- Behavioral), and (b) cope 
with feelings and consequences of the anxiety produced by approaching the feared animal 
(SEQ-Anxiety). The SEQ–Behavioral and SEQ–Anxiety were constructed for the 
purpose of this study, but based on Bandura’s recommendations for constructing self-
efficacy scales (Bandura, 2006), and on a self-efficacy questionnaire designed and 
psychometrically validated for assessing claustrophobia coping self-efficacy (Valentiner, 
Telch, Ilai, & Hehmsoth, 1993). Both the SEQ–Behavioral and SEQ–Anxiety had 
excellent internal consistency in the present study sample (α = .92 for each of the two 
scales).  
Armfield & Mattiske Disgust Questionnaire (AMDQ) 
 The AMDQ includes 8 self-report questions in which participants rate their 
disgust response from 0, strongly disagree, to 6, strongly agree. It was originally 
developed to assess response to potentially disgust-eliciting features and situations 
involving a spider, but we created a second version to assess disgust response to snakes 
as well. The original version of the AMDQ has demonstrated adequate internal 
consistency in prior research (Armfield & Mattiske, 1996). The AMDQ also had 
acceptable internal consistency in the present study sample (α = .78). 
DATA ANALYSIS PLAN  
Preliminary Analyses  
 Prior to outcome analyses, we evaluated differences between participants who 
refused treatment and participants who completed treatment. Categorical data (e.g., 
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demographic categories) were evaluated with chi-squared tests of independence, 
continuous data (e.g., sum scores on questionnaires at baseline) were evaluated using 
independent samples t-tests, and ordinal data (e.g., highest step achieved on the BAT-T 
and BAT-G at baseline) were assessed using proportional ordered logistic regression.  
 Proportional ordered logistic regression was used as opposed to other ordinal tests 
(e.g., Spearman’s correlation) because it can account for a high number of ties in the data. 
(The restricted range of the Guttman scales on the BAT-T and BAT-G ensure that several 
participants will tie for equivalent rankings if rank-ordered from least to greatest.) To test 
for pre-treatment equivalence on all outcome measures, treatment completers were 
evaluated for pre-treatment differences across the four treatment groups using ANOVAs 
for continuous data and using proportional ordered logistic regression for ordinal data.  
Outcome Analyses  
 Proportional ordered logistic regression was used to test for the impact of PE-
FMR (present or not), deepened extinction (present or not), and their interaction on the 
level of improvement in behavioral approach on BAT-T and BAT-G at post-treatment 
and follow-up. Level of improvement in behavioral approach was calculated by 
subtracting the highest step achieved at baseline from the highest step achieved at post-
treatment and follow-up BATs. For continuous outcomes, 2x2 ANCOVAs were used to 
test for the impact of PE-FMR (present or not), deepened extinction (present or not), and 
their interaction on assessments at post-treatment and follow-up, controlling for baseline 
level.  
Treatment Efficiency 
 The prediction that PE-FMR boosts the speed of fear reduction during treatment 
was tested by determining whether the participants with PE-FMR augmentation reached 
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the habituation criteria to terminate phases 1 and 2 of treatment faster than the 
participants without PE-FMR augmentation (phase 3 was not included in this analysis, 
since it was a standard length of 12 minutes for all participants). Treatment was 
terminated during phases 1 and 2 when participants reached a mild fear level (25 out of 
100 or below) while on the most difficult step in the exposure therapy treatment hierarchy 
(placing one’s hand flat on the bottom of an open tank containing the feared animal). 
When treatment was not terminated within the 40-minute maximum time limit for each 
phase, the participant was censored from the analyses. We used a Cox proportional 
hazards model to assess the likelihood of reaching the fear reduction criteria for treatment 
with and without PE-FMR augmentation for phases 1 and 2 of treatment. Deepened 
extinction augmentation will not be accounted for in this analysis since the deepened 
extinction manipulation occurs during phase 3 of treatment (see Figure 8). Furthermore, 
the total treatment duration was summed across all three treatment phases (see Figure 8) 
and an independent samples t-test was conducted to assess for differences in overall 
treatment duration for participants with and without retrieval.  
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Results 
PRELIMINARY ANALYSES 
Treatment Refusal 
 Participants were defined as refusing treatment if they completed visit 1 of the 
study (the screening/baseline visit) but failed to complete treatment. Frequency of 
treatment refusal per treatment group is included in Figure 7. Of the 164 participants 
randomized to a treatment condition, 34 participants (20.7%) refused treatment. Analyses 
suggest that treatment refusal was un-related to treatment condition (χ2(3) = 2.58, p =  
.46). Participants who refused treatment were slightly younger (M = 18.81; SD = .90) 
than those who completed treatment (M = 19.45; SD = 2.04; t(123.42) = -2.66, p = .009, 
equal variances not assumed). There were also no differences among those who refused 
versus completed treatment on fear target (i.e., snake vs. spider), gender, ethnicity, or 
race distribution (all p’s > .12 on chi-squared tests).  
 Independent sample t-tests did not identify differences between participants that 
refused and completed treatment on questionnaire outcomes, or on fear and disgust 
ratings (anticipated or peak) during either treatment context or generalization context 
BATs (all p’s ≥ .10). Proportional ordinal logistic regression indicated that participants 
who completed treatment demonstrated less behavioral avoidance on the generalization 
BAT at baseline (42 participants did not complete step 1; 44 completed step 1; 44 
completed step 2) relative to those who refused treatment (17 did not complete step 1; 11 
completed step 1; 6 completed step 2; proportional odds ratio = 2.18, p = .03). There 
were no statistically significant differences on behavioral performance during the 
treatment context BAT at baseline (proportional odds ratio = 1.69, p = .14).  
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Missing Data  
 A few data were missing due to experimental error during the administration of 
BATs (8 data points total across all three study visits; 0.1% of the treatment completer 
data set). Additionally, five participants were unable to return for one-week follow-up 
assessment (1.4% of the treatment completer data set; see Figure 7). Given the low 
prevalence of missing data and potential biases associated with missing data imputation, 
we used a pairwise deletion approach, analyzing all available data for each statistical test 
performed (Graham, 2009; Schlomer, Bauman, & Card, 2010).  
Baseline Differences 
 One-way ANOVAs comparing baseline measures across the four treatment 
groups revealed no significant differences on questionnaire and subjective BAT ratings 
(anticipated fear and disgust, and peak fear and disgust) on BATs prior to treatment (all 
p’s ≥ .12). Furthermore, proportional ordered logistic regression identified no differences 
on the highest step achieved on the treatment context or generalization context BAT’s (all 
p’s  ≥ .33).   
OUTCOME ANALYSES  
 Means and standard deviations for outcome measures are reported in Table 10. To 
assess improvement in behavioral approach at post-treatment and follow-up, we first 
calculated the number of additional steps the participant achieved at each of these time 
points beyond their baseline performance (i.e., number of steps at baseline subtracted 
from number of steps at post, and number of steps at follow-up). Proportional ordered 
logistic regression models found no impact of PE-FMR, deepened extinction, or their 
interaction on behavioral approach during BATs in the treatment or generalization 
context at post-treatment or follow-up; see Table 11).   
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 Furthermore, two-by-two ANCOVAs (controlling for ratings at baseline) found 
no impact of PE-FMR, deepened extinction, or their interaction on ratings of anticipated 
and peak, fear and disgust during the treatment context BAT or the generalization context 
BAT (see Table 12). Similarly, 2 x 2 ANCOVAs revealed no effects for questionnaire 
outcomes at follow-up (see Table 12).  
Table 10:  Descriptive statistics for outcome measures at baseline, post-treatment, and 
one-week follow-up. 
  Pre Post FU 
 Condition Mean SD Mean SD Mean SD 
BAT-T AF Exp  78.182 14.301 35.546 24.440 32.710 21.987 
 Exp + PE-FMR 75.933 13.419 31.323 25.963 30.807 25.784 
 Exp + DE 81.333 15.847 39.300 23.640 35.321 24.608 
 Exp + PE-FMR + DE 79.472 15.376 33.806 25.719 29.257 24.398 
BAT-T AD Exp  67.879 25.478 37.515 30.141 27.000 22.017 
 Exp + PE-FMR 66.500 21.817 30.548 27.057 25.387 24.587 
 Exp + DE 68.433 28.521 30.833 29.680 28.286 28.721 
 Exp + PE-FMR + DE 77.750 21.220 36.333 27.687 31.714 27.129 
BAT-T Step Exp    3.515   1.679   6.848   1.839   7.129   1.258 
 Exp + PE-FMR   3.839   1.655   6.968   1.722   7.000   1.673 
 Exp + DE   3.400   1.589   6.967   1.586   6.857   1.860 
 Exp + PE-FMR + DE   3.833   1.521   6.917   1.842   7.486   1.067 
BAT-T PF Exp  70.485 17.368 17.606 17.394 17.419 16.665 
 Exp + PE-FMR 64.968 18.846 16.097 21.958 17.581 22.000 
 Exp + DE 71.900 20.622 22.533 20.3177 21.036 20.644 
 Exp + PE-FMR + DE 65.528 20.696 18.361 20.442 16.886 18.545 
BAT-T PD Exp  64.788 26.499 17.818 21.096 18.355 20.621 
 Exp + PE-FMR 61.226 25.117 13.774 21.244 15.258 20.146 
 Exp + DE 60.033 30.788 17.667 23.525 19.000 26.273 
 Exp + PE-FMR + DE 66.278 24.354 18.861 23.351 21.457 25.295 
BAT-G AF Exp  86.485  13.231 53.515 25.676 33.903 24.800 
 Exp + PE-FMR 84.807 11.726 47.419 25.137 37.903 29.106 
 Exp + DE 86.133 16.792 53.400 23.642 37.679 24.956 
 Exp + PE-FMR + DE 83.750 16.902 44.500 24.694 30.886 25.279 
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Table 10, cont. 
 
  Pre  Post  FU   
 Condition Mean SD Mean SD Mean SD 
BAT-G AD Exp  74.485  24.700 49.515 26.822 29.387 25.082 
 Exp + PE-FMR 73.323 25.869 39.097 29.348 33.258 31.176 
 Exp + DE 71.533 28.385 40.533 31.101 30.964 30.357 
 Exp + PE-FMR + DE 78.861 21.266 42.000 27.578 32.771 26.949 
BAT-G Step Exp    0.970   0.728   2.364   1.168   2.968   1.110 
 Exp + PE-FMR   1.065   0.772   2.581   1.148   2.867   1.279 
 Exp + DE   0.933   0.828   2.567   1.223   3.000   1.109 
 Exp + PE-FMR + DE   1.083   0.937   2.667   1.014   3.000   1.111 
BAT-G PF Exp  78.727 17.145 36.606 23.255 22.807 23.263 
 Exp + PE-FMR 75.903 19.352 37.226 27.518 26.667 27.815 
 Exp + DE 78.133 20.918 40.000 24.772 25.963 25.958 
 Exp + PE-FMR + DE 74.583 20.465 31.056 22.714 24.600 25.678 
BAT-G PD Exp  66.333 25.915 35.000 24.368 21.516 20.008 
 Exp + PE-FMR 64.903 28.633 32.194 32.713 22.667 26.357 
 Exp + DE 65.267 29.611 32.067 32.077 23.259 31.527 
 Exp + PE-FMR + DE 72.806 25.075 33.389 27.114 28.171 29.806 
FSQ  Exp  88.394   9.572 --- --- 48.807 27.998 
 Exp + PE-FMR 86.839 10.441 --- --- 48.000 24.126 
 Exp + DE 89.933 10.570 --- --- 47.786 25.959 
 Exp + PE-FMR + DE 86.167 12.235 --- --- 46.000 24.546 
SBQ  Exp  57.685 17.076 --- --- 26.871 22.395 
 Exp + PE-FMR 50.869 16.309 --- --- 21.550 19.730 
 Exp + DE 54.374 17.909 --- --- 24.820 18.485 
 Exp + PE-FMR + DE 52.473 14.723 --- --- 19.967 16.323 
AMDQ  Exp  40.091   6.069 --- --- 29.226 10.459 
 Exp + PE-FMR 36.452   6.752 --- --- 27.161 10.574 
 Exp + DE 36.500   7.969 --- --- 25.071   9.576 
 Exp + PE-FMR + DE 38.722   7.792 --- --- 28.200 10.630 
SEQ –  Exp  40.015 21.730 --- --- 89.101 13.435 
Behavioral Exp + PE-FMR 44.323 20.392 --- --- 89.629 19.112 
 Exp + DE 37.008 21.224 --- --- 86.460 20.483 
 Exp + PE-FMR + DE 44.201 24.645 --- --- 89.364 17.457 
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Table 10, cont. 
 
  Pre  Post  FU   
 Condition Mean SD Mean SD Mean SD 
SEQ –  Exp  42.685 26.272 --- --- 82.845 19.219 
Anxiety Exp + PE-FMR 52.981 22.994 --- --- 85.265 20.376 
 Exp + DE 49.047 29.361 --- --- 85.271 16.516 
 Exp + PE-FMR + DE 50.417 27.267 --- --- 86.491 17.546 
ACQ-S Exp  27.212 11.776 --- ---   7.807 10.173 
 Exp + PE-FMR 26.903 10.672 --- ---   8.968   9.318 
 Exp + DE 28.133 10.890 --- ---   9.750   9.842 
 Exp + PE-FMR + DE 26.278 10.759 --- ---   7.886   8.369 
Note. BAT-T = behavioral approach test, treatment context. BAT-G = behavioral 
approach test, generalization context. AF = anticipated fear, rated before the BAT. AD = 
anticipated disgust, rated before the BAT. Step = highest step completed in the BAT.  PF 
= peak fear, rated directly after the BAT. PD = peak disgust, rated directly after the BAT. 
FSQ = Fear of Snakes/Spiders Questionnaire, sum score. SBQ = Spider/Snake Belief 
Questionnaire, average rating. AMDQ = Armfield and Mattiske Disgust Questionnaire, 
sum score. SEQ – Behavioral = Self-Efficacy Questionnaire for Behavioral Approach, 
average rating. SEQ – Anxiety, Self Efficacy Questionnaire for Anxiety Management, 
average rating. ACQ-S = Agoraphobic Cognitions Questionnaire adapted for 
Snake/Spider Phobia, sum score. Exp = Exposure therapy. Exp + PE-FMR = Reactivation 
trial 25 minutes prior to beginning exposure therapy. Exp + DE = Exposure therapy with 
deepened extinction. Exp + PE-FMR + DE = Reactivation trial 25 minutes prior to 
beginning exposure therapy with deepened extinction. Pre = baseline assessment. Post = 
assessment immediately post-treatment. FU = one week follow-up assessment.  
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Table 11:   Results for ordinal outcomes. Between-group differences in the highest step 
achieved during the BAT in the treatment and generalization contexts. 
 
Note. BAT-T = behavioral approach test, treatment context. BAT-G = behavioral 
approach test, generalization context. DE = deepened extinction. PE-FMR = reactivation 
25 minutes prior to exposure therapy. DE x PE-FMR = interaction of deepened extinction 
and retrieval 25 minutes prior to exposure therapy. Baseline = pre-treatment assessment. 
Baseline to Post Change = number of BAT steps increased from baseline to post 
treatment. Baseline to Follow Up change = number of steps increased from baseline to 
follow up. PE-FMR dummy coding (0 = no reactivation 25 minutes before treatment; 1 = 
reactivation 25 minutes before treatment); Deepened extinction dummy coding (0 = no 
deepened extinction; 1 = deepened extinction).  
 Effect Proportional 
Ordered 
Odds Ratio 
t-value p-value  
BAT-T     
        Baseline to Post Change  PE-FMR 0.814 -0.461 .645 
 DE 1.280  0.550 .583 
 PE-FMR x DE  0.805 -0.350 .727 
        Baseline to FU Change PE-FMR 0.724 -0.710 .478 
 DE 0.921 -0.179 .858 
 PE-FMR x DE  1.657  0.798 .425 
BAT-G     
        Baseline to Post Change PE-FMR 1.271  0.536 .592 
 DE 1.445  0.807 .419 
 PE-FMR x DE  0.698 -0.564 .572 
        Baseline to FU Change PE-FMR 0.747 -0.647 .518 
 DE 0.984 -0.035 .972 
 PE-FMR x DE  1.112  0.164 .870 
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Table 12:  Results for continuous outcomes. Two by two ANCOVAs testing the impact 
of treatment with and without deepened extinction, with and without 
reactivation 25 minutes before treatment, and their interaction, on 
assessment at post-treatment and one-week follow-up. 
Assessment Effect Post-Treatment Follow-Up 
     F    p Eta2      F    p Eta2 
Eta2 BAT-T: Anticipated Fear  DE 0.163 0.687 0.001 0.083 0.774 0.001 
 PE-FMR 0.409 0.523  0.003 0.069 0.794   0.001 
 DE x PE-FMR 0.009  0.926 <.001 0.205 0.652 0.002 
BAT-T: Anticipated Disgust DE 1.081  0.300  0.007 0.051 0.822 <.001 
 PE-FMR 1.393 0.240 0.009 0.104 0.748 0.001 
 DE x PE-FMR 0.961 0.329   0.006 0.026 0.873 <.001 
BAT-T: Peak Fear  DE 0.859 0.356 0.006 0.642 0.425 0.005 
 PE-FMR <.001 0.986 <.001 0.172 0.679 0.001 
 DE x PE-FMR 0.127 0.722 0.001 0.489 0.486 0.004 
BAT-T: Peak Disgust  DE 0.072  0.789 <.001 0.251 0.617 0.002 
 PE-FMR 0.310 0.579   0.002 0.121 0.728    0.001 
 DE x PE-FMR 0.078 0.781  0.001 0.046 0.832 <.001 
BAT-G: Anticipated Fear DE <.001 0.989 <.001 0.466 0.496 0.004 
 PE-FMR 0.769   0.382   0.005 0.614 0.435 0.005 
 DE x PE-FMR 0.085 0.771    0.001 1.487 0.225  0.012 
BAT-G: Anticipated Disgust DE 1.359 0.246   0.008 0.288 0.593 0.002 
 PE-FMR 2.520 0.115   0.014 0.461 0.499 0.003 
 DE x PE-FMR 0.613   0.435   0.003 0.531 0.468  0.004 
BAT-G: Peak Fear  DE 0.383 0.537 0.003 0.313 0.577 0.002 
 PE-FMR 0.093 0.762  0.001 0.700 0.405 0.005 
 DE x PE-FMR 1.279 0.260 0.009 0.335 0.564  0.003 
BAT-G: Peak Disgust  DE 0.139 0.710  0.001 0.197 0.658 0.001 
 PE-FMR 0.104    0.748 0.001 0.093 0.761  0.001 
 DE x PE-FMR 0.012 0.912 <.001 0.023 0.880  <.001 
FSQ  DE --- --- --- 0.066 0.797 0.001 
 PE-FMR --- --- --- <0.00
1 
0.986 <.001 
 DE x PE-FMR --- --- --- 0.001 0.973 <.001 
SBQ  DE --- --- --- 0.048 0.828 <.001 
 PE-FMR --- --- --- 0.024 0.878   <.001 
 DE x PE-FMR --- --- --- 0.289 0.592 0.002 
SEQ – Behavioral  DE --- --- --- 0.153 0.697 <.001 
 PE-FMR --- --- --- 0.027 0.869 <.001 
 DE x PE-FMR --- --- --- 0.055 0.815 <.001 
 
  125 
Table 12, cont. 
 
Assessment Effect Post-Treatment 
Follow-up 
Assessment 
Follow-Up 
     F    p Eta2      F    p Eta2   
SEQ –Anxiety DE --- --- --- 0.023 0.880 <.001 
 PE-FMR --- --- --- 0.001
7 
0.967  <.001 
 DE x PE-FMR --- --- --- 0.031
7 
0.859    <.001 
AMDQ  DE --- --- --- 0.299
2 
0.585  0.002 
 PE-FMR --- --- --- 0.091
0 
0.764   0.001 
 DE x PE-FMR --- --- --- .056
6   
0.812  <.001 
ACQ-S DE --- --- --- 0.720
4 
0.398 0.004 
 PE-FMR --- --- --- 0.409
9 
0.523 0.002 
 DE x PE-FMR --- --- --- 0.691
7 
0.407 0.004 
 
Note. BAT-T = behavioral approach test, treatment context. BAT-G = behavioral 
approach test, generalization context. BAT-T = behavioral approach test, treatment 
context. BAT-G = behavioral approach test, generalization context. AF = anticipated fear, 
rated before the BAT. AD = anticipated disgust, rated before the BAT. Step = highest 
step completed in the BAT.  PF = peak fear, rated directly after the BAT. PD = peak 
disgust, rated directly after the BAT. FSQ = Fear of Snakes/Spiders Questionnaire, sum 
score. SBQ = Spider/Snake Belief Questionnaire, average rating. AMDQ = Armfield and 
Mattiske Disgust Questionnaire, sum score. SEQ – Behavioral = Self-Efficacy 
Questionnaire for Behavioral Approach, average rating. SEQ – Anxiety, Self Efficacy 
Questionnaire for Anxiety Management, average rating. ACQ-S = Agoraphobic 
Cognitions Questionnaire adapted for Snake/Spider Phobia, sum score. DE = deepened 
extinction. PE-FMR = reactivation 25 minutes prior to exposure therapy. DE x PE-FMR 
= interaction of deepened extinction and retrieval 25 minutes prior to exposure therapy.   
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TREATMENT EFFICIENCY 
 Participants were coded as censored if they did not reach the fear reduction 
criteria during the 40-minute maximum duration of phase 1 and phase 2 of treatment. 
During phase 1, 17 participants (13.08%) did not reach the fear reduction criteria (n = 11 
and n = 6 in exposure without and with PE-FMR, respectively); and during phase 2, 13 
participants  (10%) did not reach the fear reduction criteria (n = 6 and n = 7 in exposure 
without and with PE-FMR, respectively).  
 A cox proportional hazards analysis revealed that participants completing 
exposure augmented with PE-FMR reached the fear reduction criterion more rapidly 
during phase 1 of treatment (B = .56, p = .003; Cox proportional hazard ratio = 1.75), but 
not during phase 2 of treatment (B = .22, p = .23; Cox proportional hazard ratio = 1.25). 
These findings suggest that at any time-point during phase 1 of treatment (exposure to the 
first snake or spider the participant encountered), participants with PE-FMR 
augmentation were nearly twice as likely to reach fear reduction criteria than those 
without PE-FMR augmentation.  
 Including all participants (adding in those censored in the survival analysis) and 
all three phases of exposure therapy, PE-FMR augmentation resulted in a 21.16% 
reduction in total treatment duration on average (treatment duration with PE-FMR, M = 
34.99 minutes, SD = 20.94; treatment duration without PE-FMR, M = 44.38 minutes, SD 
= 22.25; t(128) = 2.48 , p  = .01; see Figure 9).  
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Figure 9:  Average duration (in minutes) of phases 1 and 2 of treatment and total 
duration of treatment (including the 12 additional minutes from phase 3).  
 
Note. PE-FMR = Pre-extinction fear memory reactivation.   
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Discussion 
 The primary aim of the present study was to test the independent and combined 
efficacy of PE-FMR and deepened extinction for improving exposure therapy outcomes 
in a large sample of participants with naturally acquired fear. The primary hypotheses 
that PE-FMR and deepened extinction would enhance exposure therapy, alone and in 
combination, were not supported by the data. Neither PE-FMR nor deepened extinction 
influenced overall outcomes on behavioral approach tests or questionnaires at post-
treatment or one-week follow-up. However, analyses confirmed the secondary 
hypothesis, demonstrating that PE-FMR augmentation produced more rapid fear 
reduction during treatment. Specifically, those in the PE-FMR group reached the criteria 
for fear reduction (and termination of the treatment phase) more rapidly during phase 1 of 
exposure therapy (exposure to the first snake/spider encountered during treatment). 
Furthermore, because exposure therapy duration was individually tailored based on speed 
of fear reduction, those with the PE-FMR augmentation received a lower dose of 
exposure therapy. Even with 21% less time in exposure therapy on average, those with 
the PE-FMR augmentation had equivalent overall outcomes at post-treatment and follow-
up.   
 These findings corroborate prior data (Telch et al., 2017) in demonstrating that 
PE-FMR boosts the speed of fear extinction. The present data provide an excellent 
complement to prior research, strengthening confidence in this finding, in part because of 
the use of different types of control groups across studies. The control group in Telch et 
al. (2017) completed the reactivation procedure directly after the last exposure therapy 
trial. This had the benefit of producing equivalent duration of exposure to the feared 
animal across groups, while ensuring that only the PE-FMR augmentation group (which 
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received reactivation 30 minutes before treatment) completed exposure therapy within the 
6-hour reconsolidation update window. However, the use of this procedure in the control 
group had the drawback of limiting the strength of the interpretation of the finding that 
PE-FMR produced more rapid reduction of fear. Since the PE-FMR group received 
reactivation prior to treatment, and the control group completed this procedure directly 
after treatment, the control group had less overall time with the feared stimulus prior to 
beginning treatment. One could therefore argue that the PE-FMR augmentation group in 
this study may have displayed lower fear during the first third of treatment only because 
this group had more exposure to the feared stimulus (in the form of the 10 second 
reactivation trial) prior to beginning treatment (giving this group a head start for 
treatment). In the present study, however, the control group completed the reactivation 
procedure at the end of their baseline visit. This ensured equivalent duration of time with 
the feared animal prior to initiating exposure therapy, strengthening confidence in the 
conclusion that PE-FMR produces more rapid fear reduction during exposure therapy. 
Furthermore, we extended this finding in the present study by demonstrating that 
treatment can be terminated earlier when more rapid fear reduction occurs in the PE-
FMR group, with equivalent results being maintained at post-treatment and one-week 
follow-up assessment.  
 In regard to the null findings for the primary study hypotheses, several aspects of 
the present study increase the probability that null effects represent a true absence of 
between-group differences rather than a type II error. First, the large sample sizes in the 
present study (between 28 and 35 participants in each of the four treatment groups at 
follow-up; and 59+ participants per group when analyzing the main effects of PE-FMR or 
deepened extinction) increase the statistical power to identify between group differences 
as compared with prior studies (15 to 17 per group in Telch at al., 2017 and Shiban et al., 
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2015), which reduces the likelihood that null effects were related to sampling error or 
underpowered analyses.6 Furthermore, descriptive statistics demonstrate sufficient 
variance at all time points on continuous outcome measures, suggesting that null findings 
were not due to restricted variance in assessments or due to ceiling effects (see Table 10). 
Similarly, after treatment completion, only about two-thirds of the sample reached the 
maximum step on BAT-T (62.31% at post and 64.00% at follow-up), and less than half 
of the sample completed the maximum step on BAT-G (21.54% at post and 41.46% at 
follow-up obtaining the most challenging step) suggesting that a lack of differences on 
behavioral outcomes was also unrelated to a ceiling effect. Together, the statistical power 
to detect between-group differences due to the relatively high sample size, combined with 
the absence of ceiling effects for all except one outcome measure, increase confidence 
that null findings reflect a true absence of between-group differences in the present study.  
 The finding that PE-RFM did not boost exposure therapy outcomes corroborates 
results from Shiban et al. (2015), although the present study included a larger sample size 
and used an in vivo PE-FMR, rather than a virtual reality PE-FMR. The findings contrast 
with results of Telch and colleagues (2017) who found that PE- FMR produced lower 
fear responding in a generalization test at one-month follow-up. It is possible findings 
differed from Telch and colleagues due to procedural differences between the studies. For 
example, relative to the design of Telch et al. (2017), the BAT-generalization procedures 
in the present study provided more changes from the treatment context. Comparing the 
treatment procedure to the generalization test, Telch and colleagues changed the animal 
used (using animals of distinctly different colorations) and changed the set-up of the 
                                                
6 We conducted an a-priori power analysis for the two-tailed (α = .05), 2x2 ANCOVAs used in 
the primary outcome analyses, and found that we would have 78% likelihood of detecting main 
effects (and a 61% likelihood of detecting an interaction) of a medium effect size (f  = .25) with a 
total sample size of N =120.  
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room (changing the color and fabric of the floor mat). However, during the generalization 
test, participants performed the same task completed during treatment (i.e., standing 
barefoot within 1-foot of the feared animal). In contrast, in the generalization test in the 
present study, the animal was changed, the set up of the room was changed (participants 
approached an animal held by a researcher rather than approaching an animal in an open 
tank), and the tasks participants performed were also changed (see Methods section for 
details). Due to the change in the hierarchy of behavioral tasks in addition to the change 
in animal and change in room set-up, the present study may have provided a more 
stringent test of treatment generalization.  
 Telch et al. (2017) and the present study also differ in the time periods used for 
follow-up assessment, which may have contributed to the discrepant findings. Telch et al. 
used a one-month follow-up whereas the present study used a one-week follow-up. It is 
possible that differences between participants with and without PE-FMR may have 
emerged in the present study if a follow-up assessment had been conducted at a later time 
point. However, questionnaire assessment at six-month follow-up (although probably less 
sensitive than behavioral tests) did not identify differences in participants with and 
without PE-FMR in a prior study (Shiban et al., 2015). Furthermore, the use of self-report 
ratings throughout treatment during the present study may have served as a distraction 
during treatment, creating a cognitive load that may have interfered with treatment (e.g., 
Telch et al., 2004) and perhaps obscuring the long-term benefits of PE-FMR identified by 
Telch and colleagues (2017). On the other hand, some research suggests that discussion 
related to exposure therapy, such as labeling of emotions, does not interfere with 
treatment outcomes and produces better outcomes than distraction during treatment 
(Kircanski, Lieberman, & Craske, 2012). 
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 Differences in dosage of exposure therapy may offer another explanation for the 
differing effects of PE-FMR across studies. Both the present study and Shiban et al. 
(2015) provided a larger treatment dose (over an hour total treatment time on average in 
Shiban et al., and up to 92 minutes with length tailored to fear reduction in the present 
study), whereas Telch and colleagues provided a standardized, 18-minute exposure 
therapy protocol to all participants. It is possible that the benefits of PE-FMR, in the 
context of an already potent intervention within the specific phobia population (Őst, 
1989), were only evident with a reduced dosage of exposure therapy. Furthermore, if 
treatment length had been equivalent in the present study, it is possible that further 
benefits may have been evident at follow-up in the PE-RFM group. On the other hand, 
the tailored length of treatment provides greater generalizability of findings, as treatment 
is typically terminated in standard practice after the achievement of significant fear 
reduction. Additionally, the increased dosage of treatment in the present study is closer to 
the average reported length of specific phobia treatment when administered in a clinical 
setting (reported as 2.1 hours in prior one-session exposure-based specific phobia 
treatment; Őst, 1989), again promoting generalizability of findings from the present study 
to clinical settings.  
 Furthermore, since the procedures for PE-FMR itself differed between the present 
study and Telch et al. (2017), perhaps the PE-FMR trial in Telch et al. triggered the 
reconsolidation update mechanism whereas the procedure used in the present study did 
not. Findings from rodent models suggest that qualities of the fear memory, such as it’s 
age or the strength of reinforcement history (Alberini & LeDoux, 2013), and qualities of 
the reactivation trial, such as the level of prediction error invoked (Sevenster, Beckers, & 
Kindt, 2013), each influence susceptibility of a particular memory to reconsolidation. 
Thus, the optimum length or parameters of the reactivation trial may differ across 
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individuals and across particular fear memory structures. A promising direction for future 
research would involve identification of biomarkers (e.g., differing patterns of neural 
activity on fMRI) during PE-FMR that indicate the initiation of reconsolidation update 
rather than inhibitory learning, such that the specific procedure and duration of the PE-
FMR can be tailored to the individual patient.  
 There are additionally several possible explanations for the failure of the 
deepened extinction to augment exposure therapy outcomes. First, it may simply suggest 
that findings in animal (Rescorla, 2006) and human (Culvier et al., 2015) fear 
conditioning and extinction paradigms do not extend to the extinction of naturally 
acquired fear. Additionally, whereas Rescorla and Wagner (1972) suggest that presenting 
two feared stimuli simultaneously should produce a summation of fear responding 
(boosting prediction error and thus boosting the potency of learning), it is possible that 
the presentation of both stimuli simultaneously was simply viewed as a new context 
(more in line with the configrual processing theory presented by Pearce, 1987). 
Processing the two feared stimuli as one new context rather than an additive summation 
of elemental stimuli may produce the effect of varying the context of exposure therapy, 
but would not necessarily boost prediction error to deepen extinction (as predicted by 
Rescorla and Wagner, 1972). Although prior research has demonstrated that context 
variation boosts the potency of fear extinction learning (e.g., Mineka, Mystkowski, 
Hladek, & Rodriguez, 1999; Rodriguez, Craske, Mineka, & Hladek, 1999), it is possible 
that presenting two snakes/spiders simultaneously, even if processed as an additional 
context, does not produce meaningful improvement over exposure to two different snakes 
or spiders individually (i.e., two versus three exposure therapy contexts).   
 Furthermore, it is possible that deepened extinction was unsuccessful as an 
augmentation strategy due to limited resources to fully attend to both feared stimuli 
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simultaneously. Although the two animals (spiders or snakes) were in adjacent tanks 
during the deepened extinction procedure, it is possible that participants were visually 
focusing on only one animal at a time. Prior studies in the extinction of laboratory-
conditioned fear, in contrast, have used mixed sensory modalities to reduce the potential 
for completing attentional resources (i.e., use of an auditory stimulus (tone) as one cue 
and a visual stimulus (light) as the second cue; Jones, Ringuet, & Monfils, 2013; 
Rescorla, 2006). Future studies could examine deepened extinction using feared cues in 
separate sensory modalities, for example, combining exposure to an audio recording of a 
trauma narrative alongside trauma-related olfactory cues for PTSD, or exposure to a 
crowded mall after ingestion of caffeine for panic disorder with agoraphobia.  
  When interpreting findings from this study, it is important to note several 
strengths and limitations. Limitations include the use of a population primarily drawn 
from non-treatment seeking undergraduate psychology students. It will be important to 
extend findings, particularly the observation that PE-FMR may facilitate the speed of fear 
reduction, to treatment seeking populations, and to the multi-session exposure therapy 
protocols typically used for other anxiety disorders (e.g., Craske & Barlow, 2007; Foa, 
Hembree, & Rothbaum, 2007; Kozak & Foa, 2004). It is unclear whether repeatedly 
using PE-FMR across multiple treatment visits would produce sustained benefits in terms 
of more rapid within-session fear reduction during each session, and perhaps also 
translate to the need for less treatment visits overall for multi-session treatment protocols. 
Furthermore, the relatively short follow-up period (approximately one-week), and the 
high dose of exposure therapy (up to 92 minutes) relative to prior exposure therapy 
augmentation studies (e.g., 18 minutes in Telch et al., 2017), may have limited our ability 
to detect the influence of the augmentation strategies tested. On the other hand, the higher 
dose of exposure therapy increases generalizability of findings to clinical settings. In 
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contrast, a notable strength of this study was the relatively high statistical power for 
detecting differences between groups due to the large sample size. The high statistical 
power increases confidence that null findings represent a true similar between groups, 
rather than a failure to detect differences due to sampling error.  
 This study suggests several potential avenues for future research. First, it may be 
useful to produce conceptual replications of the null effect of deepened extinction to 
determine whether the null findings in the present study may have been an artifact of the 
specific procedures or population used in this study. These replications will be necessary 
to conclude with more confidence that the augmenting effects of the deepened extinction 
procedure observed in extinction of laboratory-conditioned fear do not extend to 
extinction of naturally acquired fears. Furthermore, it will be critical to test the potential 
utility of PE-FMR for boosting speed of fear reduction within a treatment seeking 
population and across multi-session treatment protocols. This will be critical for 
determining whether the 21% reduction in overall treatment duration observed in the 
present study could translate to shorter treatment visits, and perhaps fewer treatment 
visits, in the context of implementing multi-session exposure therapy protocols within 
treatment-seeking populations.  
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GENERAL DISCUSSION 
 More than one-fourth of the general population will meet criteria for an anxiety-
related disorder at some point in their lifetime (Kessler et al., 2005). These disorders are 
associated with reduced quality of life (Mendlowicz & Stein, 2000), work impairment 
(Greenberg et al., 1999), increased risk for physical disorders and disability (Sareen, Cox, 
Clara, & Asmundson, 2005), increased risk for comborbid psychological disorders (Grant 
et al., 2004; Wittchen et al., 2000), and suicidal ideation and attempts (Sareen et al., 
2005). Anxiety-related disorders share the common element of pathological fear 
responding, which can be defined as fearful responding in a situation in which this 
response is not protective, but instead is either unnecessary or unhelpful to such an extent 
that it causes significant distress or interference with daily life.  
 Decades of research have been geared toward identifying factors that contribute to 
the development and maintenance of the pathological fear associated with anxiety 
disorders, in an effort to facilitate its prevention and treatment (e.g., Butler, Chapman, 
Forman, & Beck, 2006; Hoffman & Mathew, 2008). However, a substantial proportion of 
patients (estimates ranging from 15 to 40%; Clark et al., 2006; Foa et al., 1999; Foa, 
Liebowitz et al., 2005; Ladouceur et al., 2000; Telch et al., 1993) do not respond to gold-
standard treatments such as cognitive-behavioral therapies. It is therefore of critical 
importance that researchers seek a better understanding of the factors that govern 
increases and decreases in pathological fear to improve prevention and treatment 
strategies. The studies in this dissertation align with this overarching goal. Study 1 
examined contributors to the development of pathological fear (i.e., PTSD symptoms) 
after exposure to environmental stress. Study 2 examined the role of safety behaviors in 
interfering with the reduction in pathological fear during exposure therapy, a treatment 
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technique commonly employed across gold-standard treatments for anxiety disorders 
(Foa, Hembree, & Rothbaum, 2007; Kozak & Foa, 2004; Heimberg & Becker, 2002). 
Finally, study 3 examined the role of novel behavioral strategies (pre-extinction fear 
memory reactivation and deepened extinction) in facilitating reductions in pathological 
fear during exposure therapy.  
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Overview of Study Findings and Implications 
 Specifically, study 1 tested whether threat perception was associated with 
increases in pathological fear (i.e., PTSD symptoms) above and beyond the level of stress 
exposure, itself. To achieve this aim, soldiers reported on their level of stress exposure, 
appraisal of stress exposure (threat perception), and psychological reactions (PTSD and 
depression symptoms) during deployment to a warzone. Soldiers with above average 
threat perception (+1 SD) experienced increases in PTSD symptoms as a function of 
increases in stress exposure. However, Soldiers with below average threat perception (-1 
SD) experienced no increase in PTSD symptoms as a function of stress exposure. Threat 
perception, but not stress level, was positively correlated with depression symptoms, a 
condition commonly comorbid with PTSD (Campbell, Felker, Liu, & Yano, 2007).  
  Combined with prior longitudinal research, results from study 1 strengthen 
confidence in the causal role of perceived threat in the development of PTSD. Whereas 
prior studies have assessed threat perception by measuring it months, or even years, after 
return from military deployment (e.g., D. W. King et al., 1995; Renshaw, 2011), this 
study assessed threat perception during deployment, which decreases the influence of 
retrospective biases. In addition to reduction in the time lapse, the greater similarity 
between the context in which the stressor was experienced and reported, likely improves 
the accuracy of the report (Grant et al., 1998).  
 Although the design of study 1 limits the strength of causal inference because 
threat exposure and appraisal were measured simultaneously, prospective data suggests 
that threat-related biases, as reflected on more experimentally controlled (although less 
generalizable) laboratory tasks, are associated with later increases in fear reactivity 
(Beevers, Lee, Wells, Ellis, & Telch, 2011; Muris, Huijding, Mayer, & Hameetman, 
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2008). Combining results across studies, data provide a strong case for the causal role of 
threat perception in the development of pathological fear. These findings thus lend 
further weight to cognitive behavioral models of pathological fear, which emphasize the 
causal role of perception in influencing behavioral (e.g., avoidance) and emotional (e.g., 
fear) responses (Beck, Emery, & Greenberg, 2005).  
 Given this knowledge, it is possible that shortly after exposure to a given 
precipitating environmental stressor, there may be a measurable increase in related and 
overgeneralized threat appraisals among those most at risk for the development of PTSD. 
In future studies, it would be useful to obtain enough assessments to provide the 
statistical power necessary to do a cross-lagged model, to ascertain whether an increase in 
threat perception in response to a given environmental stressor prospectively predicts 
subsequent increases in pathological fear (i.e., PTSD symptoms). Furthermore, given the 
stigma associated with self-report of symptoms, particularly among populations such as 
military personnel and first responders, who are often at increased risk for the 
development of psychopathology (e.g. Benedek, Fullerton, & Ursano, 2007; Berninger, 
Webber, & Niles, 2010; Smith et al., 2008), it would be useful to assess increases in 
threat perception by using implicit, rather than self-report, assessments (e.g., assessing 
bias in interpretation of ambiguous sentences; Eysenck, Mogg, May, & Richards, 1991). 
Identifying higher-than-average threat perception tendencies (either as a pre-dispositional 
risk factor, or as an early marker of pathological reactivity to stress exposure) could be 
used as a signal to deploy preventative interventions, such as closer symptom monitoring 
and interventions to correct overgeneralized threat perception. Evidence in experimental 
paradigms suggests that increasing or decreasing threat interpretation bias through brief 
computer-based interventions can respectively increase or decrease avoidance behavior 
(Lester, Field, & Muris, 2011; Menne-Lothmann et al., 2014; Muris, Huijding, Mayer, & 
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Remmerswaal, 2009). Thus, modifying threat interpretation biases in those most at risk 
for developing PTSD could reduce avoidance behavior, one of the primary risk factors 
for the development of PTSD (Dunmore, Clark, & Ehlers, 2001).  
 Whereas study 1 examined factors that contribute to the development of 
pathological fear, study 2 examined a manipulation that may interfere with the reduction 
of pathological fear during treatment. Specifically, study 2 used meta-analytic methods to 
investigate the influence of adding or removing safety behaviors (i.e., unnecessary 
protective actions) on exposure therapy outcomes. Over the last decade, there has been a 
plethora of qualitative syntheses of studies describing the influence safety behavior use 
on exposure therapy (Blakey & Abramowitz, 2016; Goetz, Davine, Siwiec, & Lee, 2016; 
Helbig-Lang & Petermann, 2010; Parrish, Radomsky, & Dugas, 2008; Rachman, 
Radomsky, & Shafran, 2008; Telch & Lancaster, 2012). Whereas some of these reviews 
concluded that safety behavior use during exposure therapy would produce deleterious 
effects and cautioned against their use (Blakey & Abramowitz, 2016; Helbig-Lang & 
Petermann, 2010; Telch & Lancaster, 2012), others suggested that using safety behaviors 
judiciously could improve exposure therapy outcomes (Rachman et al., 2008).  
 The only meta-analysis conducted to date produced inconclusive results regarding 
the impact of safety behaviors on exposure therapy outcomes, and identified moderate to 
high variability among study effect sizes (Meulders, Van Daele, Volders, & Vlaeyen, 
2016). This meta-analysis was marked by a number of methodological weaknesses, such 
as (a) examining only one outcome measure (subjective fear ratings) at one time point 
(the last available time point); (b) inclusion of several studies that employed a within 
subjects, crossover design, which increases the risk for carryover effects of learning-
based interventions such as safety behavior use/fading; (c) inclusion of assessments 
during which groups were not equated for safety behavior use during the evaluation (e.g., 
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one group had instructions to use safety behaviors, and the other did not, when providing 
fear ratings); and (d) use of a somewhat restrictive use literature review, searching for 
studies with an explicit mention of safety behaviors rather than including a broader 
category of search terms conceptually related to safety behaviors (e.g., distraction, 
response induction aids, etc.).  Therefore, study 2 in this dissertation describes a follow-
up meta-analysis, with the primary aim of re-evaluating the overall effects of adding and 
removing safety behaviors during exposure therapy, and with the secondary aim of 
evaluating moderators for any remaining variability in study effects sizes.  
 For the overall effects in study 2, we found that removing safety behaviors 
produced moderately superior outcomes (g = .44), and adding safety behaviors did not 
impact outcomes. However, there was a significant degree of variability in SB+ study 
effect sizes. With further analyses, we identified that the treatment target of exposure 
therapy moderated the impact of adding safety behaviors, such that exposure therapy 
targeting specific phobia produced a small, but statistically significant, reduction in 
treatment response (g = .12).  
 These findings suggest that clinicians should seek to remove safety behaviors 
over the course of exposure therapy to achieve better outcomes, and suggest that the 
addition of safety behaviors detracts from the efficacy of exposure therapy for specific 
phobia symptoms. However, with the exception of two studies, the procedures in all SB+ 
studies involved maintaining safety behaviors throughout exposure therapy, as opposed 
to introducing and then fading them over the course of treatment. This procedure, of 
maintaining safety behaviors throughout treatment, contrasts markedly with the 
recommendations provided by Rachman and colleagues (2008) for the judicious use of 
safety behaviors. Specifically, they recommend that safety behaviors “should be used in a 
limited manner and only for a limited period, especially in the early stages of treatment... 
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[and] once the patient is thus engaged, the pace of the treatment can be raised, and the 
safety behavior and safety gear can be (gradually) dispensed with,” and later in treatment 
“if an obstacle is encountered…the tactical use of safety behavior can remove the barrier 
and then be tapered off” (p. 171). In line with the original recommendations of Bandura, 
Jeffery, and Wright (1974) in the context of guided mastery treatment, safety behaviors 
are recommended as strategies to induce approach behavior, with the caveat that they 
should then be removed during treatment. Since the vast majority of SB+ studies did not 
use this procedure (and instead maintained safety behaviors throughout treatment) there 
is still very little data on the potential benefits or drawbacks of judicious safety behavior 
use. It is noteworthy that the only two SB+ studies that followed the judicious use 
procedure (introducing, and then fading, SBs) found no between group-differences; 
outcomes were equivalent with and without judicious safety behavior use during 
exposure therapy (Deacon et al., 2010; Antony et al., 2001). However, additional 
replications testing the judicious use of safety behaviors are needed in order to justify the 
development of clinical guidelines.  
 A careful review of the literature furthermore reveals a number of factors that 
should be considered when interpreting findings of studies that have experimentally 
manipulated safety behaviors, especially in the presence of null findings. Our review 
demonstrates that null findings have been more prevalent among SB+ studies as opposed 
to SB- studies. Thus, many SB+ studies have concluded that adding safety behaviors has 
no deleterious impact on exposure therapy outcomes. However, this interpretation must 
be made with a great deal of caution for a number of reasons. Primarily, findings from 
our meta-analysis suggest that non-equivalent testing conditions (i.e., conditions in which 
the groups differed regarding access to safety behaviors during the assessment of fear or 
other outcomes) may be contributing to the overall null findings. Specifically, we found 
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that the equivalence of testing conditions moderated the effect sizes observed in SB+ 
studies, such that when testing conditions were non-equivalent, symptom scores were 
lower in the treatment condition that had access to safety behaviors. These lower 
symptom scores may not necessarily generalize to encounters with the feared situation in 
a real-world environment, when safety behaviors may not be available for use.  
 In addition to non-equivalent testing conditions, the characteristics of most SB+ 
studies in the literature may make it more challenging to detect the influence of adding 
safety behaviors on treatment outcomes. First, the use of non-treatment seeking samples 
with relatively low clinical severity may produce a floor effect for exposure therapy. 
Second, the use of relatively short durations of exposure therapy in several of the studies 
could be insufficient for achieving adequate treatment response, which would make any 
influence of the safety behavior manipulation on treatment response more difficult to 
detect. Third, the majority of studies have evaluated the influence of safety behaviors 
selected by investigators rather than participants. However, safety behaviors are more 
accurately defined by an analysis of the function of a given behavior for an individual 
(Helbig-Lang & Petermann, 2010; Telch & Lancaster, 2012). Allowing participants to 
select their own safety behaviors would likely lead to stronger influences of the behavior 
on treatment outcomes because this would remove the guess work of investigators 
selecting a safety behavior that may or may not match the participant’s core threat. 
Furthermore, allowing participants to select their own safety behaviors would better 
mirror the types of safety behavior adaptations that would be occurring in clinical 
settings. Future studies that account for these methodological concerns would greatly 
contribute to the literature on safety behavior use in exposure therapy.  
 Due to the experimental nature of the manipulations in study 2, combined with the 
finding that removing safety behaviors had a robust and consistent benefit for enhancing 
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treatment outcomes relative to standard exposure therapy, findings lend weight to the 
conclusion that safety behaviors play an important role in maintaining pathological fear. 
This result provides a potential explanation for how some individuals can maintain 
pathological fear, despite repeated confrontations with the feared situation(s) in daily life. 
We would predict that individuals who use safety behaviors (or have them available for 
use) during these encounters would maintain some level of pathological fear over time, 
despite regular encounters with the feared situation. There are several potential 
mechanisms by which safety behaviors maintain fear, for example, blocking threat 
disconfirmation and reducing attentional resources. Further research is needed to 
determine the mechanisms by which safety behavior use may maintain fear during 
exposure therapy (for an example of one such study, see Telch and Plasencia, 2010, as 
cited in Telch & Lancaster, 2012).  
 Whereas study 2 examined the role of safety behaviors in maintaining 
pathological fear during exposure therapy, study 3 examined the use of two novel 
behavioral strategies for boosting pathological fear reduction during exposure therapy: 
pre-extinction fear memory reactivation (PE-FMR) and deepened extinction. Each of 
these strategies has been translated form basic science research in animal models 
(Monfils, Cowansage, Klann, & LeDoux, 2009; Rescorla, 2006) and human models of 
fear conditioning and extinction (Culver, Vervliet, & Craske, 2015; Schiller et al., 2010). 
PE-FMR is hypothesized to improve the efficacy of exposure therapy through the 
reconsolidation update mechanism. Specifically, according to prior research (Monfils et 
al., 2009; Schiller, Kanen, LeDoux, Monfils, & Phelps, 2013), adding PE-FMR to 
exposure therapy should ensure that the new information gained during treatment updates 
the original fear memory, rather than creasing a second, context dependent memory that 
competes with the original memory for expression.  
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 Deepened extinction, on the other hand, is hypothesized to facilitate treatment by 
increasing prediction error (i.e., increasing the discrepancy between anticipated and 
actual occurrences of the feared outcome). Prediction error tends to reduce over the 
course of treatment, potentially leading to asymptotic benefits over the course of 
treatment. However, the deepened extinction procedure, in which fear responding to each 
of two stimuli is extinguished independently and then simultaneously, would be predicted 
to increase prediction error over the course of treatment, potentially facilitating treatment 
outcomes (Leung & Westbrook, 2008). Specifically, the elemental model of associative 
learning (Rescorla & Wagner, 1972) would predict that the associations of the two 
stimuli would combine additively when they are presented simultaneously, producing a 
greater prediction error and greater treatment response.  
 Contrary to prediction, however, in study 3, neither PE-FMR nor deepened 
extinction led to greater reductions in pathological fear responding at post-treatment or 
one-week follow-up. This study represents the first experimental trial testing deepened 
extinction (DE) as a strategy for enhancing exposure therapy. Due to the large sample 
size (e.g., approximately 60 participants with and without DE), it is unlikely that the null 
finding was related to low statistical power to detect effects. (A priori power analyses 
suggest that there was only a 20% likelihood that we would have failed to detect a 
moderate-size effect, using a standard, two-tailed alpha level of .05.) However, further 
conceptual replications of this null finding are indicated, to rule out the possibility that 
null effects are specific to the procedure employed in this study. For example, DE was 
operationalized by the presentation of two feared animals (individually and then 
simultaneously), whereas in prior animal models, DE has involved the presentation of a 
tone and a light that were each associated with a shock (Rescorla, 2006). Since the animal 
models used two different sensory modalities, it is possible that a similar intervention in 
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humans would be more efficacious. Using two separate sensory modalities may increase 
the ease of attending simultaneously to both stimuli, as opposed to the procedures used in 
study 3, which involved the more challenging task of attending to and tracking the 
movement of two visual stimuli simultaneously (i.e., two feared animals in separate 
tanks).  
 Assuming the null findings for deepened extinction hold upon replication, 
findings present theoretical implications for the processing of feared stimuli. Results may 
provide evidence in favor of the configural processing model as opposed to the additive 
processing model of feared stimuli. Specifically, the additive model would suggest that 
threat prediction would increase additively when two feared stimuli are presented 
simultaneously (Rescorla & Wagner, 1972), which in turn would deepen extinction 
learning. However, the configural model would suggest that the two stimuli together 
would simply be processed as a completely new context, relative to the presentation of 
each of the two stimuli independently (Pearce, 1987). Consistent with study findings, the 
configural model would predict no augmentation effect for deepened extinction, when 
fear responses were only tested in the context of presenting a single feared animal (as 
they were in study 3). It may be useful for future studies of deepened extinction to 
incorporate a behavioral test with both animals (i.e., a two-stimulus test). The configural 
processing model would predict superior performance with DE augmentation in a two-
stimulus test, but not a one-stimulus test; whereas the additive model would predict 
superior performance both the behavioral tests (two-stimulus and one-stimulus tests).  
 In regard to the effects of PE-FMR, data across studies (Telch et al., 2017; study 
3) are converging to suggest that PE-FMR produces more rapid fear reduction during 
exposure therapy. Because study 3 provided a conceptual, rather than exact, replication of 
Telch and colleagues, results increased confidence in the robustness of this finding. Study 
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3 furthermore expanded findings from Telch and colleagues by demonstrating that we 
can end treatment early, when fear reduces more rapidly after PE-FMR augmentation, 
while maintaining equivalent outcomes through one week follow up on behavioral and 
questionnaire measures. The methods of study 3 thus strengthened the evidence that PE-
FMR can be used to improve the efficiency of exposure therapy.  
 Furthermore, findings at post-treatment (either directly after, or one day after, 
treatment) were consistent across study 3, Telch and colleagues (2017), and Shiban and 
colleagues (2015), in that no studies to date have found a benefit of PE-FMR at post-
treatment assessment. Although Telch and colleagues (2017) identified a benefit of PE-
FMR augmentation at one-month follow-up (i.e., lower fear reported during a 
generalization test), study 3 found no benefits of PE-FMR augmentation during the 
generalization test at one-week follow-up. Together, these data suggest that the benefits 
of PE-FMR may take longer (at least one month) to emerge.  
 Alternatively, it is also possible that it is also possible that procedures used by 
Telch and colleagues (2017) successfully activated the reconsolidation update 
mechanism, whereas the procedures used in study 3 did not. This would raise questions 
regarding boundary conditions of initiating reconsolidation update as opposed to 
inhibitory learning mechanisms. Between studies, procedural differences in the FMR 
procedure include duration (10 seconds in Telch and colleagues and 20 seconds in study 
3), and how imaginal elements were incorporated (including recall of a real or imagined 
encounter during the first half of FMR in study 3, and during the entire FMR procedure 
in Telch and colleagues). Differences in the exposure therapy protocols might also have 
contributed to discrepant outcomes at follow-up. Differences in the exposure therapy 
procedures between the Telch and colleagues as compared with study 3 include: (a) 
approaching a feared animal on the floor versus approaching a feared animal in a tank; 
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(b) a multi-step (graduated) versus one-step (flooding) exposure procedure; (c) using an 
un-tailored versus tailored length of treatment, and (d) assessing fear levels during versus 
after exposure therapy trials.  
 Furthermore, differences in the content of the activity during the break period 
after FMR and prior to exposure therapy could influence mechanisms of inhibitory 
learning versus reconsolidation update. Participants Telch and colleagues (2017) 
answered unrelated questions from a questionnaire, whereas participants in study 3 
watched a re-run of a comedy television show during this break period. Each of these 
procedures was designed to prevent rumination on the feared stimulus (e.g., spider or 
snake) during the break period. This was done to better equate human models with rodent 
models, to reduce the anticipatory processing that might occur in human studies but not 
rodent studies. However, it is possible that the content of the break period has an 
influence on the activation of inhibitory versus reconsolidation update mechanisms.  
 Additionally, evidence from animal models suggests that the boundary conditions 
of reconsolidation update may differ based on aspects of a particular fear memory, such 
as its strength or age (Alberini & LeDoux, 2013). Therefore, it may be necessary to tailor 
procedures to the individual to target the appropriate conditions for initiating 
reconsolidation update rather than inhibitory learning. This would require a real-time, 
direct measurement of learning mechanisms within the brain, through techniques such as 
fMRI, to enable tailoring of the procedures to biomarkers of reconsolidation as opposed 
to inhibitory learning (e.g., Schiller et al., 2013). This option is financially prohibitive at 
this point in time, but more cost efficient strategies for observing neural mechanisms are 
developing rapidly (e.g., functional near infrared spectroscopy), and it may be more 
feasible in the future.  
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 In addition to raising questions regarding the boundary conditions of 
reconsolidation update, studies suggest that PE-FMR could be operating through 
fundamentally different mechanisms in exposure therapy studies (e.g., study 3; Shiban et 
al., 2015; Telch et al., 2017) than it did in studies with rodents (e.g., Monfils et al., 2009). 
Specifically, animal models have found differences in fear renewal and spontaneous 
recovery of fear after exposure treatment with and without PE-FMR (Baker, McNally, & 
Richardson, 2013; Monfils et al., 2009). In contrast, follow-up tests in the human studies, 
examining the impact of PE-FMR on exposure therapy for specific phobias, provide little 
evidence of an increase in fear from post-treatment to follow-up, but rather show 
continued fear reduction among renewal and spontaneous recovery tests at follow-up 
relative to post-treatment (Study 3; Shiban et al., 2015; Telch et al., 2017). Although this 
hypothesis would require additional exploration, it is possible that exposure therapy in 
human models differs from rodents in that it may already include more of a combination 
of reconsolidation update and inhibitory learning, even without the addition of a 
structured PE-FMR trial. It is likely that people anticipate, and perhaps imagine, exposure 
therapy leading up to the experimental session, thus potentially providing at least one 
form of reactivation (i.e., imaginal) for all participants prior to exposure therapy. This 
hypothesis, if confirmed, may explain the observed return of fear in animal models that is 
less consistently found in exposure treatments for naturally acquired pathological fear in 
humans.   
 Furthermore, two human studies have shown evidence of more rapid fear 
reduction during treatment among those with PE-FMR (Telch et al., 2017; Study 3) 
whereas rodent studies do not (Baker et al., 2013; Monfils et al., 2009). This raises the 
question of whether the potential benefits of PE-FMR for enhancing exposure therapy are 
related to alterative mechanisms, in addition to reconsolidation update. Reconsolidation 
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update theory would predict greater resilience against return of fear, but would offer no 
ready explanation for more rapid fear reduction.  
 Evidence in animal models suggests that PE-FMR activates glutamate receptors in 
the amygdala (Monfils et al., 2009), similar to pharmacological enhancers such as D-
cycloserine (DCS; Hofmann, Smits, Asnaani, Gutner, & Otto, 2011), which also boost 
the speed of fear reduction during treatment (Norberg, Krystal, & Tolin, 2008). However, 
PE-FMR offers a non-pharmacological alternative to boosting the speed of fear reduction, 
which provides several benefits. First, using behavioral as opposed to pharmacological 
augmentation reduces logistical barriers for therapists in the community implementing 
the intervention (i.e., no need to collaborate with psychiatrists). Additionally, using 
pharmacological enhancers may introduce the possibility that participants could attribute 
improvements to the drug (Powers, Smits, Whitley, Bystritsky, & Telch, 2008), which 
may negatively impact self-efficacy and generalization of treatment.    
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Integration of Findings 
 Studies included in this program of research produced several key findings related 
to factors that influence the onset and reduction of pathological fear. Study 1 
demonstrated the role of heightened threat perception in facilitating the onset of 
pathological fear (i.e., PTSD symptoms) during exposure to environmental stress; study 2 
highlighted the role of safety behaviors in blocking the reduction of pathological fear 
during exposure therapy; and study 3 demonstrated the role of PE-FMR in facilitating the 
speed of pathological fear reduction during exposure therapy.  
 Findings from study 1 highlight individual variability in cognitive appraisal of 
events, and emphasize the importance of this appraisal in determining psychological 
reactions to environmental stress. Broadly, the importance of cognitive appraisal in study 
1 raises the question as to whether the influence of the behavioral manipulations 
examined in studies 2 and 3 may be influenced by individual differences in threat 
perception. For example, based on their hypothesized mechanisms, the impact of the 
removing safety behaviors and deepening extinction should both depend on the ability of 
the specific stimuli selected for the manipulation to increase the perception of threat. 
Increasing (false) threat perception during exposure therapy should increase prediction 
error and boost learning. Recent research even suggests that the impact of PE-FMR may 
also be dependent on the level of prediction error (difference between perceived threat 
and actual events) invoked during the retrieval trial (Sevenster, Beckers, & Kindt, 2013). 
It will then be important for exposure therapy augmentation research related to each of 
these three behavioral manipulations (deepened extinction, PE-FMR, and safety 
behaviors) to account for individual differences in the perceptions of these behavioral 
manipulations. Although it might increase variability in procedures, we may be able to 
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strengthen the findings of behavioral augmentation research in exposure therapy by 
tailoring the procedure based on an individualized functional analysis of behavioral 
manipulations. This will help ensure that we maximize threat perception (and thus 
prediction error) for the individual patient, and thereby optimize the behavioral 
manipulations to improve exposure therapy outcomes. Indeed, the strongest treatment 
augmentation effect from the program of research in this dissertation (i.e., the beneficial 
effect of fading participant-identified, idiosyncratic safety behaviors) was driven by a 
series of studies that tailored the behavioral manipulation to the individual. Although this 
increased tailoring of behavioral manipulations runs the risk of increasing variability due 
to differences in procedures, it will come with the benefit of increasing the potency of 
experimental manipulations. This individualized functional analysis and tailoring of 
behavioral manipulations has the potential to produce more potent methods of enhancing 
exposure therapy in future studies.  
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Conclusions and Future Directions 
 Findings from the studies in this dissertation suggest several key areas for future 
research. Results from study 1 suggest the possibility of using threat perception as a 
marker of populations at increased risk for the development of PTSD symptoms, 
particularly among individuals exposed to high levels of environmental stress. Correcting 
overgeneralized threat perception, possibly through cost-efficient, computer-based 
strategies (e.g., Lester, Field, & Muris, 2011; Muris, Huijding, Mayer, & Remmerswaal, 
2009) is one potential target area for future work in the prevention of anxiety disorders. 
Furthermore, meta-analytic findings from study 2 provide strong evidence in favor of 
removing safety behaviors over the course of exposure therapy, and given their 
deleterious effects under certain circumstances (e.g., in phobia treatment), provide data to 
suggest that clinicians should be cautious when introducing safety behaviors during 
treatment. More research is needed to determine the relative benefits and drawbacks 
regarding the use of judicious safety behaviors, given that a systematic review of the 
literature reveals very few experimental studies in this area. Findings from study 3 did 
not demonstrate greater reductions in pathological fear as a result of adding PE-FMR or 
deepened extinction to exposure therapy, either alone or in combination. However, results 
suggest that PE-FMR increases the speed of fear reduction during treatment. If findings 
extend from single session to multi-session exposure therapy protocols, PE-FMR may be 
a useful strategy for facilitating the speed of fear reduction. Increasing the speed of fear 
reduction could reduce dropout prior to treatment response by (a) reducing the number of 
sessions needed for treatment response, and (b) increasing treatment buy-in by facilitating 
successful experiences earlier in the course of therapy. Findings from each of the studies 
in this program of research highlight critical areas for future work, to continue to push the 
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envelope on the development of strategies to prevent and treat pathological fear across 
anxiety-related disorders.  
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